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900558-CA

The Division of Securities and
Utah Department of Commerce,
State of Utah,
Respondent.

This matter is before the court upon appellant's Motion for
Reconsideration of June 18, 1991

Order and Supporting Memorandum,

filed 24 June 1991.
Now therefore, IT IS HEREBY ORDERED that Exhibits NN and RR
in the addendum of appellant's reply brief are stricken, subject to
petitioners' prevailing on a renewed motion for the panel to take
judicial notice of such exhibits.
h i s / p ^ d a y of J u l y 1991,
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I hereby certify that on the 10th day of July, 1991, a true and
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Earl S. Maeser, Director
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160 East 300 South, 2nd Floor
Salt Lake City, Utah 84145-0802
R. Paul Van Dam
State Attorney General
David N. Sonnenreich
Assistant Attorney General
Fair Business Enforcement Unit
115 State Capitol
Salt Lake City, UT 84114
Dated this 10th day of July, 1991.
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S T A T E O F I JTAH,
Case

900558 rA

Respondents

STATE 01-

)
) ss.
SALT LAKF COUN'I .' )
] cl m Mi cI ;i3cJ C o o m b s , on h i s c )ath, d e p o s e s and says as
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1991:
1
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- t' Lant is Petitioners1 counsel in the
..*- is 1 .i.cenwM I In pi ,irt i ee law in the

State of Utah and he has personal knowledge of that set forth
herein.
2.

Each of the exhibits attached to Petitioners' Reply

Brief are true and correct copies of what they purport to be.
Accordingly, as contemplated in this Court's Order of January 22,
1991,

the Court may take judicial notice of such exhibits for

purposes of this appeal.
3.

In the event the Court questions the authenticity of

exhibits relating to the NASD arbitration between Johnson-Bowles
and OTRA Clearing, it is welcome to confirm the authenticity
thereof with Ms. Virginia Hall, c/o Arbitration Department, NASD,
Inc.,
94104.

425 California Street, Room 1400, San Francisco, California
The arbitration was denominated as Otra Clearing, Inc.

v. Johnson-Bowles and Marlen V. Johnson, NASD Case No. 757.
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Johnson-Bowles Company, Inc., and Marlen V. Johnson v.
The Division of Securities and the Utah Department of
Commerce, State of Utah, Case No, 900558-CA
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The undersigned hereby certifies that on the Jf%0 day of
May, 1991, (s)he hand-delivered a true and correct copy of
the foregoing AFFIDAVIT to:
DAVID N. SONNENREICH, ESQ.
ASSISTANT ATTORNEY GENERAL
FAIR BUSINESS ENFORCEMENT UNIT
115 STATE CAPITOL
CAPITOL
SALT LAKE CITY, U
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This Reply Brief is submitted on behalf of Petitioners
Johnson-Bowles Co., Inc., and Marlen V. Johnson.

For

convenience, Respondents are together referred to herein as the
"Division."

Along with their principal brief, Petitioners filed

an Addendum comprising Exs. A through KK.

For continuity, all

exhibits attached hereto continue as Exs. LL through UU.1
RESPONDENTS AND THEIR COUNSEL HAVE RECKLESSLY AND
REPEATEDLY MISSTATED THE RECORD AND FACTS IN THEIR OPPOSING
BRIEF.
The Division's opposing brief is riddled with
misstatements of the evidence and record.

For instance, while it

is undisputed that Petitioners did not directly violate the
Division's March 1989, Orders prohibiting offers or sales and,
while Petitioners were never even charged with such, the Division
repeatedly deceives the Court by stating that they did.2
Not content with these deceptions, the Division further
asserts that not only did Petitioners "knowingly violate" its
orders, they "helped others to violate" such orders.

Division

1

Certain exhibits attached hereto relate to matters which have occurred since the date
Petitioners' brief was filed in January, 1991. As per this Court's Order of January 22, 1991 on file herein, the
Court may take judicial notice of these additional exhibits.
See e j . , p. 5, Division's Opposing Brief, entitled "Nature of the Case"; p. 13, "Course of
Proceedings and Disposition Below," deliberately ignoring that the Division amended its petitions in July 1989,
to delete the very claim that Petitioners directly violated the Division's March 1, 1989, Summary Order; p. 14,
"Summary of Argument", stating that, "by purchasing U.S.A. Medical stock from six Utah sellers," Petitioners
"willfully violated the Division's order . . . ."; p. 45, The Johnsons' behavior constituted as direct and willful a
violation of a Division order as can be imagined." Cf. p. 75, Petitioners' brief.

-1 -

brief, p. 5.

On the contrary, the Securities Advisory Board

expressly found that Petitioners did not "sjlicit" their sellers.
Ex. EE, 112, p. 6.3

Thus, the record is clear that Petitioners

"helped" no one do anything.

At the same time, the Division has

filed no cross-appeal, complaining about the very findings and
conclusions it and its counsel drafted behind Petitioners'
backs.4
Most disturbing and pernicious is the Division's
repeated reference on page after page of its brief to
Petitioners' unsolicited "purchasing" to complete outstanding
NASD contracts as "trading".
brief.

See e.g., pp. 35-36, Division

The Division thus seeks to deceive the reader into

believing that Petitioners truly did violate the Division's March
1989, Orders directly.

On the contrary, Petitioners were never

even charged with "trading".
brief.

See Ex. L and p. 75, Petitioners1

Furthermore, Don Sorensen, Johnson-Bowles' CPA, testified

that Johnson-Bowies' last trade in U.S.A. Medical occurred on
February 2, 1989, nearly one month before the Division issued its
Summary Order.

R. 1042; p. 183, lines 4-6, Hearing Transcript.

Petitioners admittedly purchased nearly 400,000 shares of

^
In other words, Petitioners did not violate the registration provisions of §5, Securities Act of
1933, or Utah's counterpart, Utah Code Ann. §61-1-7, because they neither offered, sold, nor made an offer to
buy any securities. Section 5, Securities Act of 1933, Vol. 1, Fed. Sec. L. Rep. (CCH) 1567 at p. 1576, Rel.
#1422 ( 1 1 / 2 1 / 9 0 ) .
4

See pp. 79-81, Petitioners' brief.

-2-

U.S.A. Medical stock (out of 26 million shares issued and
outstanding) from 7 individuals "during March 1989."

However,

private, unsolicited purchases between informed, consenting
adults is not "trading" because such transactions are
"off-market".

If the Division is correct and an "off-market,"

unsolicited, private purchase is tantamount to "trading", then
anyone who has ever bought or sold stock privately should
register as a securities broker-dealer.5
In its Statement of Facts, the Division further deceives
the Court as to the very definition and purpose of "short
selling", all as if such were relevant to Petitioners' liability.
Division's brief, p. 6, n. 6.

On the contrary, Judge Aldon

J. Anderson recently addressed this issue in Carlson v. Bagley
Securities, Inc., et al., U.S. District Court Case
No. 89-C-1062A, Memorandum Opinion (DC Utah

April 8, 1991), a

true and correct copy of which is attached hereto as Ex. MM.
Therein, Judge Anderson states:
The authority of a broker-dealer to sell
short is well established in the securities
industry. See 1 T. Hazen, The Law of
Securities Regulation §10.3 at 531 (2d ed.
1990). Despite plaintiffs' assertion that the
practice is "selling nothing", the ability of

^
See definition of "dealer" which excludes a person buying or selling for his or her own account,
Section 3(a)(5), Securities Exchange Act of 1934, Vol. 2, Fed. Sec. L. Rep. (CCH) 1120,136 at p. 15,052. In
addition, a person such as Petitioner Johnson who is associated with an NASD member such as
Johnson-Bowles is permitted under the NASD Rules of Fair Practice to engage in private securities transactions.
See §40, Private Securities Transactions, NASD Manual (CCH) 112200, pp. 2186-87, Rel. #289 (July 1988), a
true and correct copy of which is attached hereto as Exhibit LL.

-3-

a broker-dealer to sell short from a trading
account performs an important function in
balancing supply and demand in the over-thecounter market. [Emphasis added.]
The Division's relentless deceit upon this Court is
further exemplified in ill, p. 10, Division brief.

Therein, the

Division states that there was "no gap in coverage" between the
Temporary Stop Trading Order and the Permanent Stop Trading
Order.

This brazen statement is so contrary to the facts and law

that Rule 3 3 sanctions should be imposed on Respondents and their
counsel.

By statutory interpretation, the Summary Order of March

1, 1989 —

a relative of the Temporary Restraining Order —

only be effective 10-days.

could

Utah Code Ann. §61-1-14(3), Ex. C.6

In fact, the Division's permanent default order was not issued
until March 29, 1989, nearly 3 weeks after the March 1, Summary
Order had expired by operation of law.
Findings of Fact; R. 1132-1133, Ex. EE.

H's 7 and 9, p. 4-5,
Yet, throughout the

Division's opposing brief, it erroneously states that there was
no hiatus in the orders.7
Not content with the foregoing misstatements of the
evidence and record, the Division proceeds with:
There is nothing in the record that clearly
establishes whether Otra Clearing House [sic]
made its buy-in before the Division issued its

Utah Code Ann, §61-1-14(3) unambiguously states: "The executive director may not extend
any summary order for more than ten business days." In this case, the Summary Order was never extended.
'

See also pp. 40-44, Division's brief, in which it reiterates this false assertion.

Stop Trading Order (or before Otra became
aware of the Order).
Division brief, p. 11, 112. Despite this statement, Marlen
Johnson testified to the contrary at the hearing.

P. 88, lines

3-25, Hearing Transcript; R. 947.8
Finally, the Division repeatedly engages in the crudest
form of logical fallacy known to man:

it misstates each of

Petitioners1 arguments, thereby enabling it to refute arguments
Petitioners never made.9
COUNTERPOINT I
PART OF THE FINDINGS OF FACT ARE "CLEARLY
ERRONEOUS." NONETHELESS, THE CONCLUSIONS OF LAW
ARE NEITHER "CORRECT," "REASONABLE" NOR "RATIONAL."
A.

Paragraph 14 of the findings of fact is "clearly

erroneous".
Petitioners have no dispute with the findings of fact in
the August 13, 1990, Order other than paragraph 14 thereof.

This

is because the parties stipulated to the remainder of the
findings on July 8, 1990.

Ex. CC, Petitioners1 Addendum.

Paragraph 14 of the findings, R. 1135, Ex. EE, states:
14.

On March 20, 1990, Respondent Marlen

°
Furthermore, since the hearing, Otra's president, John M. Whitesides, has testified at an NASD
arbitration hearing between Petitioners and Otra that Otra knew about the Division's Summary Order. See Ex.
NN hereto, lines 1-13, page 169 of the transcript of such arbitration hearing of which this Court may take
judicial notice.
Petitioners also object to being recklessly lumped together by the Division as "the
Johnsons." Johnson-Bowles is not Marlen V. Johnson's alter ego and either one's liability herein is not
contingent upon the alleged conduct of the other.

-5-

V, Johnson purchased 54,000 shares of
U.S.A. Medical Corporation securities from
Mr. Sax. During the instant proceeding,
Respondent testified that he purchased those
securities for an entity known as January
Corporation as the means to possibly satisfy a
pending NASD arbitration proceeding between
Rer ondent Johnson-Bowles Company, Inc. and
Otra Clearing, Inc. regarding the March 1,
1989, buy-in of U.S.A. Medical Corporation
securities by Otra Clearing, Inc. On March
29, 1990, Respondent Marlen Vernon
Johnson — through January Corporation — sold
the 54,000 shares to a firm known as Sorensen,
Chiodo & May.
To demonstrate that findings of fact are "clearly
erroneous," an appellant must "marshall the evidence" in support
of such findings.10
Petitioners have not "marshalled the evidence" in
support of the entire findings because they have no dispute with
the findings other than 114.

Petitioners thus "marshall the

evidence" in support of 114 of the August 13, 1990, Findings as
follows:
(1) In March 1990, a year after
Petitioner Johnson's March 1989 purchases,
Petitioner Johnson testified he purchased, for
January Corporation, 54,000 shares of
U.S.A. Medical from Richard Sax for the
purpose, if necessary, of satisfying an
outstanding NASD contract with OTRA Clearing,

1

°
Scharf v. BMG Corp., 700 P.2d 1068, 1070 (Utah 1985); State v. Moore, 147 Utah Adv
Rep. 28, 32, 802 P.2d 732 (Ct. of App. 1990); State ex rel., M.S. v. Slata, 155 Utah Adv. Rep. 23, 24, _ P.2d
_ (Ct. of App. 1991). In Saunders v. Sharp, 154 Utah Adv. Rep. 5, 6, _ P.2d _ (Utah 1991), the Utah
Supreme Court held that if the appellant fails to marshall the evidence, the appellate court assumes the that the
record supports the findings of the trial court and proceeds to review the accuracy of the lower court's
conclusions of law and the application of that law in the case. Grayson Roper Ltd v. Finlinson, 782 P.2d 467,
470 (Utah 1989).
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Inc., a dispute subject of NASD arbitration
(R. 1012-1013, 1017, 959-960; p. 153, lines
18-25, p. 154, lines 1-19, p. 158, lines
23-24, p. 100, lines 13-25, p. 101, lines
1-24, Hearing Transcript);
(2) On March 29, 1990, Petitioner
Johnson, through January Corporation, gave
Johnson-Bowies' CPA's, Sorensen, Chiodo & May,
a security interest in such 54,000 shares as
collateral security for a pre-existing
accounting bill of $15,000 (R. 1017; p. 158,
lines 3-19, Hearing Transcript);
(3) While January Corporation's cost
basis in the stock was $4,290, the so-called
"pledge" to Sorensen, Chiodo & May was
accounted for by way of a stock confirmation
showing a charge of $30 (R. 1018; p. 159,
lines 5-19, Hearing Transcript);
(4) Petitioners stipulated to the
authenticity of all documents pertaining to
this innocuous transaction (R. 1147-1153);
and,
(5) Petitioner Johnson testified at the
hearing that the transaction was not intended
as a "sale" of anything (R. 1013, 1017, 1018,
and 1026; p. 154, lines 16-19, 158, lines
10-14, p. 159, lines 10-13, p. 167, lines
15-23, Hearing Transcript).
The Division put on no evidence that January Corporation's March
1990 "pledge" of 54,000 shares was anything other than what
Mr. Johnson testified it to be, namely, collateral security (and
good faith) for a pre-existing and outstanding accounting fee. 11

^1
Furthermore, if the "pledge" was indeed a "sale," why did the parties have no arrangement as
to the extent it reduced the $15,000 debt? The fact is, the transaction had no effect on reducing the debt. Thus,
it could not be a "sale" as it was not a disposition for Value." See former Utah Code Ann. § 6 1 - l - 1 3 ( 1 5 ) ( a ) ,
as in effect, 1989, now amended as§13(16)(a). More importantly, the "public" was certainly not harmed by
this transaction, nor are Sorensen, Chiodo & May complaining.
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In fact, the Division had an opportunity to cross-examine Don
Sorensen in this regard and it failed to do so, leaving
Mr. Johnson's prior testimony intact and unrebutted.
R. 1045-1049; pp. 186-190, Hearing Transcript.
The findings in 114 were neither contemplated in nor
embraced by the Division's July 19, 1989 Amended Petitions.
R. I6I-I08; Ex. L.

To be sure, January Corporation is not a

party to these proceedings.

Moreover, the Division made no

motion under Rule 15(b), Utah Rules of Civil Procedure, to amend
its Amended Petitions to conform to such "evidence".
The foregoing constitutes the sum of all "marshalled"
evidence by which the Securities Advisory Board, in secret and
clandestine conjunction with the Division's counsel, Mark
J. Griffin, "found" 114 of the August 13, 1990, Findings of Fact.
As a result, there is no evidence to support a finding that
January Corporation's use of 54,000 shares of U.S.A. Medical as
collateral security on an outstanding accounting fee was a "sale"
of securities by Johnson or Johnson-Bowles.12

1 z

Significantly, Rule 144 of the General Rules and Regulations of the Commission, Reg.
§230.144, Vol. 1, Fed Sec. L. Rep. (CCH) 12705A, a true and correct copy of which is attached hereto as Ex.
OO, provides a "safe harbor" under which certain transactions in securities are not deemed to be unlawful
distributions of securities. Rule 144(d)(3) (iv) sets forth conditions under which a pledgee may "tack" the
holding period of the pledgor for purposes of subsequently selling pledged stock to satisfy a debt or other
obligation. CCH at p. 2783-84. Under the Rule, a pledge of securities is not a sale. In addition, the
transaction in issue is not an ordinary pledge sitL ition. A typical pledge involves putting up stock as collateral
— at the outset — in exchange for the borrowing of money. Such did not occur here as Sorensen, Chioclo &
May had already advanced money in the form of services rendered and the 54,000 shares were put up after the
fact to make the accountants, as prior creditors, r, el secure.
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Based on the foregoing, 114 is not supported by
"substantial evidence."

Grace Drilling v. Board of Review, 110

Utah Adv. Rep. 34, 776 P.2d 63, 68 (Ut. Ct. of App. 1990).
B.

The conclusions of law are erroneous under the

"correctness of error" and/or the "reasonableness/rationality"
standards.
If "findings" are "clearly erroneous," it follows, a
fortiori, that conclusions of law based thereon must be
erroneous.
Nonetheless, even if findings of fact are not "clearly
erroneous" and not against the clear weight of evidence, the
"conclusions" may be erroneous under the "correctness of error
standard."

Bevans v. Industrial Commission, 131 Utah Adv. Rep.

99, 790 P. 2d 573, 576 (Ut. Ct. of App. 1990).

Because this case

further requires review of mixed questions of law and fact,
review boils down to whether the conclusions of law are
"reasonable and rational."

Pro-Benefit Staffing, Inc. v. Board

of Review, 106 Utah Adv. Rep. 34, 775 P.2d 439, 442 (Ut. Ct. of
App. 1989).

Based on Petitioners' brief, they are not. 13
COUNTERPOINT II
THE DIVISION MISCONSTRUES PETITIONERS1
CONSTITUTIONAL ARGUMENTS

J

The conclusions of law also fail under the correction-of-error standard applicable to
undisputed facts. Vali Convalescent v. Division of Health Care Financing, 140 Utah Adv. Rep. 21, 27, 797 P.2d
438 (Ut. Ct. of App. 1990).
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Contrary to the Division's baldfaced assertions, the
"heart" of this appeal is not an argument that the Division's
March 1989 Orders conflict with the NASD Rules of Fair Practice.
Division brief, p. 21-26.14

Petitioners have never contended

they were required to violate a Division order to fulfill their
NASD obligations.
it isn't true.

Such was not put forth by Petitioners because

On the contrary, the Summary Order merely sought

to prevent innocent Utah residents from acquiring "tainted"
U.S.A. Medical stock, an objective clearly within the police
power of the Division.

This is undisputed and it is irrelevant

to this appeal.
Not content with one mischaracterization on this score,
the Division compounds its sophistry:

Petitioners have never

argued that NASD Rules "preempt" the Division's March 1, 1989
Summary Order.

Division brief, p. 21. What ij* "preempted" is an

NASD member's obligation to comply with the NASD Rules of Fair
Practice vis-&-vis the Division's irrational interpretation of
its regulatory authority and purpose.

For instance, the Division

claims that dishonoring NASD executory contracts is "honest and
ethical":

the NASD takes an opposite view.

pp. 25-26, Petitioners' brief.

See p. 13, 117, and

Accordingly, all of Point II of

the Division's brief, being based on false premises, is illogical
and fallacious.

1 4

Furthermore, contrary to the Division's assertions, the record is clear that this argument also
was not, by any means, the basis of Petitioners' motion for summary judgment. Id.
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A.

Petitioners were subject to discipline by the NASD

had they failed to honor their NASD contracts.
The Division further deceives this Court by contending
that Petitioners cite no authority for the proposition that had
they failed to honor their NASD contracts, they could have been
expelled by the NASD and fined.

Division brief, p. 22. On the

contrary, In re: Shaskan & Company, Inc., and Friedman & Company,
authority cited in Petitioners* brief, stand for this very
proposition.

See pp. 25-26, Petitioners' Brief.

Further, at

page 9 3 of the hearing transcript, R. 952, Mr. Johnson testified
that Ken Schaeffer, Assistant Director of the NASD in Denver told
him that, "we had to honor the contracts under any circumstances,
or the NASD would take charge and we would be fined."

Division

brief, p. 22, note 20. While the Division had a year and a half
to contact Mr. Schaeffer and obtain an affidavit or other
evidence from the NASD to the contrary, no evidence was adduced
at the hearing to rebut the foregoing law and evidence.
B.

Petitioners were also subject to discipline by the

NASD for failing to honor a prospective "buy-in."
On page 23, Division brief, the Division articulates its
grand solution to this entire case:

Johnson-Bowles should have

allowed $500,000 worth of "buy-ins" and then Petitioners would
not have been subjected to NASD sanctions.
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Ironically, this

brilliant solution would have created more problems than ever.15
For instance, the Petitioners, not having over $500,000 with
which to honor s zh "buy-i.

" could have been subjected to

disciplinary actun by the NASD for the failure to I Dnor a
"buy-in."

In the Matter of the Application of Nassau Securities

Service, November 19, 1964, SEC Ex. Act. Release No. 7464, 42
S.E.C. 445, [f64-'66 Transfer Binder] Fed. Sec. L.
177,158, Ex. PP hereto, is directly on point.

.;ep. (CCH)

In Nassau, the

SEC, on appeal from the NASD, held that the failure of an NASD
member who made a short sale to pay a $325 balance arising out of
a "buy-in" executed by the purchaser was a violation of the NASD
rules requiring members to observe "high standards of commercial
honor and just and equitable principles of trade."16
Consequently, the censure, fine and assessed costs imposed by the
NASD was upheld.

The claim by the applicant that its refusal was

based on suspected fraud was not justified since the applicant
along with some other 16 dealers, participated in making a market
in the stock, was aware of the factors which it claims suggested
a manipulation, and when notified of the "buy-in," it attempted
to get another extension for delivery.
Regardless of Nassau, an NASD disciplinary action was in
fact initiated against Johnson-Bowles in the NASD Denver office

"
It would also have furthered the fraud because the U.S.A. Medical criminals were happily
sitting with sell orders on the other side of every prospective "buy-in."
1

6

In other words, Article III, §1, NASD Rules of Fair Practice, Ex. H, Petitioners' Addendum.
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in September, 1989, NASD Complaint No. DEN-914.

This complaint

was the result of Johnson-Bowies' failure to honor the March 1,
1989 "buy-in" undertaken by Otra.

Such action was brought to the

attention of the ALJ as set forth on pp. 822 through 825, Vol.
Ill, of the record, Ex. QQ hereto.

Unfortunately for

Petitioners, it was ignored.
C.

Expecting Johnson-Bowles to defend several NASD

disciplinary actions and otherwise arbitrate $500,000 worth of
potential "buy-ins" is an irrational and ludicrous alternative.
The Division claims that if "buy-ins" were made at
prices Johnson-Bowles felt was too high, it could have sought
NASD arbitration.

Division brief, p. 24.

Ironically, this

occurred with respect to the Otra Clearing, Inc., "buy-in" and
yet Petitioners have not prevailed.

For example, at January end,

1991, a panel of three NASD arbitrators made an arbitration award
against Petitioners in an amount now totaling $108,000.00, an
amount Otra Clearing is now seeking to convert into a judgment.
A true and correct copy of the arbitration award, of which this
Court may take judicial notice, is attached hereto and
incorporated by reference as Ex. RR.

Thus, the alternative that

Petitioners should have gone out-of-business and defended several
NASD arbitrations and several NASD disciplinary actions, as
opposed to doing what they did, is clearly irrational,
unreasonable, illogical, and naive.
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As evidenced by the record,

Petitioners' fears of facing $500,000 worth "buy-ins" were
legitimate and not a pipe dream.
COUNTERPOINT III
THE ALJ'S DENIAL OF PETITIONERS'
SEVERAL MOTIONS WAS ERROR.
A.

Converting the administrative adjudicative

proceedings from informal to formal was error.
The Division devotes several pages to the argument that
the ALJ's order converting the proceedings from informal to
formal was correct.

Division brief, pp. 26-28.

The Division

adds nothing to the arguments presented in Petitioners' principal
brief at pages 23-24.

Conversion was not "in the public

interest" simply because Johnson-Bowles' conduct had no impact or
effect on "the public."

Further, in order to usurp the express

right to a trial de novo in the district court, the movant must
show that the defending party will not be prejudiced.

The

Division failed to carry its burden on both accounts.17
B.

The ALJ's denial of Petitioners' Rule 12(b)(1)

motion was fundamental error.
The fundamental error of the ALJ's August 29, 1989,
Order denying Petitioners' Rule 12(b)(1) motion is succinctly set
forth on page 4 thereof, top.

(See R. 152, top; Ex. N,

1 1

There is no reason to believe the Securities Advisory Board hearing this case had any greater
expertise than a Third Judicial District Court judge. Cf. Division brief, p. 16-17, note 15. This is evident from
the results. Further, the panel was not composed of a lawyer, but two industry and two lay persons, the latter of
whom may have known nothing about securities law.
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Petitioners' Addendum.)

Therein, the ALJ premises his decision

on the following:
Respondents' assertion that the NASD rules of
conduct [sic] should be accorded the force and
effect of federal law . . . is not wellfounded.
This conclusion defies Western Capital & Securities,
Inc. v. Knudsvig, (Ut. Ct. of App. Case No. 88-0198-CA, February
7, 1989), 101 Utah Adv. Rep. 65, 768 P.2d 989, ['89 Transfer
Binder] Fed. Sec. L. Rep. (CCH) 194,3 37.
confirms this error.

More recent authority

Lowenschuss v. The Options Clearing Corp.,

et. al., (Del. Ch. Ct., Dec. 21, 1989), [Current Transfer Binder]
Fed. Sec. L. Rep. (CCH) 195,675 at p. 98,156-157 (a state has no
subject matter jurisdiction over violations of the Securities
Exchange Act of 19 34, including violations of any rules and
regulations promulgated thereunder).

[Emphasis added.]

If a

state has no power or authority to enforce or interpret NASD
Rules of Fair Practice, it certainly has no authority or power to
regulate NASD members regarding federal, NASD business in a
manner diametrically inconsistent therewith.
Had the ALJ properly concluded that the NASD Rules of
Fair Practice have force and effect of federal law, Petitioners'
Rule 12(b)(1) motion would have been granted.
C.

Petitioners' Rule 12(b)(6) Motion should have been

granted as to Count I, the Division's "dishonest or unethical
business practices" claim.
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With regard to the ALJfs Rule 12(b)(6) ruling, the
Division wholly ignores arguments 4A, B, D, H-N in Petitioners'
brief.

See Division brief, pp. 30-36.18

While; the Division dis-

cusses Petitioners' arguments 4F and G, rebuttal is not
merited.19

Instead of addressing Petitioners' other points, the

Division dwells on Petitioners' privileges and immunities
argument.

On this score, the Division claims that Johnson-Bowles

is not a citizen of these United States and therefore the
privileges and immunities clause offers it no protection.

If so,

what country is Johnson-Bowles supposed to be a citizen of?
what about Petitioner Johnson?20

And

Further, Petitioners do not

belabor this argument because according to their research, the
privileges and immunities clause is intimately related to the
equal protection clause of the 14th Amendment and involves a
similar analysis.21

1 b

Because Petitioners are indeed citizens of

Cf. Petitioners' brief, pp. 43-63.

1

^
This is also the case with the Division's irrelevant reference to criminal aiding and abetting.
Division brief, pp. 18-19, note 17. The Division has never charged Petitioners' sellers with criminal conduct
and aiding and abetting cannot lie without a principal violation. Further, the finding that Petitioners didn't
"solicit" their sellers renders the Division's argument frivolous. See pp. 55-59 and 70-75, Petitioners' brief.
2

^
To be sure, authority holds that federal licensees have property rights under the Constitution.
Gonzalez v. Freeman, 334 F.2d 570 (D.C. Cir. 1964) (due process is involved in suspending a federal licensee's
right to enter contracts).
2 1

Nowalk, Rotunda & Young, Constitutional Law, Hornbook Series, West Publishing
Company, St. Paul, Minn. (1978), pp. 276 (discussing Toomer v. Witsell, 334 U.S. 385 (1948), and
explaining that the test to determine a violation of the Article IV privileges and immunities clause is whether
there are valid reasons for a state to make distinctions based on one's state citizenship and whether the degree of
discrimination bears "a close relation" to these reasons).
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these United States and the State of Utah, Petitioners'
privileges and immunities argument has not been rebutted.22
On page 33, the Division again mischaracterizes
Petitioners' argument.

Petitioners have not argued that "the

order suspending their licenses was an illegal ex post facto law
under Article I, Section 10 of the Constitution."

What they have

argued is that they had no notice that purchasing securities in
private transactions at a time when the Division's March Orders
may not have been in effect was sanctionable conduct impairing
their livelihoods.

Simply put, the attempt to discipline

Petitioners, after the fact, has the effect of an ex post facto
law.

While the Division further argues that the prohibition

against ex post facto laws only applies to criminal penalties,
the Division ignores the fact that administrative adjudicative
proceedings may be considered quasi-criminal.
On page 34, Division brief, the Division once again
misstates Petitioners' argument.

Petitioners have never argued

that they had a constitutional right to sell U.S.A. Medical stock
during the effectiveness of the Division's March Orders. What
was argued is that Petitioners have a constitutional right not to
have federal executory contracts arbitrarily interfered with by a
state entity.

The issue is not whether Petitioners had any right

to "offer or sell" any U.S.A. Medical stock during the pendency

z z

This case is also one of reverse-discrimination by a state because Petitioners have been
targeted only because they are Utah citizens.

-17-

of a "stop order," because they never did.23

To be sure,

Johnson-Bowies' last "trading" transaction in U.S.A. Medical
stock was on February 2, 1989.

The ministerial "delivery" of

securities under Article 8, U.C.C., is not the same as entering
into new contracts for the "offer or sale" thereof.
The Division fails to distinguish Brewster v. Maryland
Securities Commissioner, 548 A.2d 157 (Md. App. 1988), a
"dishonest and unethical practices" case.

Petitioners have cited

this case for principle that in order to be disciplined for such
alleged misconduct requires notice (i.e., reference to "business
practice, custom and usage"),

id. at p. 159-160.

For example,

registration of an unsolicited, "off-market" purchase is not —
and never has been —

required.

Thus, by suspending all

exemptions from registration, such a transaction is unaffected.24
In short, nothing in the "business practice, custom or usage" of
the securities industry would give a person notice that the
Division deemed the mere purchase of securities on an unsolicited
basis as requiring registration.
2

3
The Division also argues that Petitioners violated the SECs 10-day suspension order issued
on March 6, 1989. Division brief, p. 42, note 36. This argument begs the same question and is not supported
by evidence that Petitioners purchased stock sometime "during March 1989." Further, this argument is frivolous
because buying stock from six Utah residents is not interstate conduct triggering application of the SECs order.
Moreover, Petitioners were never charged with violating the SECs 10-day suspension order. To be sure, the
Securities Advisory Board never found that Mr. Johnson's purchase from New York resident Sheldon Flateman
was a violation of the SECs 10-day suspension order.
^^
This is confirmed by the plain language of §5 (the registration provisions) of the Securities
Act of 1933 which only requires registration for an "offer to buy" securities (i.e., a solicitation). The same is
even more evident in the Utah Uniform Securities Act which only requires registration for "offers or sales". See
Utah Code Ann. §61-1-7. Thus, if unsolicited purchases need not be registered under state and federal
securities law, it is certainly preposterous to require an exemption for them.
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D.

The Failure to either Grant or Consider Other

Motions of Petitioners was Error,
Respecting Petitioners1 motion for summary judgment, the
Division contends that the motion was not granted because
"'dishonest or unethical conduct1 was certainly not disputed."
Division brief, p. 38. This is not what occurred.
itself made a cross-motion for summary judgment.

The Division

Yet, the ALJ

denied both motions for summary judgment, determining that the
issue of "solicitation" was a material issue of fact necessary to
impose liability under Division Rule R177-6-lg.
AA.

R. 597-608; Ex.

Ironically, subsequent to the ALJ's decision denying both

motions for summary judgment, the Securities Advisory Board
"found" that:
. . . there is no sufficient evidence to find
that respondents or any of their agents
solicited any of the above named seven (7)
individuals to sell their U.S.A. Medical
Corporation securities.
Paragraph 12, page 6, last sentence, Findings of Fact and
Conclusions of Law, R. 1134, Ex. EE.
In light of the Board's findings of no "solicitation,"
and assuming the ALJ's summary judgment decision, Ex. AA, is
otherwise correct, the proceedings should be reversed and
vacated.
The Division next argues that other procedural
objections posed by the Petitioners' brief are moot.
brief, pp. 38-40.

This is not true.
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Division

The Division further

contends that two motions made by the Petitioners on August 20,
1990 and supported by an affidavit are also moot.

This is

because Petitioners allegedly "waived" their objections by
failing to raise such in their August 23, 1990, Request for
Agency Review before the Department of Commerce.

Division brief,

p. 39. As with other reckless assertions in the Division brief,
this too is an outrageous falsehood.

As set forth on pages 6,

bott., 7, top, of Petitioners' August 23, 1990, Request for
Agency Review, R. 857 bott., 858, top, Ex. SS hereto, Petitioners
specifically sought a ruling from Director Buhler on such
motions.

See also Argument 8, pp. 78-81, Petitioners' brief.
Lastly, since Petitioners filed their principal brief,

the Division has approved a registration of the securities of
U.S.A. Medical (now known as Life Concepts, Inc.).

A Division

Certified Copy of the Prospectus and Certificate of Registration
announcing the effectiveness of the registration statement are
together attached hereto as Ex. TT. An examination of the
Prospectus reveals that the Division has not required anything to
be disclosed to the public about U.S.A. Medical that would have
affected Petitioners' decision to purchase U.S.A. Medical
securities during March 1989.

Thus, the absence of an effective

registration statement on U.S.A. Medical's securities in March
1989 had no bearing on Petitioners' conduct as mere purchasers.
See Petitioners' argument 4M on pp. 60-62 of their brief, citing
SEC v. Ralston Purina Company, 346 U.S. 119 (1953).
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COUNTERPOINT IV
THE DIVISION FAILED TO PROVE THAT
PETITIONERS PURCHASED STOCK DURING
A TIME PERIOD IN WHICH EITHER
MARCH ORDER WAS IN EFFECT.
The Division argues that its March 1989 Orders were in
effect throughout March 1989, namely, at all times when
Petitioners admittedly purchased U.S.A. Medical stock.
brief, pp. 40-44.

Division

This argument is neither the law nor is it

supported by the record.

The law is clear that the Division's

Summary Order of March 1, 1989, was only valid for ten (10) days.
Further, it was not extended for an additional ten day or lesser
period as permitted under Utah Code Ann. §61-1-14(3), Ex. C.

The

Division deliberately misleads the Court by quoting the portion
of the statute whereby the order can be made permanent.

Reading

the statute from the Division's perspective, it would be
ludicrous for a statute to provide that a "permanent order'1 may
be extended for any period of up to but not exceeding ten (10)
days.
While Petitioners did receive notice of the March 1,
Summary Order, Ex. J, they were not a respondent therein and they
were not aware that they could have, even if they wanted to, made
a written request that the matter be set down for a hearing.

In

fact, the Petitioners never received any notice that the matter
was set for hearing or scheduled to be made permanent on or about
March 29, 1989.

The Order was thus made permanent three weeks

-21 -

after its expiration and without notice or opportunity to be
heard.

As a result, it is undisputed that there were nearly

three weeks during March 1989 _i which no Division order
suspending exemptions was in place.

At the same time, the

Stipulation entered into between the Petitioners and the Division
sets forth that Petitioners purchased stock subject of the
Amended Petitions "during March."
Petitioners' Addendum.

R. 1156; p. 3, 112, Ex. CC,

The Division put on no evidence as to

exactly when such purchases occurred and contrary to the
Division's disingenuous contentions, the burden is not on the
Petitioners to prove a negative; nor is it their burden to prove
that they acted "honestly or ethically." Steadman v. Securities
& Exchange Commission, (U.S. Sup. Ct., Feb. 15, 1981) 450 U.S.
91, 67 L.Ed. 2d 69, 101 S.Ct. 999, [f81 Transfer Binder] Fed.
Sec. L. Rep. (CCH) 197,878 (discussing the prosecutor's burden of
proof in SEC administrative proceedings).

The conclusions of law

are thus "incorrect" because the Division failed to carry its
burden (i.e., it failed to show that Petitioners' conduct in any
way undermined its orders).
In nearly two pages of discussion, the Division
mistakenly analogizes its power and authority to permanently
suspend exemptions with the SEC's authority to suspend
registration statements.

The SEC's authority to suspend

registration statements is analogous to Utah Code Ann. §61-1-12,
not §61-1-14.

Yet the Division cites SEC Rule 261 for the
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proposition that the SEC may suspend all exemptions on a
permanent basis.

On the contrary, Rule 261, a true and correct

copy of which is attached hereto as Ex. UU, solely involves the
SEC's ability to permanently suspend a registered exemption such
as the Regulation A exemption.25

Rule 261, promulgated under

Regulation A, only applies to an exemption conferred by the
filing of a registered exempt offering statement.

This false

argument is typical of the reckless deception repeatedly used by
the Division to stack the deck and otherwise mislead this Court.
COUNTERPOINT V
THE DIVISION'S ORDER SUSPENDING
PETITIONERS' LICENSES FOR ONE YEAR
AND PLACING THEM ON PROBATION FOR
TWO YEARS IS IRRATIONAL AND UNREASONABLE
IN LIGHT OF THE FACT THAT NO VIOLATION
OCCURRED AND NO ONE SUSTAINED OR COULD
HAVE SUSTAINED DAMAGE FOR PETITIONERS' CONDUCT.
The Division's final argument is that the sanction
imposed was reasonable in light of "severity and willful nature"
of Petitioners' conduct.
of this entire appeal.

This statement alone begs the question

To be sure, who has been harmed?

The Division argues that Petitioners profited "to the
tune of more than $500,000," and this false assumption allegedly
justifies its pound of flesh.

The fallacy here is that avoiding

being defrauded out of $500,000 is not the same as making a
Z!3

See ej., Tabby's International, Inc. v. SEC, (5th Cir. 1973), 479 F.2d 1080, 1083, [1973
Transfer Binder] Fed. Sec. L. Rep. (CCH) 194,014; In the Matter of Capital Leasing Corp., (1964) Securities
Act Release No. 33-4714, 42 S.E.C. 232, [1964-1966 Transfer Binder] Fed. Sec. L. Rep. (CCH) 177,128.
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"profit" of $500,000.

In fact, the Division seriously takes the

position that it would have preferred seeing $500,000 go into the
pockets of the U.S.A. Medical criminals, namely, those on the
other side of every prospective "buy-in."

This is precisely what

would have occurred had "buy-ins" been effectuated through the
market.

Ironically, such would have undermined the objectives

underlying the Division's Orders more than anything Petitioners
did or ever could have done.
CONCLUSION
The Division fails to recognize Petitioners' upstanding
and noble responsibility in having exposed the entire
U.S.A. Medical stock fraud and doing everything possible to see
that it attained a price it was worth, namely zero.

The Division

ignores that U.S.A. Medical's price was artificial and that no
one should be forced by state government to further a fraud, let
alone to the extent of $500,000.

The Division also ignores that

protecting oneself from a ^raud is not the same as "profiting", a
conclusion of law so bizarre as to be incomprehensible.
Mitigating one's damages —
others —

damages caused by

is not a "dishonest or unethical business practice."

Acting in good faith to protect other innocent parties,
specifically one's fellow NASD members, from sustaining hundreds
of thousands of dollars in damage is also not "dishonest or
unethical."

In addition, single-handedly uncovering and exposing

an egregious fraud and otherwise handing government a fraud case
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against others on a silver platter can hardly be "dishonest or
unethical."
conduct —

The irony of this case is that Petitioners' noble
far from furthering any fraud —

frustrated the fraud.

At the same time, the Division contends by default that,
extorting Petitioners with a $50,000 fine when government has no
power or authority to impose a fine of even 500 is apparently
"honest or ethical" and certainly not tantamount to government
misconduct, let alone a crime.

Thus, the real question is: who

is the most "dishonest or unethical", the Petitioners, who mitigated theirs and others' damages in good faith, thereby
preventing the criminals in the scheme from reaping $500,000 or
more in illegal profits or, the Division, who committed the crime
of extortion and blackmail upon Petitioners?

In Viacom

International, Inc. v. Icahn, (S.D. NY, 1990) 747 F.Supp. 205,
[1990 Transfer Binder] Fed. Sec. L. Rep. (CCH) 195,473, the
U.S. district court for the Southern District of New York defined
extortion as "the use of wrongful means to achieve a wrongful
objective."

The Court held that "both elements occur whenever

one exploits fear to obtain property to which one has no lawful
claim."

Viacom at CCH p. 97,482.

While criminal extortion is

hardly "honest or ethical", seeking $50,000 for fear of impairing
Petitioners* livelihoods is precisely what the Division and its
counsel have done in this case with impunity.
Code Ann. §76-6-406.

See e.g., Utah

Cf. Utah Code Ann. §76-8-509.

17, 529, Petitioners' brief.

See also p.

Petitioners submit that an
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investigation of the Division and Attorney General's office
should be ordered and felony extortion charges brought against
all culpable parties.
Based on the foregoing, the August 13, 1990, Findings of
Fact, Conclusions of Law and Order should be reversed and
vacated.
Respectfully submitted thi

attorney for Petitioners
PROOF OF SERVICE
The undersigned hereby certifies that on the 30th day of
May, 1991, (s)he hand-delivered two (2) true and correct copies
of the foregoing REPLY BRIEF OF PETITIONERS with attendant
exhibits to:
Earl S. Maeser, Director
Utah Division of Securities
Utah Department of Commerce
160 East 300 South, Second Floor
P.O. Box 45802
Salt Lake City, Utah 84145-0802
and two (2) of the same to:
R. Paul Van Dam
Attorney General
David N. Sonnenreich
Assistant Attorney General
Fair Business Enforcement Unit
115 State Capitol Building
Salt Lake City, Utah .84114

1000.01A:REPLY.1-8 (FOOT.5-6)
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# # • Selected NASD Notices to Members
85-89 Adoption of New Rule of Fair Practice Relating to Permission for
Members to Alter Their Methods of Operation Under SEC Rule
15c3-3 ("Customer Protection Rule")
(December 31, 1985)
H 2199

Approval of Change in Exempt Status Under SEC Rule
15c3-3

Sec. 39. (a) Application—For the purposes of this section, the term "member"
shall be limited to any member of the Association who is not designated to another selfregulatory organization by the Securities and Exchange Commission for financial
responsibility pursuant to Section 17 of the Securities Exchange Act of 193< and Rule
17d-l promulgated thereunder.
(b) A member operating pursuant to any exemptive provision as contained in
subparagraph (k) of SEC Rule 15c3-3 under the Securities Exchange Act of 1934
("Rule 15c3-3"), shall not change its method of doing business in a manner which will
change its exemptive status from that governed by subparagraph (k)(l) or (k)(2)(b) to
that governed by subparagraph (k)(2)(a), or from subparagraph (k)(l), (k)(2)(a) or
(k)(2)(b) to a fully computing firm that is subject to all provisions of Rule 15c3-3, or
commence operations that will disqualify it for continued exemption under Rule 15c3-3
without first having obtained the prior written approval of the Association.
(c) In making the determination as to whether to approve, deny in whole or in
part an application made pursuant to subsection (b), the Association staff shall
consider among other things the type of business in which the member is engaged, the
training, experience and qualifications of persons associated with the member, the
member's procedures for safeguarding customer funds and securities, the member's
overall financial and operational condition and any other information deemed relevant
in the particular circumstances and the time these measures would remain in effect.
[Adopted effective November 7, 1985.]
U 2200

Private Securities Transactions

Sec. 40. (a) Applicability—No person associated with a member shall participate
in any manner in a private securities transaction except in accordance with the
requirements of this section.
(b) Written Notice—Prior to participating in any private securities transaction,
an associated person shall provide written notice to the member with which he is
associated describing in detail the proposed transaction and the person's proposed role
therein and stating whether he has received or may receive selling compensation in
connection with the transaction; provided however that, in the case of a series of
related transactions in which no selling compensation has been or will be received, an
associated person may provide a single written notice.
(c) Transactions for Compensation—
(1) In the case of a transaction in which an associated person has received or
may receive selling compensation, a member which has received notice pursuant
to Subsection (b) shall advise the associated person in writing stating whether the
member:
(A) approves the person's participation in the proposed transaction, or
(B) disapproves the person's participation in the proposed transaction.
(2) If the member approves a person's participation in a transaction pursuant
to Subsection (c)(1), the transaction shall be recorded on the books and records of

1f 2199 Art. Ill, Sec. 39

©1988, Commerce Clearing House, Inc.
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the member and the member shall supervise the person's participation in the
transaction as if the transaction were executed on behalf of the member
(3) If the member disapproves a person's participation pursuant to Subsec
tion (c)(1), the person shall not participate in the transaction in any manner
directly or indirectly
(d) Transactions Not For Compensation—In the case of a transaction or a series ot
related transactions in which an associated person has not and will not receive any
selling compensation, a member winch has received notice pursuant to Subsection (b)
shall provide the associated person prompt written acknowledgement of said notice and
may, at its discretion, require the person to adhere to specified conditions in connection
with his participation in the transaction
(e) Definitions—For purposes of this section, the following terms shall have the
stated meanings
(1) "Private securities transaction" shall mean any securities ansaction
outside the regular course or scope of an associated person's emplov ^nt with a
member, including, though not limited to, new offerings of securities wmch are not
registered with the Commission, provided however that transactions subject to the
notification requirements of Article III, Section 28 of the Rules of Fair Practice
transactions among immediate family members (as defined in the Interpretation
of the Board of Governors on Free-Riding and Withholding) for which no associ
ated person receives any selling compensation, and personal transactions in
investment company and variable annuity securities, shall be excluded
(2) "Selling compensation" shall mean any compensation paid directlv or
indirectly from whatever source in connection with or as a result of the purchase
or sale of a security, including, though not limited to, commissions, finder s fees
securities or rights to acquire securities, rights of participation in profits, tax
benefits, or dissolution proceeds, as a general partner or otherwise, or expense
reimbursements
[Adopted effective November 12, 1985 ]
• • • Cross Reference
Article III, Sec 1 —Business Conduct of Members
§ 2151
Article III, Sec 28 —Transactions for Personnel of Another Member
§2178
• • • Selected NASD Notice to Members
85-21 Solicitation of Comments on Proposed Rule on Private Securities
Transactions
(March 29, 1985)
85-54 Propose New Rule of Fair Practice Relating to Private Securities
Transactions
(August 13, 1985)
85-84 New Rule of Fair Practice Relating to Private Securities Transactions
(December 18, 1985)

[The next page is 2189 ]
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IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF UTAH
CENTRAL DIVISION
JOHN E. CARLSON and LINDA D.
CARLSON,
Plaintiffs,
Case No: 89-C-1062A
vs.
MEMORANDUM OPINION
BAGLEY SECURITIES, INC., EDWARD
DALLIN BAGLEY, EDWARD BRYAN
BAGLEY,
LISA
BAGLEY,
and
CAROLYN CREAMER BAGLEY, and
JOHN
DOES
V
through
X,
INDIVIDUALS,

(In lieu of findings of fact
and conclusions of law pursuant
to Fed. R. Civ. P. 52(a))
Judge Aldon J. Anderson

Defendants.

On January 17-18, 1991, a bench trial was held in the above
matter.

Plaintiffs John E. Carlson and Linda D. Carlson were

represented by Ronald E. Nehring, Thomas M. Melton and Stephanie A.
Beam.

Defendants Bagley Securities, Inc., Edward Dallin Bagley,

Edward Bryan Bagley, Lisa Bagley and Carolyn Creamer Bagley were
represented by Richard J. Leedy. The parties presented documentary
and sworn testimony.

The trial was continued until February 12,

1991 at which time the court heard closing arguments and took the
matter under advisement.

Having thoroughly reviewed the evidence

and the extensive briefing of the parties, the court is prepared to
issue its ruling.

I.
Plaintiffs

John

E.

Facts

Carlson

and

Carlsons") are residents of Minnesota.

Linda

D.

Carlson

("the

In early 1989, Mr. Carlson

became aware of a company called Dial-A-Gift through conversations
with Robert Lorsbach, a Salt Lake City stockbroker associated with
Aesir Securities.

The Carlsons had previously invested in stocks

through Lorsbach while he was associated with another brokerage
house.

Lorsbach recommended Dial-A-Gift stock to the Carlsons as

a potential investment but could not personally execute the sale
because Aesir Securities was not yet registered

to transact

business in Minnesota. Lorsbach suggested that they could cortact
Todd

Knowles who

was working

at

Bagley

registered in Minnesota to make the trade.

Securities

and

was

(Tr. Vol I, pp. 4-8).^

In early April 1989, Carlson telephoned Knowles to inquire if
Knowles would purchase for him approximately $80,000 in Dial-A-Gift
shares at the quoted price of $4 per share.

At Lorsbach!s

suggestion, Carlson told Knowles he wanted the stock certificates
to be delivered to him.

Knowles agreed and told Carlson that he

1

A11 citations to the transcript are to the reporter's partial
transcript of trial.
For ease of reference, each partial
transcript will be designated as follows:
January
January
January
January

17,
17,
18,
18,

1991,
1991,
1991,
1991,

a.m.
p.m.
a.m.
p.m.
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—
—
—
—

Volume
Volume
Volume
Volume

I
II
III
IV

could expect to receive the stock certificates within ten days to
two weeks after the trade.

(Tr. Vol. I, pp. 8-10, Vol. IV p. 49).

Lorsbach was also in communication with Knowles.

Lorsbach gave

Knowles a price quote on Dial-A-Gift shares at Aesir Securities and
told Knowles that he could purchase the stock from Aesir.

(Tr.

Vol. IV p.44).
Todd Knowles attempted to fill Carlson's order but because of
tight market conditions was able to purchase only a portion of the
requested shares.

(Tr. Vol. I, p. 13, Vol. IV p. 49). Lorsbach

was in contact with Knowles on a daily basis and continued to press
Knowles to fill the order.
Because of the difficulty in filling the order by purchasing
the shares on the market, Bagley Securities decided to become a
market maker in Dial-A-Gift and to short the remaining shares to
Carlson. Carlson and Lorsbach claim that Knowles did not disclose
that Bagley Securities intended to short the shares.

(Tr. Vol. I

p. 34, Vol. II p. 28). Knowles claims that Lorsbach agreed to the
short sale and further agreed that Bagley Securities could deliver
the certificates as the short was covered.
58).

(Tr. Vol. IV pp. 56-

Bagley Securities sold Carlson a total of 17,500 Dial-A-

Gift shares of which 4,700 were purchased by Bagley Securities from
other market makers (agency trades), and 12,800 were shorted to
Carlson from the trading account of Bagley Securities (principal
-3-

trades).

Carlson paid Bagley Securities a total of $79,159 for the

shares.

(Tr. Vol. IV pp. 68-74, Exb.47).

By early May, 1989, Carlson became concerned that he had not
yet received the certificates.
repeatedly
delay.

asked

Knowles

Over the next two weeks, Carlson

and Bagley

Securities to explain

the

After each request, Carlson was told that the certificates

were on their way.

(Tr. Vol. I pp. 22-25).

By letter dated

May

23, 1989, Bagley Securities

informed

Carlson that Bagley Securities had purchased 17,500 shares of DialA-Gift stock from Midwest Clearing Corporation and that Carlson
would receive the securities as soon as Bagley received them from
Midwest. (Ex. 30)' Carlson called Lorsbach after receiving the May
23rd letter.

Lorsbach told Carlson that he couldnft believe that

they had purchased the shares. (Tr. Vol. I, p. 3 0)

Based upon the

reassurances in the letter, Carlson was willing to give Bagley more
time to produce the certificates.
Carlson's patience eventually wore thin and by letter dated
June 20, 1989 demanded delivery of the certificates within five
days. (Doc. 31).
counsel

dated

distribution

Bagley Securities responded with a letter from

July
of

5,

1989

Dial-A-Gift

which
shares

alleged
had

that

occurred

a
and

fraudulent
informed

Carlson that Bagley Securities would not deliver the certificates
until the allegations were disproved.
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Bagley Securities did not

offer to return Carlson's money.

(Exb. 28).

On November 29, 1989, plaintiffs filed suit against Bagley
Securities.2

In December, 1989, Carlson learned that Bagley

Securities had attempted to make partial delivery of the stock by
transferring 17,200 shares of Dial-A-Gift stock into his account at
National Securities.

Carlson refused delivery because the price

quotes for the shares had significantly fallen.

(Tr. Vol. I,

p.40).

II.

Analysis

In their first amended complaint, plaintiffs allege fourteen
separate causes of action including violations of federal and state
securities laws, conversion, breach of contract, negligence and
breach

of fiduciary

duty.

Plaintiffs seek compensatory

and

punitive damages under various statutory and common law provisions.

A.

Plaintiffs1 Claims Under Federal Securities Laws

Section 10(b) of the Securities Exchange Act of 1934 makes it
unlawful for "any person [t]o use or employ, in connection with the
purchase or sale of any security, . . . any manipulative or

2

The complaint was later amended to include claims against
Edward Dallin Bagley ("Dal Bagley"), Edward Bryan Bagley, Lisa
Bagley and Carolyn Creamer Bagley as officers and directors of
Bagley Securities.
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deceptive device" that violates SEC rules.

IT J.S.C. §78j(b).

Rule 10b-5 gives meaning to this prohibition.

I makes it illegal

"for any person . . . to make any untrue stateir. nt of a material
fact or to omit to state a material fact necessary in order to make
the statement made . . . not misleading . . . in connection with
the purchase or sale of any security."

17 C.F.R. §240.10b-5

(1990).
Plaintiffs

allege that Bagley

Securities and

Dal Bagley

violated Rule 10b-5 by failing to disclose that Bagley Securities
intended to short the Dial-A-Gift shares to Carlson and by failing
to deliver the certificates as requested by Carlson.

Plaintiffs

claim that at the time Bagley Securities issued the confirmation
slips evidencing each trade, Bagley Securities knew or should have
known that it could not provide the certificates requested by the
Carlsons.

In support of their claim, plaintiffs identify a series

of alleged misrepresentations and omissions which plaintiffs claim
are actionable under Rule 10b-5.
First, plaintiffs claim that Bagley Securities had a duty to
disclose that Bagley Securities was shorting the Dial-A-Gift shares
to the Carlsons•

While acting on behalf of the Carlsons, Bagley

Securities made both principal and agency trades. An agency t~ade
is one in which a broker goes out in the market and purchases
shares from third parties on behalf of the customer.
-6-

A principal

trade is one in which the broker sells the shares to the customer
from the firm's trading account.

Bagley Securities sold Carlson

4,700 shares on an agency basis and 12,800 shares from its trading
account.

(Tr. Vol. Ill pp. 85-90, Vol. IV pp. 83-86).

Because

Bagley Securities did not hold an inventory of Dial-A-Gift shares
in its trading account, the account was short 12,800 shares.
Although Knowles claims that Lorsbach was aware of Bagley
Securities1 plan to short the sale, Lorsbach claims that he was
unaware of such a plan.

However, Lorsbach testified that Bagley

Securities1 "decision to sell long or short is their choice." Tr.
Vol II p. 28).
The authority of a broker-dealer to sell short is well
established in the securities industry. See 1 T. Hazen, The Law of
Securities Regulation

§ 10.3 at 531 (2d ed. 1990).

Despite

plaintiffs1 assertion that the practice is "selling nothing," the
ability of a broker-dealer to sell short from a trading account
performs an important function in balancing supply and demand in
the over-the-counter market. However, because the practice can be
abused by unscrupulous broker-dealers, short selling is highly
regulated.

Id. at 532; 17 C.F.R. § 240.15c3-l, 15c3-3 (1990).

Carlson did not independently investigate Dial-A-Gift as an
investment but relied on Lorsbach!s advice.

(Tr. Vol. I, p. 46).

Lorsbach claimed, and Carlson acknowledged that Lorsbach dealt with
-7-

Knowles as Carlson's agent.

The evidence showed that Lorsbach

worked as a registered representative for Aesir Securities which
controlled a large block of Dial-A-Gift shares and would have been
aware of tight market conditions. The court believes that Lorsbach
was aware, either by conversation with Knowles or by logical
inference from the surrounding conditions, that Bagley Securities
As Carlson's agent, Lorsbachfs

intended to short the shares.
knowledge is imputed to Carlson.

Plaintiffs also claim that Bagley Securities violated Rule
10b-5 by failing to deliver the certificates as promised. Although
short sales are highly regulated by the SEC and the National
Association of Securities Dealers ("NASD11), the court is unaware of
any rule which requires a market maker to cover a short position
and deliver certificates to a customer within a specific time
frame.

Instead,

NASD

Rule

15c3-3

states

that

[njothing stated in this rule shall be construed as
affecting the absolute right of a customer of a broker or
dealer to receive in the course of normal business
operations following demand made on the broker or dealer,
the physical delivery of certificates for: (1) Fully-paid
securities to which he is entitled . . . .
NASD Rule 15c3-3(l), NASD Manual (CCH 1989).
Plaintiffs rely on a series of cases before the Securities and
Exchange Commission in support of their argument that such conduct
violates Rule 10b-5. These administrative proceedings resulted in
disciplinary action against broker-dealers who sold short to their
-8-

customers and failed to cover the shorts within a reasonable time.
However, in each case cited by plaintiffs, the dealer shorted the
stock

without

any

intention

to

cover

the

transaction

and

appropriated the customer's funds for the brokerfs own use. See In
re Sebastian, 38 S.E.C. 865 (1959) ("Registrant's sale of the
securities without informing the customer that the securities were
pledged

and would

not

promptly

be

released

from

such

lien

constituted a misrepresentation of a material fact and the sale
operated as a fraud and deceit upon the purchaser."); In re
Bliedung, 38 S.E.C. 518 (1958) (broker-dealer "had no intention of
filling their orders promptly and [] he intended using their funds
in his other business activities") ; In re Shaver & Co. 36 S.E.C. 92
(1954)

(broker-dealer

appropriated

customers1

funds

with

no

intention of filling orders); In re Ankenv, 29 S.E.C. 514 (1949)
("The record thus makes it plain that Ankeny had no real intention
of filling his customers1 orders promptly"). The present case may
be distinguished in at least two ways.

First, the evidence

suggested that at the time of the transaction, Bagley Securities
fully intended to cover the short and deliver the shares. Second,
there is no evidence that Bagley Securities appropriated the
Carlson's funds for its own use at the time of the short sale.
Bagley Securities was required to maintain sufficient funds in a
reserve account at Midwest Clearing, to cover the short in its
-9-

trading account.
benefit

of

Because Bagley Securi' .es would not receive the

these

funds

until

the

short

was

covered,

Bagley

Securities would have little to gain by promising delivery without
intending to deliver.
While the.failure of a broker-dealer to disclose that he is a
market maker states a claim under Rule 10b-5 Bischoff v. G.K. Scott
& Co., Inc. 687 F. Supp. 746, 751 (E.D.N.Y. 1986), the court has
found no authority which states that a market maker is required to
disclose whether it is short or long in its trading account.
each trade was executed

by

Bagley

Securities

for the

After

Carlson

account, Bagley Securities sent Carlson a confirmation slip.

Each

slip identified Bagley Securities as a market maker in Dial-A-Gift
stock.3
Plaintiffs claim that after the confirmation slips were issued
and after the Carlsons had made payment in full for the securities,
Bagley Securities made certain misrepresentations concerning its
intention to deliver the certificates.
omission

to be

actionable

under

For a misrepresentation or

§ 10(b)

and

Rule

10b-5,

the

challenged statement must have been made "in connection with the
3

Each confirmation slip showed the date of the trade, the
quantity and price of shares purchased.
Confirmation slips
documenting agency or long trades showed that a commission was
charged on the transaction. Those confirmation slips evidencing
principal or short trades showed that no commission was charged or
billed to the Carlsons. Each slip carried the notation, "WE ARE A
MARKET MAKER IN THIS SECURITY." (Exbs. 4-11).
-10-

purchase or sale of . . . [a] security."
C.F.R. § 240.10b-5.

15 U.S.C. §78j (b) ; 17

In order to satisfy the "in connection with"

requirement, there must be an actual purchase or sale of a security
that is connected with a challenged statement.

Blue Chip Stamps v.

Manor Drug Store, 421 U.S. 723, 737-38 (1975).

Statements which

occur after the actual purchase of a security cannot form the basis
for

liability

Educational

under

Corp..

Rule
720

10b-5.
F.

Supp.

Ballan
241,

v.
250

Wilfred
(E.D.N.Y.

American
1989);

Konstantinakos v. F.D.I.C., 719 F. Supp. 35, 38 (D. Mass. 1989);
Perez-Rubio v. Wyckoff. 718 F. Supp. 217, 236

(S.D.N.Y. 1989);

Seattle-First National Bank v. Carlstedt, 678 F. Supp. 1543, 1547
(W.D. Okl. 1987).
Shortly after the sales were made, Carlson began to inquire as
to when he might expect delivery of the certificates.

Bagley

Securities avoided a direct reply to Carlson1s requests until May
23, 1989 when Dal Bagley wrote Carlson that Bagley Securities had
purchased

17,500

shares

Clearing Corporation.

of

Dial-A-Gift

stock

through

Midwest

In fact, when the letter was written, Bagley

Securities had not yet covered the short in the trading account.
However, these subsequent misrepresentations are not actionable
under Rule 10b-5.

-11-

B.

Plaintiffs1 Claims Under the Utah Uniform Securities Act
Plaintiffs' claims under state securities laws are based on

the same conduct alleged as violations of Rule 10b-5.

Section 61-

1-22(1;(b) of the Utah Uniform Securities Act provides that any
person who:
offers, sells, or purchases a security by means of any
untrue statement of a material fact or any omission to
state a material fact necessary in order to make the
statements made, in the light of the circumstances under
which they are made, not misleading, the buyer not
knowing of the untruth or omission, and who does not
sustain the burden of proof that he did not know, and in
the exercise of reasonable care could not have known, of
the untruth of omission, is liable to the person selling
the security to or buying the security from him . . . .
Utah Code Ann. § '61-1-22(1) (b) (Supp. 1989).
As discussed above, the misrepresentation by Bagley Securities
of its intent to deliver the certificates occurred after the sale
had been made. Plaintiffs have failed to identify any other untrue
statement or omission of a material fact by which means Bagley
Securities

offered

or

sold

Dial-A-Gift

shares.

Therefore,

plaintiffs1 claims under state securities laws must be denied.

C.

Plaintiffs' Common Law Causes of Action

1. Fraud
Plaintiffs claim that the confirmation slips and subsequent
representations by Bagley Securities, including the May 23, 1989
letter to Carlson, were intentional or reckless misrepresentations
-12-

which induced the Carlsons to advance funds or to forego further
inquiry

into

the

whereabouts

of

their

stock

certificates.

Plaintiffs' claim for fraud against defendants must fail because
plaintiffs have failed to show by clear and convincing evidence
that defendants falsely represented a material fact to induce the
plaintiffs to purchase Dial-A-Gift stock-

See Schwartz v. Tanner,

576 P. 2d 873, 875 (Utah 1978) ("The elements of actionable fraud to
be proved are a false representation of an existing material fact,
made knowingly or recklessly for the purpose of inducing reliance
thereon,

upon

which

plaintiff

reasonably

relies

to

his

detriment.") .

2.

Conversion

Plaintiffs

claim

that

Bagley

Securities

converted

their

property, namely the money paid and certain Dial-A-Gift shares, to
its own use.

Plaintiffs' claim for conversion is not a proper

remedy because plaintiffs were never in actual possession of the
Dial-A-Gift certificates which were to be purchased for them. See
Benton v. State, 709 P.2d 362, 365 (Utah 1985) ("A conversion is an
act of wilful interference with a chattel, done without lawful
justification by which the person entitled thereto is deprived of
its use and possession.11).
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3,

Breach of Contract
However, plaintiffs1 ninth cause of action, for breach of

contract against Bagley Securities, is a proper remedy.
Carlson

instructed

Knowles

to

purchase

the

shares,

When
Bagley

Securities was aware that Carlson wanted to receive the actual
stock certificates.

Dal Bagley

understood

that when Bagley

Securities sold the Carlsons the shares, Bagley had an enforceable
contract with Carlson to deliver the shares.

The terms of that

contract were established by the oral communications between Bagley
Securities and Carlson, either directly or through Lorsbach his
agent.
Each confirmation slip sent to Carlson established the exact
quantity and price of shares he was to receive from Bagley
Securities. Although a specific date was not set for the delivery
of the shares, it was clear that Carlson was to receive the actual
certificates.

Utah law provides as follows:

Unless otherwise agreed, the transferor of a certificated
security or the transferor, pledgor, or pledgee of an
uncertificated security on due demand must supply his
purchaser with any proof of his authority to transfer,
pledge, or release or with any other requisite necessary
to obtain registration of the transfer, pledge, or
release of the security . . . .
Failure within a
reasonable time to comply with a demand made gives the
purchaser the right to reject or rescind the transfer,
pledge, or release.
Utah Code Ann. § 70A-8-316

(Supp. 1990).

Carlson repeatedly

demanded delivery of the Dial-A-Gift certificates and was entitled
-14-

to receive them within a reasonable time.
The determination of a reasonable date for delivery must be
made in light of all the facts and circumstances. Carlson entered
his order for the Dial-A-Gift shares on the advice of Lorsbach.
Lorsbach represented to Knowles that the stock was available from
Aesir Securities. However, the early trading experience of Bagley
Securities showed that large blocks of Dial-A-Gift shares were
difficult to obtain at the price which was then being quoted. When
Bagley Securities was unable to fill Carlson's order, Lorsbach
pressured Knowles to complete the transaction or cancel the order.
The logical inference is that Carlson expected the shares to rise
in value in the near future.

When Bagley Securities decided to

short the shares, Bagley Securities gambled that it would be able
to obtain the shares to cover the short and to make a profit on the
transaction.
Bagley Securities claims that it was impossible to deliver the
certificates as requested by Carlson. A contractual obligation to
perform may be discharged "if an unforeseen event occurs after
formation of the contract and without fault of the obligated party,
which event makes performance of the obligation impossible or
highly

impracticable."

Western

Properties v.

Southern Utah

Aviation, Inc., 776 P.2d 656, 658 (Utah Ct. App. 1989) (footnotes
omitted). The burden of demonstrating impossibility of performance
-15-

is on the defendant.

Holmgren v. Utah-Idaho Sugar Co., 582 P. 2d

856, 861 (Utah 1978).

In the present case, the short supply and

rising price of Dial-A-Gift shares was not an unforeseen but a
specifically contemplated possibility.
When asked about his efforts to cover the short created by the
sale to Carlson, Dal Bagley testified that he became a market maker
and quoted the highest bid for the stock.

He also testified that

he unsuccessfully attempted to purchase or borrow shares from Olsen
& Company.

However, Dal Bagley admitted that he would have been

able to acquire the necessary shares to cover the short if he had
been willing to pay enough money.
Bagley Securities

identified

(Tr. Vol. II pp. 102-103).
itself as a market maker by

listing its name in the Pink Sheets published by the National
Quotation Bureau. However, Bagley Securities did not list a bid or
asked

price

for Dial-A-Gift

shares.

Although

there was

some

testimony that all market makers should be called before a stock is
purchased or sold, the only way that a prospective seller of DialA-Gift shares would know of Bagley Securities1 bid price would be
by telephoning Bagley Securities.

Dal Bagley himself testified

that a broker is required to call only three market makers for a
price.

(Tr. Vol. Ill p. 12) .

Dal Bagley testified that he did not cover the short because
he and other market makers would be injured.
-16-

He also testified

that the decision to cover the short would be made by someone who
sold him the stock.

(Tr. Vol. Ill pp. 9-12).

Dal

Bagley's

testimony suggests that he was simply unwilling and not unable to
purchase the stock on the open market to meet his the obligation to
deliver the certificates to Carlson.

It was not until November,

1989, after the price of Dial-A-Gift shares drastically fell, that
any

attempt

Securities

was
has

made

to

deliver

failed

to

carry

the
its

certificates.

burden

of

Bagley

demonstrating

impossibility of performance.
The testimony at trial concerning a reasonable period of time
for the delivery of stock certificates was uncertain.

While some

witnesses suggested that certificates might be delivered in a few
weeks, other witnesses testified that extenuating
might delay the delivery for several months.

circumstances

The evidence showed,

however, that the delay in this case was unreasonable and resulted
in a material breach of the contract between the plaintiffs and
Bagley Securities.
In connection with their breach of contract claim, plaintiffs
have

requested

rescission

of

the

contract.

This

remedy

is

specifically authorized by Utah Code Ann. § 70A-8-316 and seeks to
place each party in the position it was in before the contract was
made.

-17-

III.

Conclusion

The evidence at trial showed that at the time the Dial-A-Gift
shares were shorted to the Carlsons, Bagley Securities fully
intended to deliver the requested certificates.

While Bagley

Securities did make subsequent misrepresentations concerning the
certificates, these misrepresentations are not actionable under
federal or state securities laws.
However, Bagley Securities did fail to perform its contractual
obligation to deliver the certificates within a reasonable time.
Plaintiffs have requested and are entitled to reject or rescind the
transaction.

The evidence showed that plaintiffs paid Bagley

Securities a total of $79,159.00 for Dial-A-Gift shares and that no
certificates were delivered.

Judgment will be entered against

Bagley Securities in that amount. All other claims are dismissed.

IT IS SO ORDERED.
DATED this

ft

day of April, 1991.
BY THE COURT:
/

sM^*^?/*

Aldon J. Anderspn
United States Senior Judge
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THE WITNESS:
the money.

Well, I realized I hadn't gotten

And I realized that -- we realized that this

whole USA Medical thing was up in the air.

And to be

very honest, we weren't sure who was on first, who was
on second, whatever.

We knew the fact that the State of

Utah had suspend it and the S.E.C. had suspended it.
The S.E.C. in turn lifted its suspension.

So we

had to make an assumption the S.E.C. had looked at it
and said well, there's nothing to -- I mean we have
looked at our suspension and that the stock in fact
would be, you know, trading again or active again.

And

that if nothing else, Marlen needed some time to work
out the money.
I, you know, it's a situation —

the brokerage

business is an incredibly dollar and cent-oriented
thing, but it's based upon a good old boy's hand
shake.

I mean these traders will trade millions of

dollars a day on each other's word.

And a contract is a

contract.
And there are people in this industry that OTRA
will not trade with, we will not let our correspondents
trade with, because they're not nice people.

And there

are people in this industry that if they bought a
million dollars worth of stock from us, we wouldn't bat
an eye, because they are reputable people and we have
169
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Persons Deemed Not to Be Engaged in a
Distribution and Therefore Not Underwriters
Preliminary Note to Rule 144

Rule 144 is designed to implement the fundamental purposes of the Act, as
expressed in its preamble, "To provide full and fair disclosure of the character of the
securities sold in interstate commerce and through the mails, and to prevent fraud in
the sale thereof
" The rule is designed to prohibit the creation of public markets in
securities of issuers concerning which adequate current information is not available to
the public. At the same time, where adequate current information concerning the issuer
is available to the public, the rule permits the public sale in ordinary trading
transactions of limited amounts of securities owned by persons controlling, controlled
by or under common control with the issuer and by persons who have acquired
restricted securities of the issuer.
Certain basic principles are essential to an understanding of the requirement of
registration in the Act.
1. If any person utilizes the jurisdictional means to sell any non-exempt security to
any other person, the security must be registered unless a statutory exemption can be
found for the transaction.
2. In addition to the exemptions found in Section 3, four exemptions applicable to
transactions in securities are contained in Section 4 Three of these Section 4 exemptions are clearly not available to anyone acting as an "underwriter" of securities (The
fourth, found in Section 4(4), is available only to those who act as brokers under certain
limited circumstances.) An understanding of the term "underwriter" is therefore
important to anyone who wishes to determine whether or not an exemption from
registration is available for his sale of securities.
The term underwriter is broadly defined in Section 2(11) of the Act to mean any
person who has purchased from an issuer with a view to, or offers or sells for an issuer
in connection with, the distribution of any security, or participates or has a direct or
indirect participation in any such undertaking, or participates or has a participation in
the direct or indirect underwriting of any such undertaking. The interpretation of this
definition has traditionally focused on the words "with a view to" in the phrase
"purchased from an issuer with a view to . . distribution " Thus, an investment
banking firm which arranges with an issuer for the public sale of its securities is clearly
an "underwriter" under that Section. Individual investors who are not professionals in
the securities business may also be "underwriters" within the meaning of that term as
used in the Act if they act as links in a chain of transactions through which securities
move from an issuer to the public. Since it is difficult to ascertain the mental state of
the purchaser at the time of his acquisition, subsequent acts and circumstances have
been considered to determine whether such person took with a view to distribution at
the time of his acquisition. Emphasis has been placed on factors such as the length of
time the person has held the securities and whether there has been an unforeseeable
change in circumstances of the holder. Experience has shown, however, that reliance
upon such factors as the above has not assured adequate protection of investors
through the maintenance of informed trading markets and has led to uncertainty in the
application of the registration provisions of the Act.
It should be noted that the statutory language of Section 2(11) is in the disjunctive. Thus, it is insufficient to conclude that a person is not an underwriter solely
because he did not purchase securities from an issuer with a view to their distribution.
It must also be established that the person is not offering or selling for an issuer in
connection with the distribution of the securities, does not participate or have a direct
or indirect participation in any such undertaking, and does not participate or have a
participation in the direct or indirect underwriting of such an undertaking.

H2705A Reg. §230.144
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In determining when a person is deemed not to be engaged in a distribution
several factors must be considered.
First, the purpose and underlying policy of the Act to protect investors requires
that there be adequate current information concerning the issuer, whether the resales
of securities by persons result in a distribution or are effected in trading transactions
Accordingly, the availability of the rule is conditioned on the existence of adequate
current public information.
Secondly, a holding period prior to resale is essential, among other reasons, to
assure that those persons who buy under a claim of a Section 4(2) exemption have
assumed the economic risks of investment, and therefore are not acting as conduits for
sale to the public of unregistered securities, directly or indirectly, on behalf of an issuer
It should be noted that there is nothing in Section 2(11) which places a time limit on a
person's status as an underwriter. The public has the same need for protection afforded
by registration whether the securities are distributed shortly after their purchase or
after a considerable length of time.
A third factor, which must be considered in determining what is deemed not to
constitute a "distribution," is the impact of the particular transaction or transactions
on the trading markets. Section 4(1) was intended to exempt only routine trading
transactions between individual investors with respect to securities already issued and
not to exempt distributions by issuers or acts of other individuals who engage in steps
necessary to such distributions. Therefore, a person reselling securities under Section
4(1) of the Act must sell the securities in such limited quantities and in such a manner
as not to disrupt the trading markets. The larger the amount of securities involved, the
more likely it is that such resales may involve methods of offering and amounts of
compensation usually associated with a distribution rather than routine trading transactions. Thus, solicitation of buy orders or the payment of extra compensation are not
permitted by the rule.
In summary, if the sale in question is made in accordance with all of the provisions
of the rule, as set forth below, any person who sells restricted securities shall be deemed
not to be engaged in a distribution of such securities and therefore not an underwriter
thereof. The rule also provides that any person who sells restricted or other securities on
behalf of a person in a control relationship with the issuer shall be deemed not to be
engaged in a distribution of such securities and therefore not to be an underwriter
thereof, if the sale is made in accordance with all the conditions of the rule.
Reg. §230.144. (a) Definitions. The following definitions shall apply for the
purposes of this rule.
(1) An "affiliate" of an issuer is a person that directly, or indirectly through one or
more intermediaries, controls, or is controlled by, or is under common control with, such
issuer.
(2) The term "person" when used with reference to a person for whose account
securities are to be sold in reliance upon this rule includes, in addition to such person,
all of the following persons:
(i) Any relative or spouse of such person, or any relative of such spouse, any
one of whom has the same home as such person;
(ii) Any trust or estate in which such person or any of the persons specified in
paragraph (a)(2)(i) of this section collectively own ten percent or more of the total
beneficial interest or of which any of such persons serve as trustee, executor or in
any similar capacity; and
(iii) Any corporation or other organization (other than the issuer) in which
such person or any of the persons specified in paragraph (a)(2)(i) of this section
are the beneficial owners collectively of ten percent or more of any class of equity
securities or ten percent or more of the equity interest.
Federal Securities Law Reports
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(3) The term "restricted securities" means:
(i) securities that are acquired directly or indirectly from the issuer, or from
an affiliate of the issuer, in a transaction or chain of transactions not involving
any public offering; or
(ii) securities acquired from the issuer that are subject to the resale limitations of Regulation D (§ 230.501 through § 230.506 of this chapter) or Rule 701(c)
(§ 230.701(c) of this chapter) under the Act; or
(iii) securities that are subject to the resale limitations of Regulation D and
acquired in a transaction or chain of transactions not involving any public
offering; or
(iv) securities that are acquired in a transaction or chain of transactions
meeting the requirements of Rule 144A (§ 230.144A of this chapter). [Amended in
Release No. 33-6862 (fl 84,523) effective April 30, 1990, 55 F.R. 17933.]
.10 Annotations of rulings under paragraph
(a) of Rule 144—See fl 2706.222; 2706.223;
2706.2235; 2706.3039; 2706.307; 2706.308;

2706.3081; 2706.38; 2706.382; 2706.385;
2706.412; 2706.4153; 2706.5012; 2706.5013;
2706.5061; 2706.735 and 2706.83.

(b) Conditions to be Met. Any affiliate or other person who sells restricted
securities of an issuer for his own account, or any person who sells restricted or any
other securities for the account of an affiliate of the issuer of such securities, shall be
deemed not to be engaged in a distribution of such securities and therefore not to be an
underwriter thereof within the meaning of Section 2(11) of the Act if all of the
conditions of this rule are met.
(c) Current Public Information. There shall be available adequate current public
information with respect to the issuer of the securities. Such information shall be
deemed to be available only if either of the following conditions is met:
(1) Filing of Reports. The issuer has securities registered pursuant to Section
12 of the Securities Exchange Act of 1934, has been subject to the reporting
requirements of Section 13 of that Act for a period of at least 90 days immediately
preceding the sale of the securities and has filed all the reports required to be filed
thereunder during the 12 months preceding such sale (or for such shorter period
that the issuer was required to file such reports); or has securities registered
pursuant to the Securities Act of 1933, has been subject to the reporting requirements of Section 15(d) of the Securities Exchange Act of 1934 for a period of at
least 90 days immediately preceding the sale of the securities and has filed all the
reports required to be filed thereunder during the 12 months preceding such sale
(or for such shorter period that the issuer was required to file such reports. The
person for whose account the securities are to be sold shall be entitled to rely upon
a statement in whichever is the most recent report, quarterly or annual, required
to be filed and filed by the issuer that such issuer has filed all reports required to
be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the
preceding 12 months (or for such shorter period that the issuer was required to file
such reports) and has been subject to such filings requirements for the past 90
days, unless he knows or has reason to believe that the issuer has not complied
with such requirements. Such person shall also be entitled to rely upon a written
statement from the issuer that it has complied with such reporting requirements
unless he knows or has reason to believe that the issuer has not complied with such
requirements. [As amended in Release No. 34-5452 (If 9928) effective March 15,
1974.]
(2) Other Public Information. If the issuer is not subject to Section 13 or
15(d) of the Securities Exchange Act of 1934, there is publicly available the
information concerning the issuer specified in paragraph (a)(5)(i) to (xiv), inclusive, and paragraph (a)(5Xxvi) of Rule 15c2-ll (§240.15c2-ll of this chapter)
under that Act or, if the issuer is an insurance company, the information specified
1f 2705A.10
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in Section 12(g)(2)(G)(i) of that Act [Amended in Release No 33-6862 (If 84,523),
effective April 30, 1990, 55 F R 17933 ]
.30 Annotations of rulings under paragraph
(c) of Rule 144.—See 1(2706 141, 2706 2237,
2706 2241, 2706 328, 2706 49, 2706 4901,
2706 4902, 2706 4903, 2706 491, 2706 4911,

2706 4912, 2706 4915, 2706 4916, 2706 4917,
2706 492, 2706 4921, 2706 494, 2706 495,
2706 496, 2706 497, 2706 5151, 2706 58,
2706 581, 2706 70, 2706 86, 2706 88 and 2706 92

(d) Holding Period for Restricted Securities. If the securities sold are restricted
securities, the following provisions apply.
(1) General rule. A minimum of two years must elapse between the later of
the date of the acquisition of the securities from the issuer or from an affiliate of
the issuer, and any resale of such securities in reliance on this section for the
account of either the acquiror or any subsequent holder of those securities, and if
the acquiror takes the securities by purchase, the two-year period shall not begin
until the full purchase price or other consideration is paid or given by the person
acquiring the securities from the issuer or from an affiliate of the issuer.
(2) Promissory Notes, Other Obligations or Installment Contracts. Giving the
issuer or affiliate of the issuer from whom the securities were purchased a
promissory note or other obligation to pay the purchase price, or entering into an
installment purchase contract with such seller, shall not be deemed full payment
of the purchase price unless the promissory note, obligation or contract:
(i) provides for full recourse against the purchaser of the securities;
(ii) is secured by collateral, other than the securities purchased, having a fair
market value at least equal to the purchase price of the securities purchased, and
(ii) shall have been discharged by payment in full prior to the sale of the
securities.
(3) Determination of Holding Period. The following provisions shall apply for
the purpose of determining the period securities have been held:
(i) Stock Dividends, Splits and Recapitalizations. Securities acquired
from the issuer as a dividend or pursuant to a stock split, reverse split or
recapitalization shall be deemed to have been acquired at the same time as
the securities on which the dividend or, if more than one, the initial dividend
was paid, the securities involved in the split or reverse split, or the securities
surrendered in connection with the recapitalization;
(ii) Conversions. If the securities sold were acquired from the issuer for a
consideration consisting solely of other securities of the same issuer surrendered for conversion, the securities so acquired shall be deemed to have been
acquired at the same time as the securities surrendered for conversion;
(iii) Contingent Issuance of Securities. Securities acquired as a contingent payment of the purchase price of an equity interest in a business, or the
assets of a business, sold to the issuer or an affiliate of the issuer shall be
deemed to have been acquired at the time of such sale if the issuer or affiliate
was tht committed to issue the securities subject only to conditions other
than the payment of further consideration for such securities. An agreement
entered into in connection with any such purchase to remain in the employment of, or not to compete with, the issuer or affiliate or the rendering of
services pursuant to such agreement shall not be deemed to be the payment
of further consideration for such securities.
(iv) Pledged Securities. Securities which are bona fide pledged by an
affiliate of the issuer when sold by the pledgee, or by a purchaser, after a
default in the obligation secured by the pledge, shall be deemed to have been
acquired when they were acquired by the pledgor, except that if the securities
were pledged without recourse they shall be deemed to have been acquired by
Federal Securities Law Reports
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the pledgee at the time of the pledge or by the purchaser at the time o
purchase.
(v) Gifts of Securities. Securities acquired from an affiliate of the issue)
by gift shall be deemed to have been acquired by the donee when they wen
acquired by the donor.
(vi) Trusts. Where a trust settlor is an affiliate of the issuer, securities
acquired from the settlor by the trust, or acquired from the trust by the
beneficiaries thereof, shall be deemed to have been acquired when such
securities were acquired by the settlor
(vii) Estates. Where a deceased person was an affiliate of the issuer
securities held by the estate of such person or acquired from such estate b>
the beneficiaries thereof shall be deemed to have been acquired when the)
were acquired by the deceased person, except that no holding period is
required if the estate is not an affiliate of the issuer or if the securities are
sold by a beneficiary of the estate who is not such an affiliate.
NOTE: While there is no holding period or amount limitation for estates anc
beneficiaries thereof which are not affiliates of the issuer, paragraphs (c), (h) and (1) oi
the rule apply to securities sold by such persons in reliance upon the rule.
(viii) Rule 145(a) transactions. The holding period for securities
acquired in a transaction specified in Rule 145(a) shall be deemed tc
commence on the date the securities were acquired by the purchaser in such
transaction. This provision shall not apply, however, to a transaction effectec
solely for the purpose of forming a holding company.
[Amended in Release No. 33-6862 (f 84,523), effective April 30, 1990, 55
F.R. 17933.]
.40 Annotations of Rulings under paragraph (d) of Rule 144.—See fl 2706 153,
2706.185; 2706.2236; 2706.3001; 2706.3042;
2706.3051; 2706.308; 2706.3510, 2706 391,

2706 41 thru 2706 421, 2706.429, 2706 4410
2706 625, 2706 641, 2706 642, 2706 732,
2706810,2706 93

(e) Limitation on amount of securities sold. Except as hereinafter provided, the
amount of securities which may be sold in reliance upon this rule shall be determined as
follows:
(1) Sales by affiliates. If restricted or other securities are sold for the account of an
affiliate of the issuer, the amount of securities sold, together with all sales of restricted
and other securities of the same class for the account of such person within the
preceding three months, shall not exceed the greater of (i) one percent of the shares or
other units of the class outstanding as shown by the most recent report or statement
published by the issuer, or (ii) the average weekly reported volume of trading in such
securities on all national securities exchanges and/or reported through the automated
quotation system of a registered securities association during the four calendar weeks
preceding the filing of notice required by paragraph (h), or if no such notice is required
the date of receipt of the order to execute the transaction by the broker or the date of
execution of the transaction directly with a market maker, or (iii) the average weekly
volume of trading in such securities reported through the consolidated transaction
reporting system contemplated by Rule HAa3-l under the Securities Exchange Act of
1934 (§ 240.1 lAa3-l) during the four-week period specified in subdivision (ii) of this
paragraph.
[Amended in Release No. 33-5717 (If 80,601), June 8, 1976, 41 F. R. 24702;
Release No. 33-5979 (If 81,731), effective September 25, 1978, 43 F. R. 43711; Release
No. 33-5995 (1f8l,759), effective November 15, 1978, 43 F. R. 54230; Release No
34-16589 (If 82,455), effective April 5,1980, 45 F. R. 12377.]
U 2705A.40
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(2) Sales by persons other than affiliates. The amount of restricted securities sold
for the account of any person other than an affiliate of the issuer, together with all
other sales of restricted securities of the same class for the account of such person
within the preceding three months, shall not exceed the amount specified in paragraphs
(e)(l)(i), (l)(ii) or (l)(iii) of this section, whichever is applicable, unless the conditions
in paragraph (k) of this rule are satisfied. [Amended in Release No. 33-5979 (If 81,731),
effective September 25, 1978, 43 F. R. 43711; Release No. 33-5995 (f 81,759), effective
November 15, 1978, 43 F. R. 54230; Release No. 33-6032 (If 81,992), effective March
12, 1979, 44 F. R. 15612; Release No. 33-6286 flf 82,821), February 6, 1981, effective
March 16, 1981, 46 F. R. 12195.]
(3) Determination of Amount. For the purpose of determining the amount of
securities specified in paragraphs (e)(1) and (2) of this rule, the following provisions shall apply:
(i) Where both convertible securities and securities of the class into
which they are convertible are sold, the amount of convertible securities sold
shall be deemed to be the amount of securities of the class into which they are
convertible for the purpose of determining the aggreagte amount of securities
of both classes sold;
(ii) The amount of securities sold for the account of a pledgee thereof, or
for the account of a purchaser of the pledged securities, during any period of
three months within two years after a default in the obligation secured by the
pledge, and the amount of securities sold during the same three-month period
for the account of the pledgor shall not exceed, in the aggregate, the amount
specified in subparagraph (1) or (2) of this paragraph, whichever is applicable. [Amended in Release No. 33-5995 (If 81,759), effective November 15,
1978, 43 F. R. 54230.]
(iii) The amount of securities sold for the account of a donee thereof
during any period of three months within two years after the donation, and
the amount of securities sold during the same three-month period for the
account of the donor, shall not exceed, in the aggregate, the amount specified
in subparagraph (1) or (2) of this paragraph, whichever is applicable;
[Amended in Release No. 33-5995 (f 81,759), effective November 15, 1978,
43 F. R. 54230.]
(iv) Where securities were acquired by a trust from the settlor of the
trust, the amount of such securities sold for the account of the trust during
any period of three months within two years after the acquisition of the
securities by the trust, and the amount of securities sold during the same
three-month period for the account of the settlor, shall not exceed, in the
aggregate, the amount specified in subparagraph (1) or (2) of this paragraph,
whichever is applicable; [Amended in Release No. 33-5995 (fl 81,759), effective November 15,1978, 43 F. R. 54230.]
(v) The amount of securities sold for the account of the estate of a
deceased person, or for the account of a beneficiary of such estate, during any
period of three months and the amount of securities sold during the same
period for the account of the deceased person prior to his death shall not
exceed, in the aggregate, the amount specified in subparagraph (1) or (2) of
this paragraph, whichever is applicable; Provided, That no limitation on
amount shall apply if the estate or beneficiary thereof is not an affiliate of
the issuer; [Amended in Release No. 33-5995 (jf 81,759), effective November
15,1978,43 F.R. 54230.]
(vi) When two or more affiliates or other persons agree to act in concert
for the purpose of selling securities of an issuer, all securities of the same class
sold for the account of all such persons during any period of three months
shall be aggregated for the purpose of determining the limitation on the
Federal Securities Law Reports
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amount of securities sold; [Amended in Release No 33-5995 (1f8l,759),
effective November 15,1978,43 F. R. 54230 ]
(vii) Securities sold pursuant to an effective registration statement
under the Act or pursuant to an exemption provided by Regulation A under
the Act or in a transaction exempt pursuant to Section 4 of the Act and not
involving any public offering need not be included in determining the amount
of securities sold in reliance upon this rule [As amended in Release No.
33-5432 (f 79,633), effective March 15,1974, 39 F R. 6069 ]
.50 Annotations of rulings under paragraph
(e) of Rule 144.—See f 2706 2201, 2706 2231,
2706 2241, 2706 3025, 2706 303, 2706 3031,
2706 3033, 2706 3034, 2706 3035, 2706 3036,
2706 3037, 2706 304, 2706 3042, 2706 3043,
2706 3047, 2706 305, 2706 3051, 2706 3052,
2706 3053, 2706 3054, 2706 3055, 2706 3056,

2706 306, 2706 328, 2706 3853, 2706 412,
2706 481, 2706 50, 2706 501, 2706 5011,
2706 5012, 2706 5014, 2706 502, 2706 503,
2706 504, 2706 505, 2706 506, 2706 5060,
2706 5061, 2706 64, 2706 642, 2706 652,
2706 723, 2706 732, 2706 86, 2706 88, 2706 92,
270693

(f) Manner of sale The securities shall be sold in "brokers' transactions" within
the meaning of section 4(4) of the Act or in transactions directly with a "market
maker," as that term is defined in section 3(a)(38) of the Securities Exchange Act of
1934, and the person selling the securities shall not (1) solicit or arrange for the
solicitation of orders to buy the securities in anticipation of or in connection with such
transaction, or (2) make any payment in connection with the offer or sale of the
securities to any person other than the broker who executes the order to sell the
securities. The requirements of this paragraph, however, shall not apply to securities
sold for the account of the estate of a deceased person or for the account of a
beneficiary of such estate provided the estate or beneficiary thereof is not an affiliate of
the issuer; nor shall they apply to securities sold for the account of any person other
than an affiliate of the issuer, provided the conditions of paragraph (k) of this rule are
satisfied. [Amended in Release No. 33-5979 (f 82,731), effective September 25, 1978,
43 F. R. 43711; Release No. 33-6286 (1(82,821), February 6, 1981, effective March 16,
1981,46 F.R. 12195.]
.60 Annotations of rulings under paragraph
(0 of Rule 144.—See f 2706 2241, 2706.2262,

2706 2237, 2706 328, 2706 4231, 2706 656,
2706 6561, 2706 86,2706 90, and 2706 92

(g) Brokers' Transactions. The term "brokers' transactions" in Section 4(4) of the
Act shall for the purposes of this rule be deemed to include transactions by a broker in
which such broker—
(1) does no more than execute the order or orders to sell the securities as
agent for the person for whose account the securities are sold, and receives no more
than the usual and customary broker's commission,
(2) neither solicits nor arranges for the solicitation of customers' orders to buy
the securities in anticipation of or in connection with the transaction; provided,
that the foregoing shall not preclude (i) inquiries by the broker of other brokers or
dealers who have indicated an interest in the securities within the preceding 60
days, (if) inquiries by the broker of his customers who have indicated an unsolicited bona fide interest in the securities within the preceding 10 business days; or
(iif) the publication by the broker of bid and ask quotations for the security in an
inter-dealer quotation system provided that such quotations are incident to the
maintenance of a bona fide inter-dealer market for the security for the broker's
own account and that the broker has published bona fide bid and ask quotations
for the security in an inter-dealer quotation system on each of at least twelve days
within the preceding thirty calendar days with no more than four business days in
succession without such two-way quotations,
Note to Subparagraph g(2)(ii). The broker should obtain and retain in his
files written evidence of indications of bona fide unsolicited interest by his
1f 2705A.50
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customers in the securities at the time such indications are received. [As amended
in Release No. 33-5452 (If 79,633), effective March 15, 1974.]
.70 Annotations of rulings under paragraph
(g) of Rule 144.—See 1(2706.215, 2706 2237,
2706.285, 2706.328, 2706.387, 2706 388,

2706 4172, 2706 444, 2706 6561, 2706 6563,
2706 6565, 2706 6567, 270686, and 2706 92

(3) after reasonable inquiry is not aware of circumstar s indicating that the
person for whose account the securities are sold is an undei >riter with respect to
the securities or that the transaction is a part of a distribution of securities of the
issuer. Without limiting the foregoing, the broker shall be deemed to be aware of
any facts or statements contained in the notice required by paragraph (h) below
Notes, (i) The broker, for his own protection, should obtain and retain in his
files a copy of the notice required by paragraph (h).
(ii) The reasonable inquiry required by paragraph (g)(3) of this section should
include, but not necessarily be limited to, inquiry as to the following matters:
a. The length of time the securities have been held by the person for
whose account they are to be sold. If practicable, the inquiry should include
physical inspection of the securities;
b. The nature of the transaction in which the securities were acquired by
such person;
c. The amount of securities of the same class sold during the past three
months by all persons whose sales are required to be taken into consideration
pursuant to paragraph (e) of this section;
d. Whether such person intends to sell additional securities of the same
class through any other means;
e. Whether such person has solicited or made any arrangement for the
solicitation of buy orders in connection with the proposed sale of securities;
f. Whether such person has made any payment to any other person in
connection with the proposed sale of the securities; and
g. The number of shares or other units of the class outstanding, or the
relevant trading volume.
(h) Notice of proposed sale. If the amount of securities to be sold in reliance upon
the rule during any period of three months exceeds 500 shares or other units or has an
aggregate sale price in excess of $10,000, three copies of a notice on Form 144 shall be
filed with the Commission at its principal office in Washington, D. C; and if such
securities are admitted to trading on any national securities exchange, one copy of such
notice shall also be transmitted to the principal exchange on which such securities are
so admitted. The Form 144 shall be signed by the person for whose account the
securities are to be sold and shall be transmitted for filing concurrently with either the
placing with a broker of an order to execute a sale of securities in reliance upon this
rule or the execution directly with a market maker of such a sale. Neither the filing of
such notice nor the failure of the Commission to comment thereon shall be deemed to
preclude the Commission from taking any action it deems necessary or appropriate
wua respect to the sale of the securities referred to in such notice. The requirements of
this paragraph, however, shall not apply to securities sold for the account of any person
other than an affiliate of the issuer, provided the conditions of paragraph (k) of this
rule are satisfied. [Amended in Release No. 33-5307 (f 79,001), effective November 1,
1972, 37 F. R. 20577; Release No. 33-5452fl[79,633), effective March 15, 1974, 39 F.
R. 6069; Release No. 33-5452A, effective March 15, 1974, 39 F. R. 8914; Release No.
33-5560 (f 80,066), effective March 15, 1975, 40 F. R. 6487; Release No. 33-5995
(f81,759), effective November 15, 1978, 43 F. R. 54230; Release No. 33-6286
(If 82,821), February 6, 1981, effective March 16, 1981, 46 F. R. 12195.]
Federal Securities Law Reports
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(h) of Rule 144.—See f 2706.2237; 2706.301;
2706.3011; 2706.3012; 2706.3015; 2706.417;
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2706.419; 2706.500; 2706.59; 2706.611; 2706.635;
and 2706.636.

(i) Bona Fide Intention to Sell. The person filing the notice required by paragraph
(h) shall have a bona fide intention to sell the securities referred to therein within a
reasonable time after the filing of such notice.
(j) Non-exclusive rule. Although this rule provides a means for reselling restricted
securities and securities held by affiliates without registration, it is not the exclusive
means for reselling such securities in that manner. Therefore, it does not eliminate or
otherwise affect the availability of any exemption for resales under the Securities Act
that a person or entity may be able to rely upon. [Added in Release No. 33-6032
(f81,992), effective March 12,1979, 44 F. R. 15612]
(k) Termination of certain restrictions on sales of restricted securities by persons
other than affiliates. The requirements of paragraphs (c), (e), (f) and (h) of this rule
shall not apply to restricted securities sold for the account of a person who is not an
affiliate of the issuer at the time of the sale and has not been an affiliate during the
preceding three months, provided a period of at least three years has elapsed since the
later of the date the securities were acquired from the issuer or from an affiliate of the
issuer. In computing the three-year period for purposes of this provision, reference
should be made to paragraph (d) of this section. [Amended in Release No. 33-6286
(H82,821), effective March 16, 1981, 46 F.R. 12195; Release No. 33-6488 (If 83,429),
effective October 31, 1983, 48 F.R. 44770; and Release No. 33-6862 (f 84,523),
effective April 30,1990, 55 F.R. 17933.]
.90 Annotations of rulings under Rule 144
generally.—See
f 2706.221;
2706.223;

2706.2235; 2706.228; 2706.3012; 2706.39;
2706.4171; 2706.611; 2706.795.

[Adopted in Release No. 33-5223 (1f 78,487), effective April 15, 1972, 37 F. R. 596;
Release No. 33-5307 (f 79,001) effective November 1, 1972, 37 F. R. 20577; Release
No. 33-5452 (1f79,633), effective March 15, 1974, 39 F. R. 6069; Release No.
33-5452A, effective March 15, 1974, 39 F. R. 8914; Release No. 33-5560 (If 80,066),
effective March 15, 1975, 40 F. R. 6487; Release No. 33-5613 (If 80,293), effective
September 11, 1975, 40 F. R. 44541; Release No. 33-5517 (1f 80,601), June 8, 1976, 41
F. R. 24701; Release No. 33-5979 (If 81,731), effective September 25, 1978, 43 F. R.
54230; Release No. 33-6032 (1f 81,992), effective March 12, 1979, 44 F. R. 15612;
Release No. 33-6180 (1f 82,426), effective February 25, 1980, 45 F. R. 6362; Release
No. 34-16589 (H 82,455), effective April 5, 1980, 45 F. R. 12377; Release No. 33-6286
(If 82,821), February 6, 1981, effective March 16, 1981, 46 F. R. 12195; Release No.
33-6389 (If 83,106), effective April 15, 1982, 47 F. R. 11251; Release No. 33-6488
(If 83,429), effective October 31, 1983, 48 F. R. 44770; Release No. 33-6768 (1f 84,231),
effective May 20, 1988, 53 F. R. 12918; and Release No. 33-6862flf84,523), effective
April 30, 1990, 55 F.R. 17933.]
[H 2705AA]

Private Resales of Securities to Institutions
Preliminary Notes to Rule 144A
1. This section relates solely to the application of Section 5 of the Act and not to
antifraud or other provisions of the federal securities laws.
2. Attempted compliance with this section does not act as an exclusive election;
any seller hereunder may also claim the availability of any other applicable exemption
from the registration requirements of the Act.
3. In view of the objective of this section and the policies underlying the Act, this
section is not available with respect to any transaction or series of transactions that,
although in technical compliance with this section, is part of a plan or scheme to evade
the registration provisions of the Act. In such cases, registration under the Act is
required.
1f 2705A.80

Reg. § 230.144

©1990, Commerce Clearing House, Inc.

EXHIBIT "PP

8 2, 2 0 0

[ f 77,158]

Number 20—50
12-2-64

New SEC Rulings
Nassau Securities

Service

In the Matter of the Application of Nassau Securities Service.

Securities Exchange Act Release N o . 7464. N o v e m b e r 19, 1964. Findings and opinion
of the Commission in full text.
NASD—Disciplinary Action on Member Upheld—Refusal to Pay Balance Arising
Out of Buy-in Not Justified.—The failure of a N A S D member w h o made a short sale to
pay a balance arising out of a buy-in executed by the purchaser was a violation of the
N A S D rules requiring m e m b e r s to observe "high standards of commercial honor and
just and equitable principles of trade." Consequently, the censure, fine and assessed costs
imposed by the N A S D w a s upheld. T h e claim by the applicant that its refusal was based
on suspected fraud was not justified since the applicant along with some other 16 dealers,
participated in making a m a r k e t in the stock, was aware of the factors which it claims
suggest a manipulation, and when notified of the buy-in, attempted to get another extension for delivery.
See ^[25,681, " E x c h a n g e Act—Securities Associations" division, Volume 2.
Irving Garber, for Nassau Securities Service.
Marc A. W h i t e and Lloyd J. Derrickson, for the National Association of Securities
Dealers, Inc.
Nassau Securities Service ("applicant"),
a member of the National Association of
Securities Dealers, Inc. ( " N A S D " ) , a registered securities association, has applied
pursuant to Section 15A(g) of the Securities Exchange Act of 1934 for review of
disciplinary action taken against it by the
NASD.1
O n the basis of a complaint filed by
another member, James A n t h o n y & Co.,
Inc. ("complainant"), c h a r g i n g applicant
with failure to settle a $325 balance arising
out of a "buy-in" executed by complainant
under Section 59 of the N A S D Uniform
Practice Code, 8 the N A S D found that applicant violated Section 1, Article I I I of
the N A S D Rules of Fair Practice, which
requires a member in the conduct of liis
business to "observe high standards of
commercial honor and just and equitable
principles of trade." Applicant was censured, fined $1,000 and assessed costs of
$256.67. Applicant and the N A S D filed
briefs with us and we heard oral argument.
i Under Section 15A(h) of the Act. which
defines the nature of our review, we must
dismiss these proceedings if we find that applicant engaged in the conduct found by the
NASD and that such conduct violated the
NASD rule and was inconsistent with just and
equitable principles of trade, unless we further
find that the penalties imposed by the NASD
are excessive or oppressive having due regard
to the public Interest, and should be cancelled
or reduced.

1177,158

O u r findings are based upon an independent
review of the record.
[Buy-in

Procedure]

O n October 24, 1962, applicant made a
short sale of 100 shares of stock of Cryplex
Industries, Inc. ("Cryplex") to complainant
at $6.75 a share, for settlement on October
30. Complainant had other transactions in
Cryplex, one of which was a sale by it on
October 25, for settlement on October 31,
of 100 shares to H a m p s t e a d Investing Corp.
( " H a m p s t e a d " ) at $7 per share. Under
date of October 31, one day after the settlement date for the sale by applicant, complainant, in accordance with the N A S D
buy-in procedure, notified applicant that if
delivery was not made by November 1
complainant would buy-in the shares on
the market for applicant's account. Applicant requested and received an extension
of time from complainant, and on November 2 it purchased 100 Cryplex shares from
another dealer at $8.25 per share. Subse- Section 59 of the NASD Practice Code provides in substance that where a seller has not
performed its part of a contract for the sale
of securities by the d-Jte delivery is due. the
buyer, after giving due notice, may purchase,
i.e., "buy-in," in the open market and for the
account and risk of the seller, the securities
which were to have been delivered.

© 1964, Commerce Clearing House, Inc.
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quently, under date of November 9, at
which time delivery had not yet been made
on any of these transactions, Hampstead
wrote complainant notifying it that unless
its shares were delivered to it by 2:15
P. M. November 13, Hampstead would
buy-in complainant. Complainant informed
applicant on the morning of November 13
that if applicant did not deliver its shares
by that afternoon, and that if Hampstead
executed its buy-in against complainant,
complainant would deem that buy-in a
close-out of its contract with applicant,
thus, in effect, executing its buy-in against
applicant. Applicant failed to deliver the
shares by the afternoon of November 13,
and on that day Hampstead executed its
buy-in against complainant by purchasing
the Cryplex shares at $10 per share and
complainant sent a confirmation to applicant notifying it of the execution of the
buy-in against complainant and the consequent close-out of applicant's transaction.
On November 14, applicant received late
delivery of the 100 Cryplex shares which
it had purchased on November 2 and tendered them to complainant.* The tender was
refused as too late. Subsequently, Hampstead was paid the balance owed it by complainant, but applicant has not paid complainant the $325 difference between its
contract price and the buy-in price.
Applicant claimed befo r e the N A S D and
here that the market for Cryplex stock
was manipulated, and that the buy-in procedure was being used as a part of the
manipulation scheme. In support of this
contention it stated that the price of $10
per share was an unreasonably high price
in relation to the company's earnings, 4 and
that it had been told by another dealer
that "they're going to box" applicant in
on the
ick. It further asserted that the
circumst inces here are very similar to
8
The NASD noted that applicant did not
require its seller to guarantee delivery on the
settlement date even through complainant's
notice of buy-in had been previously received
and even 'hough applicant admitted that, on
previous '^casions, he had been the subject
of buy-ins.
* Applicant recites that a report of the issuer
showed earnings of one cent per share for the
year ending September 20, 1962. The issuer had
made a public offering of 80,000 shares at $3.75
per
share in April 1962.
5
Recent price quotations for Cryplex have
been in the range of SI.50 to $2 per share. A
number of the dealers quoting prices for
Cryplex stock in 1962, including Hampstead,
are not now in business. Hampstead, which
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those in two previous instances where it
was bought-in on other securities at very
high prices, after which the prices of such
securities dropped substantially and some
of the dealers involved went out of business
and could not be located, and that it had
reported those situations to the N A S D
without any results.* It states that it refused to pay complainant in order to force
the N A S D to make an investigation of
the Cryplex market.
The N A S D asserts that applicant's obligation to complainant is clear, and that
applicant offered no evidence to support
the claim of manipulation and in fact was
itself making a market in Cryplex and
appeared in tbe sheets with an offer of $10
per share when the buy-in took place.
In this case we are called upon to decide
whether under all the circumstances applicant's refusal to pay the $325 balance arising out of a buy-in effected in accordance
with the N A S D rules was without equitable excuse or justification.* W e conclude
that it was. Applicant, although claiming
before us and the N A S D that it suspected
fraud in the trading of Cryplex, was itself,
along with some 16 other dealers, participating in the making of a market in Cryplex
during the period involved and at that time
it was aware of most of the factors which
it claims suggest a manipulation. 7 Furthermore, the record indicates that applicant,
when bought-in by complainant, did not
communicate its asserted suspicions of fraud
to complainant. Rather, applicant sought
to secure another extension of time in
which to make delivery of the shares.
Applicant's contention that complainant
should have "accommodated" it by staying
the buy-in a second time is unreasonable.
T o have granted applicant's request would
have meant as indicated by the District
had been one of the underwriters in the Cryplex
public offering in 1962, withdrew its brokerdealer
registration in April 1964.
6
See ElUot Evans Compiny, Securities Exchange Act Release No. 7378 (July 29, 1964);
Franklin & Company, 38 S. E. C. 113, 116 (1957).
7
In response to the admonition of the Chairman of the subcommittee of the Board of
Governors that applicant had a duty to stop
trading Cryplex if it suspected a manipulation,
applicant stated that it was, at that time,
attempting to trade its way out of a short
position. However, we note that applicant was
entering oiTers as well as bids and its bids
were consistently among the lowest, facts that
would not indicate a desire on its part to purchase shares in order to cover a short position.
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Aetna Life Ins. Co.
Committee that complainant, already boughtin by its vendee, would be assuming applicant's obligation.
Although applicant asserts that it is not
attempting to avoid the obligation and indicates that it has offered to put the $325
in escrow pending an investigation of the
Cryplex market, it admits that it never
made such an offer to complainant and it
did not attempt to communicate with complainant in order to seek a satisfactory
solution. Although applicant claims that
it suspected fraud it was not justified in
resorting to non-payment of an obligation
owed to a fellow member of the NASD as
a lever to secure an investigation.

plicant's conduct was inconsistent with just
and equitable principles of trade and contrary to the requirements of Section 1,
Article I I I of the NASD Rules. Under
all the circumstances we cannot find that
the penalty of censure and a $1,000 fine
imposed by the NASD is excessive or
oppressive having due regard to the public
interest.

We conclude that applicant had no equitable
justification for its refusal to honor its
obligation to complainant, and that ap-

and

Accordingly, I T IS ORDERED that the
application for review of the disciplinary
action taken by the National Association
of Securities Dealers, Inc. against Nassau
Securities Service be, and it hereby is, dismissed.
By the Commission (Chairman COHEN
Commissioners

WOODSIDE, OWENS

and

BUDGE), Commissioner WHEAT not partici-

pating.

and Surety Company; Farmington Valley Insurance Company.
Investment Company Act Release No. 4082, November 19, 1964.
opinion of the Commission in full text.
Transactions Between Affiliated Persons—Exchange of Securities^
ihibition.—A
sale by an affiliate of an affiliated person of a registered investment cona^P and purchase
of other securities from the investment company incident to a plai^^^n! erger involving
the affiliated persons are prohibited by Section 17(a) of the In^^Bnent Company Act.
However, the transfer effecting the exchange of securities wa^^Bmpted from the prohibition where requirements of Section 17(b) of the Act, as toj^^ronablene ss and fairness,
were met.
^^y
See If 48,134, 48,137, "Investment Companies—Affil^^^ Functions, Directors" division of Volume 3.
^^W
Transactions Between Affiliated P e r s o n s — E x e j ^ K n from Prohibition.—A sale to
and purchase of securities from a registered inve^^Kit company by an affiliated person
of an affiliated person of the investment c o m a f through an exchange of securities
incident to a plan of merger involving the^^Bnated persons were held exempted by
Section 17(b) of the Investment Companyj/Hr from the prohibition of transactions between affiliates under Section 17(a) of th^Hct. The terms of the proposed transactions,
including the consideration to be paid j^Pfceived, were reasonable and fair and did not
involve overreaching by any person^Brcerned and the proposed transaction was consistent with the policy of the r e & « B c a investment company and the general purposes
of the Act.
jSr
See ^48,162—48,164, "Irry^Pnent Companies—Affiliates; Functions; Directors" division, Volume 3.
mtm
Affiliated Person—Mnmion.—An insurance company was determined to be an
affiliated person of a a^^Rered investment under Section 2 (a) (3) of the Investment
Company Act, sinceJjHnnvestment company held 5.09% of its outstanding voting securities. A company j f i m e d by the insurance company as part of a plan of merger and
exchange of sto^H^uso was held to be an affiliated person of the insurance company
under the A c t j H r
See ^jmBBE* "Investment Companies—Definitions" division of Volume 3.
Diversified Company—Limitations.—A registered diversified investment company
would meet the 10% limitations of Section 5 (b) (1) of the Investment Company Act
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JOHN MICHAEL COOMBS, ESQ., No. 3639
72 East 400 South. Ste. 220
Salt Lake City. UT 84111
Telephone: (801)359-0833
Attorney for Respondents

ARTMENT OF
COMMERCE

BEFORE THE SECURITIES DIVISION
OF THE DEPARTMENT OF COMMERCE
OF THE STATE OF UTAH

IN THE MATTER OF THE REGISTRATION
OF:

NOTICE OF NEWLY DISCOVERED
FACTS AND EVIDENCE

JOHNSON-BOWLES COMPANY. INC.
CRD NO. 07678

Case No. SD-89-46BD

IN THE MATTER OF THE REGISTRATION
OF:
MARLEN VERNON JOHNSON

Case No. SD-89-47AG

CRD NO. 2598888

Respondents, by and through their counsel, hereby give notice that yesterday
their counsel was apprised of pertinent material facts and evidence which directly bear on
the Administrative Law Judge's Order of August 29. 1989. and Respondents' pending Rule
12(b)(6) Motion.
The newly discovered facts, events, and evidence, comprise the following: The
NASD and Otra Clearing. Inc.. a California NASD member, have brought a disciplinary
complaint against Respondents before the NASD Business District Conduct Committee.
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District No. 3, alleging that Respondents' failure to honor trades with Otra in the securities
of U.S.A. Medical constitute violations of the Rules of Fair Practice of the NASD and/or the
Government Securities Rules of the NASD, the provisions of the federal securities laws,
and/or the rules of the Municipal Securities Rule-making Board. The NASD Disciplinary
Action is denominated by Complaint No. DEN-914 and entitled Otra Clearing, Inc. v.
Johnson-Bowles Company, Inc., and Marlen Vernon Johnson. Such has been brought in
reliance on Art. IV, §2 of the NASD Rules of Fair Practice, entitled "Complaints by public
against members for violations of rules". NASD Manual, Rules of Fair Practice (CCH) H2202.
The Division is requested to take judicial notice of the foregoing disciplinary proceedings in
accordance with the Utah Rules of Evidence as contemplated in §63-46b-8(1)(b)(iv), Utah
Code Ann. The foregoing is significant in that it evidences the undeniable conflict between
federal securities laws and the instant state administrative adjudicative proceedings as
Respondents have continuously and consistently alleged throughout these entire
proceedings to no avail. In other words, the foregoing evidences that Respondents could
not comply with their federal Exchange Act obligations and at the same time not violate
state law as contemplated in the instant state administrative proceedings. [Emphasis
added.] The foregoing further evidences the undeniable conflict the instant proceedings
pose between state and federal law. Further, it is significant that the NASD/Otra
disciplinary action, which seeks to revoke or suspend the NASD registration of Respondents,
is not brought as an ordinary NASD arbitration matter. On the contrary, such is brought to
discipline Respondents for alleged violations of federal law — federal violations which
allegedly justify putting Respondents out of business for reasons diametrically opposite to
those alleged in the instant administrative proceedings. The foregoing further evidences
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that the Division's representations at the hearing on Respondents' Rule 12(b)(1) Motion on
July 14, 1989, that the NASD would not discipline Respondents for not honoring Exchange
trades is patently erroneous and false as Respondents have further contended all along.
A true and correct copy of the NASD Notice of Complaint is attached hereto and
incorporated by reference as Exhibit "A".
DATED thlsy/, day of November.

The undersigned hereby certifies that on t h e / , day of November. 1989, (s)he
mailed a true and correct copy of the foregoing NOTICE OF NEWLY DISCOVERED EVIDENCE
by regular mail, postage prepaid to John C. Baldwin, Director and Kathleen C. McQinley,
Director of Broker-Dealer Section, Securities Division. Utah Department of Commerce, 160
East 300 South, P.O. Box 45802. Salt Lake City. Utah 84145-0802; Administrative Law Judge
J. Stephen Eklund. Esq., Department of Commerce, 160 East 300 South, P.O. Box 45802.
Salt Lake City, Utah 84145-0802; Craig F. McCullough, Esq., Callister, Duncan. & Nebeker.
Co-Counsel to Respondents, 8th Floor, Kennecott Bldg., 10 East South Temple Street, Salt
Lake City, Utah 84133; and Mark J. Griffin. Esq.. Assistant Attorney General, 115 State
Capitol Building, Salt Lake City, Utah 84114.
~
*
^

J:N0TICE.l

-3-

CP-2 (4/89)

National Association of Securities Dealers, Inc.
NOTICE OF COMPLAINT
Complaint No.: DEN-914
Date Filed:
October 25, 1989
Origin:
To:

Name and Address of Respondent(s):
Johnson-Bowies Company, Inc., 430 East 400 South, Salt Lake City, UT 84111
and Marlen Vernon Johnson, 430 East 400 South, Salt Lake City, UT 84111

From: OTRA CLEARING, INC
116 North Maryland, Suite 120
Glendale, California 91206
You are hereby notified that a complaint has been filed by Otra Clearing, Inc., a true copy of which
is attached hereto, alleging that you have violated the Rules of Fair Practice of the NASD, and/or the
Government Securities Rules of the NASD, the provisions of the federal securities laws, and/or the rules
of the Municipal Securities Rulemaking Board
All individual respondents named in this proceeding are reminded of the requirement to immediately
update their application for registration (Form U-4) upon receipt of this notice ot complaint to reflect that
they have been named a respondent in this complaint
ANSWER: Pursuant to Article II Section 3(a) of die Code of Procedure applicable to disciplinary actions
involving members and associated persons, you are required to submit to the District Business Conduct
Committee^ three (3) copies of a written answer to said complaint within twenty (20) calendar days of the
date of this notice on the forms enclosed herewith. The answer should be complete and responsive to
each allegation contained in the complaint. If applicable, attenuating or mitigating circumstances should
be discussed in the answer in order to give the Committee, benefit of this information. In complaints
involving multiple respondents, copies of the answers submitted by each respondent will be mailed to all
other respondents,
HEARING: If you desire and indicate such in year answer, a hearing on this matter will be held at least
ten (10) calendar days after notice of its time and place has been sent to you.
EVIDENCE AT HEARING: Upon respondent's request, the NASD staffs witness list and proposed
exhibits for the hearing shall be made available to the respondent no later than five business days before
the hearing. Similarly a respondent shall submit to the NASD staff its proposed exhibits and witness list
no later than five business days prior to the hearing.
OFFER OF SETTLEMENT: Pursuant to Artide II Section 11 of the Code of Procedure you may
propose an offer of settlement to Otra Clearing, Inc. Such offer must be in writing and contain a detailed
restatement of the complaint, a consent to findings of fact and violations, a proposed sanction to be
imposed, and a waiver of all rights of appeal
Questions regarding the above should be directed to:
,

Cynthia King Sadick, Senior Regional Attorney, (303) 298-7234
(Name, Title, Telephone No.)
//1

y, _
>
C l t ) >-6^5
i • V:>( • ;/, //.?
District Director
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for District No. 3
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NATIONAL ASSOCIATION OF SECURITIES DEALERS, INC.
1735 K STREET, N.W., WASHINGTON, D.C. 20006
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EXHIBIT "RR"

Arbitration

January 14, 1991

National Association of
Securities Dealers, Inc.
425 California St., Rm. 1400
San Francisco, CA 94104
(415) 781-3343
FAX: (415) 362-9946

John Michael Coanbs, Esq.
72 East 400 South, Ste. 220
Salt Lake City, UT 84111
Subject: NASD Arbitration Number 90-00757
OTRA Clearing, Inc. vs. Johnson Bowles Company, Inc. and Marlen
Vernon Johnson
Dear Mr. Cocmbs:
In accordance with the NASD Code of Arbitration Procedure, a decision in the
above-captioned matter has been reached by the arbitrators and is enclosed.
Any questions regarding this decision should be directed to me.
«MSt not Contact the arbitrators directly,
Very truly yours,

Virginia Hall
Arbitration Administrator
415-781-3343

VH:REH:LC09A
Enclosure

The parties.

NATIONAL ASSOCIATION OF SECURITIES DEALERS, INC.
In the Matter of the Arbitration Between
Otra Clearing, Inc.
Claimant
AWARD
vs.
NASD # 90-00757
Johnson-Bowles Company, Inc.
Marlen Vernon Johnson
Respondents
SUMMARY OF ISSUES
Claimant alleged Respondents failed to fulfill a contract
for the purchase and sale 01 150,000 shares of U.S.A. Medical
common stock. Claimant alleged that Johnson-Bowles was a market
maker for this stock and, as such, was obligated to complete the
transaction. Claimant further alleged that it was compelled to
buy-in the shares on behalf of Respondent Johnson-Bowles, and
that it suffered a monetary loss from Respondents' failure to pay
for the buy-in.
Claimants alleged violations of federal
securities laws and the NASD rules of Fair Practice.
Respondents denied all allegations of wrong-doing, and
asserted that a scheme to perpetrate a stock fraud was undertaken
by third parties which victimized Respondents and left them
unable to complete the transaction. Respondents further asserted
that rulings of the State of Utah Division of Securities and of
the U.S. District Court for the Central Division of Utah rendered
the further trading of USA Medical illegal in the State of Utah,
thus relieving them of the obligation to complete the
transactions at the time.
Respondents alleged that a later
attempted delivery of the shares to Claimant was refused.
DAMAGES AND RELIEF REQUESTED
Claimant requested actual damages of $89,600.00, punitive
damages of $100,000.00, plus interest, attorneys' fees and costs
of arbitration.
Respondents requested dismissal of all claims and an award
of attorneys' fees.
DAMAGES AND RELIEF AWARDED
This claim was filed with the NASD on M?rch 14, 1990. A
pre-hearing telephone conference was held October 31, 199 0, and
lasted one (1) session. On December 13 and 14, 1990, the
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undersigned arbitrators heard the
controversy between the
parties as set forth in submissions to arbitration signed by
Claimant on March 13, 1990, by Johnson-Bowles Company on May 7,
1990, and by Marlen Johnson on December 13, 1990. The hearing
was conducted in Salt Lake City, Utah and lasted four (4)
sessions.
The arbitration panel, having considered the
pleadings, the testimony, and the evidence presented at the
hearing, has determined in full and final resolution of the
issues submitted as follows:
1.

Respondents Johnson-Bowles and Marlen Johnson are
jointly and severally liable for and shall pay to
Claimant the sum of $89,600.00 plus interest at the
rate of 10% from February 23, 1989 to date of payment.

2.

The claim for punitive damages is dismissed.

3.

The parties shall each bear their respective costs
including attorneys' fees.

4.

In accordance with Section 44 of the NASD Code of
Arbitration Procedure, the NASD shall retain the
$1,000.00 filing fee previously deposited by the
Claimant as an assessment of forum fees. Respondents
are jointly and severally assessed forum fees of
$4,000.00, payable to the NASD.
OTHER ISSUES

This claim was ordered to arbitration by Order dated March
1, 1989, in Case No. 89-C-157-G in the United States District
Court for the District of Utah, Central Division.
ARBITRATORS CONCURRING
DATE SERVED: 1/14/91

Peggy Peterson
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Arbitration

State of California

)
)

County of San Francisco

)

A r e i i A V I T OF a a f l f j g E N a t i o n a l Association of
Securities Dealers, Inc.
425 California St., Rm. 1400
San Francisco, CA 94104
SS.
(415) 781-3343
FAX:

<415) 362-9946

I, Rhenee M. Ong, hereby declare, depose and state under penalty of
perjury that:
1.
I am over eighteen years of age, am not a party to the arbitration
proceedings, and am employed by the National Association of Securities
Dealers, Inc. in San Francisco, California.
2.

On January 14r 1991 . I enclosed a true, accurate and complete copy

of:
AWARD SERVED:
NASD Arbitration Number 90-00757
OTRA Clearing, Inc. vs. Johnson Bowles Company, Inc. and Marlen Vernon
Johnson
in a properly addressed wrapper, with postage prepaid, and deposited it in a
post office or official depository under the exclusive care and custody of
the United States Postal Service within this state. The addressee(s) and the
address(es) to which the above document(s) was/were sent is/are:
John Michael Coombs, Esq.
72 East 400 South, Ste. 220
Salt Late City, IJT 84111
Christopher Condie, Esq.
Van Wagoner & Stevens
215 South State Street
Suite 500
Salt Lake City, UT 84111
3.
The address (es) set forth in paragraph 2 is/are the address (es)
designated for that purpose by a party/parties to the arbitration or
its/their counsel or is/are the last known address (es) thereof.
4.
I declare under penalty of perjury, pursuant to 28 U.S.C. 1746,
that the foregoing is true.

M. Ong/
%D6CJ!

EXHIBIT "SS

JOHN MICHAEL COOMBS. ESQ.. No. 3639
72 East 400 South. Ste. 220
Salt Lake City. UT 84111
Telephone: (801)359-0833
Attorney for Respondents

BEFORE THE SECURITIES DIVISION
OF THE DEPARTMENT OF COMMERCE
OF THE STATE OF UTAH

IN THE MATTER OF THE REGISTRATION

REQUEST FOR AGENCY REVIEW
OF ENTIRE RECORD AND
SUPPORTING BRIEF

OF:
JOHNSON-BOWLES COMPANY. INC.
CRD NO. 07678

Case No. SD-89-46BD

IN THE MATTER OF THE REGISTRATION

OF:
MARLEN VERNON JOHNSON

Case No. SD-89-47AG

CRD NO. 2598888

REQUEST
PLEASE TAKE NOTICE that in accordance with Utah Code Ann. §63-46b-12
and/or R151-46b-12 of the Rules of Procedure for Adjudicative Proceedings Before the
Department of Commerce, Respondents hereby request agency or superior agency review
of the entire record before the Administrative Law Judge Including, but not limited to the
August 13,1990, Findings of Fact, Conclusions of Law, and Order. This request for agency
review is not intended by Respondents to be a waiver of any right to judicial review under
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Utah Code Ann, §61-1-23. §63-46b-14. and/or §63-46b-16. Respondents interpret the
UAPA and the corollary Department of Commerce Rules as requiring this request for agency
review before judicial review is either permissible or available. By filing this Request.
Respondents further do not intend to waive a ruling by the ALJ (or anyone else) on their
pleadings filed August 20. 1990 relative to the August 13. Order. This is because under
applicable rules. Respondents have no choice but to file this Request on or before today.
August 23,1990. Respondents have also not furnished a copy of this Request to the ALJ in
that they understand that the matter is out of his hands and he will not be participating in
any decision on this Request. Respondents also incorporate herein by reference as Exhibit
"A", a true and correct copy of the official transcript of the July 16,1990, proceedings
before the Securities Advisory Board and the ALJ.
BRIEF
The following will serve as Respondents' Brief in support of this Request for
Agency Review. Respondents make reference to the various memorandums in support of
and in reply to the motions and subsequent orders issued by the ALJ in the record. The
orders from which agency review is sought are numbered hereinbelow and the pleadings to
which the reviewing or presiding officer is

acted to refer to in each regard are further

referenced below. The pleadings referenced below are in no way intended to be exhaustive
of what is otherwise in the record and which should be considered in ruling on this Request.
The reviewing officer is also directed to hear the tapes of any oral argument that occurred,
as applicable to otherwise ensure that the ALJ did not err. Based on the foregoing, and, for
the sake of convenience, the reviewing officer is directed to the following in the record.
1.

Order Granting The Division's Motion to
Convert

07/14/89

Reference is made to: Respondents' Objection
to Motion to Convert.

05/30/89

Reference is also made to tape of oral argument.
With respect to this ruling, a ruling which determined the rights of Respondents throughout
the remainder of the proceedings (and which prejudiced them accordingly). Respondents
further submit that the Division promulgated its own set of rules whereby actions such as
those brought against Respondents would strictly be designated as informal proceedings.
Even in light of its own rules which the Division is obligated to follow, the Division still
elected to bring the proceedings as informal at the outset and. while it never had or stated
any legitimate grounds to convert. Respondents submit that it otherwise waived any right or
other ability to convert the proceedings to formal. Further, the ALJ's order granting the
motion to convert is erroneous in that its only effect Is to deprive Respondents of a trial de
novo in the district court without any other basis in law or fact. For instance, so-called
"cost-effectiveness" cannot be a basis for such order in that, after 1% years of costly and
time consuming litigation, the Division has spent a fortune of the taxpayers' money in this
litigation and a trial de novo in the district court would have been simpler, more efficient.
cheaper, and swifter. Furthermore, if the ALJ is correct in his order granting the motion to
convert, there would never be a circumstance when any informal proceeding could not be
converted to formal simply because. Hke a spoiled child, that is what the Division, or any
other agency, desires. The ALJ's Order is thus further contrary to what the legislature has
provided by statute, namely, allowing those such as Respondents with the right to a trial de
novo.
PLEADINGS
2.

DATES

Order Denying Respondents' Rule 12(b)(1)
Motion.
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08/29/89

O'KK C^>4

Reference is made to: Respondents' Supporting
Memorandum

07/03/89

Reference is also made to: Affidavit in Support
of 12(b)(1) Motion.

07/13/89

Reference is further made to: Respondents'
letter or Reply Memorandum to the ALJ.

07/13/89

Reference is further made to Respondents' Brief in Support of Request for Agency Review
of the ALJ's 8/29/89 order dated September 11.1989. and Respondents' Reply
Memorandum in Support of Request for Agency Review dated October 6.1989. The
reviewing officer is requested to address all issues presented in such memorandums and
pleadings, item by item, more especially those that the ALJ neglected to address.
3.

Order Denying Respondent's 12(b)(6) Motion
Reference is made to: Respondents' Supporting
Memorandum.
Reference is further made to Respondents
Reply Memorandum.

12/18/89

09/27/89
10/25/89

Respondents assign error on the basis of any one or all of the arguments presented In the
foregoing pleadings and request that the reviewing officer address all arguments posed
therein, item by item. There are also several Constitutional issues that the ALJ wholly
neglected to address and which should be addressed for purposes of judicial appeal.
4.

5.

Order Granting the Division's Motion to
Dismiss Respondents' Counterclaim.
(Separate from the order in #3 above.)

12/18/89

Reference is made to the Respondents' Opposing
Memorandum.

11/09/89

Order Denying Respondents' Motion for Summary
Judgment.

03/23/90

Reference is made to: Respondents' Supporting
Memorandum.

11 /28/89
{h'lr
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their Reply Memorandum.

12/21 /89

their Objection and Motion to Strike.

12/21/89

Respondents' counsel's Rule 56(f) Affidavit
in Opposition to Petitioner's Motion for Partial
Summary Judgment.

12/21/89

Reference is further made to: Affidavits of the five (5) Utah residents from whom
Respondents purchased the stock in issue, filed November 28,1989, with the ALJ, including
the 11 /29/89 affidavit of Carl Smith. Reference is further made to the Affidavit of Bruce
Eatchel dated December 20,1989 and Respondents' Supporting Affidavit dated November
27.1989.
The Order Denying Respondents' Motion for Summary Judgment was
erroneous in that the ALJ was indeed competent to rule on the merits and his ruling should
have been the subject of a Request for Agency Review and subsequent Judicial Review as
opposed to proceeding unnecessarily with a trial on July 16,1990. Respondents believe
that the August 13,1990, Order was pre-ordained and in the interest of expediting the
process, the ALJ could have made the same ruling relative to Respondents' Motion for
Summary Judgment. The fact of the matter is that there was no issue of fact for a trial and
the ALJ was Just as competent as the Securities Advisory Board to make an ultimate ruling.
The ALJ's 3/23/90, which concluded the contrary, was thus error and needlessly resulted In
a trial on July 16.1990.
However, most significantly, the ALJ erred In that Respondents should have
been granted summary Judgment dismissing the proceedings on the basis of the arguments
presented In the above-referenced pleadings. For instance. Respondents cannot be liable,
as a matter of law, for aiding and abetting in that they neither created (nor participated in)
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the problem which caused exemptions to be unavailable nor did they solicit their sellers as a
matter of law —thereby nc* "substantially participating'' in any underlying wrong. In
addition. Respondents are otherwise within the class of persons (i.e.. purchasers) that
registration statutes were enacted to protect. Thus, the Division's aiding and abetting
theory is fundamentally and logically flawed. See the law cited by Respondents in the above
memorandums and the Schvaneveldt case quoted in Exhibit MAM attached hereto and
incorporated by reference. Further see the transcript of Mr. David R. King's expert
testimony in Exhibit "A" hereto. See also Kerbs v. Fall River Industries. Inc.. 602 F.2d 731
(1974). the leading 10th Circuit case on aiding and abetting in the securities law context.
6.

Findings of Fact, Conclusions of Law and
Order.

08/13/90

See the entire transcript attached hereto as Exhibit "A".
In support of Request for Agency Review of this particular order, reference is
made to the transcript of the proceedings held on July 16.1990. which evidence that the
August 13. Order Is not supported in the least by the evidence. A true and correct copy of
the official transcript of the July 16.1990. hearing, with Respondents' counsel's
corrections, is attached hereto and incorporated by reference into the record as Exhibit
"A". Specifically, the Findings of Fact are superfluous and unsupported by the record; the
Conclusions of Law do not follow from the Findings or the record of proceedings; and the
Order, including the Sanction, is neither supported by the Findings of Fact nor the
Conclusions of Law.
In further support of review of this particular Order. Respondents incorporate
by reference their August 20.1990. Objection to the form of content of such order, their
counsel's supporting affidavit dated August 20, and their Demand for Disclosure of how and
*.,;
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by whom the August 13, Order was prepared, also dated August 20. Respondents are
prejudiced on appeal by the August 13. Findings of Fact. Conclusions of Law, and Order
("Order") in its present form. This is because the appellate court must defer to the finder of
fact and may only overturn such Order in the event it concludes that no reasonable person
could have made the findings set forth in such Order. Because the Order is grossly
one-sided and "padded" with ridiculous material which is not reflective of what actually
occurred on July 16. 1990. Respondents are infinitely prejudiced on appeal. In addition,
considering that the Securities Advisory Board acted as a de facto Jury, there should be no
findings of fact or conclusions of law. simply a verdict and corollary sanction analogous to a
sentencing. It such event, it would be the transcript which would alone go up on appeal all
by itself, not the prejudicial and biased Order in addition thereto (which will now get the
most attention).
CONCLUSION
Based on the foregoing and Utah Code Ann. §63-46b-12(1)(b)(ii). Respondents
pray for reversal of the Orders referred to above and for an order dismissing and vacating
the proceedings, more especially the August 13.1990. Order, as a matter of law.
In accordance with applicable Department of Commerce Rules, this document
is intended to serve, on the basis of the portions of the record referred to. as a Brief in
Support of Respondents' Request for Agency Review. Again, the citations to the record are
not exclusive of what the reviewing officer should direct his attention to in ruling on this
Request.
The parties seeking review have further signed this Request as required under
Utah Code Ann. §63-46b-12(b)(1). Respondents further waive oral argument in that they
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believe their arguments are sufficiently presented in the record and in the ALJ's tape
recordings of oral argument on each motion. The reviewing officer is also respectfully
requested to listen to the tape recorded proceedings of formal hearings heard on each of
the foregoing motions, as applicable.
DATED this 23rd day of August. 1990/

Coombs
ttorney for Respondents

JOHNSON-BOWLES. COMPANY. INC..
Respondent

By: MaNenV.
Its: President

Matylen\f\. Johnson, Respondent
CERTIFICATE OF SERVICE
The undersigned hereby certifies that on the 23rd day of August. 1990. (s)he
hand-delivered a true and correct copy of the foregoing REQUEST FOR AGENCY REVIEW OF
ENTIRE RECORD AND SUPPORTING BRIEF to John C. Baldwin. Director and Kathleen
C. McGlnley. Director of Broker-Dealer Section. Securities Division. Utah Department of
Commerce. 160 East 300 South. P.O. Box 45802. Salt Lake City. Utah 84145-0802; Mark J.
Griffin. 115 State Capitol. Salt Lake City. Utah 84114; and Craig F. McCullough. Esq.. of
Callister. Duncan & Nebeker. Co-Counsel to Respondents. 8th Floor, Kenqecott Bldg.. 10
East South Temple Street. Salt Lake City. Utah 841:

J:REQUEST.fl-ll
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File Copy

SECLT.riESD.

'fVON

CERTIFICATE OF REGISTRATION
(Not transferable)
File Number 3334-14/A05794-21
THIS CERTIFIES THAT
USA MEDICAL CORPORATION ("USA") whose
address is 2020 South 1900 West, Ogden, Utah 84401, has complied
with the requirements of §61-1-10 of the Utah Uniform Securities
Act, and is granted this registration FROM March 1, 1991 TO
February 29, 1992 (Unless sooner revoked by this Division as
provided by law).
This certificate applies only to previously distributed
securities currently held by bona fide purchasers who purchased the
securities in the public market. USA shall provide the Division
copies of its shareholder list at pre-determined
intervals
throughout the effectiveness of this registration.
Within two
weeks of the effective date, USA shall provide each current
shareholder a copy of its f^nal prospectus.
USA shall advise
current shareholders to dis lose information contained in the
prospectus to prospective purchasers and brokers through whom ^ales
are solicited.
STATE OF UTAH
\ SS
COUNTY OF SALT LAKE J

UTAH SECURITIES DIVISION

S w W A M O H f l R u U . DOCUMENT ON FILE IN MY

° F ^NE«Wo E ^W0i:SA..WV«.0M
THIS_!ii£_DAY O F ^ Y K ^

nU

~

-PECTO I
SAA

PROSPECTUS
FOR REGISTRATION PRIOR TO SECONDARY T R A D I N G ^
LIFE CONCEPTS, INC.
(Formerly U.S.A. Medical Corporation)/^
(A Wyoming Corporation)
&
2020 South 1900 West
8
Ogden, Utah 84401
\$

jjpff JQ0
*
Wl
D
sffi°fcZecf
iSg^S^

26,352,500 Shares Outstanding
Common Capital Shares (Par Value $.001 Per Sha
(ALTHOUGH 26,352,500 AMOUNT OF SHARES REPRESENT THE OUTSTANDING SHARES AS OF
DECEMBER 31, 1989, THE COMPANY BELIEVES THAT NOT ALL OF THE OUTSTANDING
SHARES ARE HELD BY BONA FIDE PURCHASERS.
THE ATTORNEY'S OPINION AS TO
LEGALITY OF THE SHARES AND THE ATTORNEY'S OPINION AS TO TRADEABILITY OF THE
SHARES APPLY ONLY TO THE SHARES THAT ARE HELD BY BONA FIDE PURCHASERS.)
Life Concepts, Inc., (formerly U.S.A. Medical Corporation), a Wyoming
corporation (hereinafter the "Company"), was incorporated on January 12,
1979.
The Company has manufactured and markets medical products which
include general aspirators.
(See "Description of Business" and "Risk
Factors.")
Purchase of the shares of the Company's common stock (the "Shares")
involve a high degree of risk to the public investors and shares should be
purchased only by persons who can afford to lose their entire investment.
(See "Risk Factors.")
Although the Company is not a development stage
corporation, it has had only limited operations since March 1989, there has
been no public market for the shares of the Company, in Utah for over one
year, and there can be no assurance that a public market will develop. This
prospectus relates only to securities that are offered to residents of the
state of Utah through the "secondary trading" market.
THESE SECURITIES HAVE NOT BEEN REGISTERED WITH THE UNITED STATES
SECURITIES AND EXCHANGE COMMISSION BECAUSE THEIR SECONDARY TRADING IS
BELIEVED TO BE EXEMPT FROM REGISTRATION UNDER SECTION 4(1) OF THE SECURITIES
ACT OF 1933 AND RULE 144 PROMULGATED THEREUNDER BY THE SECURITIES AND
EXCHANGE COMMISSION. THE SECURITIES ARE REGISTERED UNDER THE SECURITIES LAWS
OF THE STATE OF UTAH.
THESE SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE SECURITIES
AND EXCHANGE COMMISSION NOR THE SECURITIES DIVISION OF ANY STATE NOR HAS THE
COMMISSION OR ANY STATE PASSED UPON THE ACCURACY OR ADEQUACY OF THIS
PROSPECTUS. NEITHER THE UTAH SECURITIES DIVISION NOR ANY OFFICER OF THE
STATE OF UTAH HAS PASSED UPON THE MERITS OF THESE SECURITIES OR UPON THE
ACCURACY OR COMPLETENESS OF THIS PROSPECTUS. NO PERSON HAS BEEN AUTHORIZED
TO MAKE ANY STATEMENTS NOT CONTAINED IN THIS PROSPECTUS. ANY REPRESENTATION
'TO THE CONTRARY IS A CRIMINAL' OFFENSE.
The Date of this Prospectus is March 1, 1991 (As amended to March 9, 1991)
Brokers must provide m i s prospectus to p u r c h a s e r < # j ^ receive a signed
"representation form" from purchasers for one year ^¥V®fe5)Ftftfe^«fcective date
of
the
prospectus.
*• THE UNDERSIGNED, DIRECTOR or THE
U i
UUG
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*

SECURITIES DIVISION OF THE DEPARTMENT OF

COMMERCES© HEREBY CERTIFY THAT
THE ANNEXED AND FOREGOING IS A TRUE AND F U l t
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OFFICE AS SUCH DIRECTOR.
WITNESS MY HAND AND SEAL OF SAID DIVISION

THIS^JL^DAY OP

4 ^ * /

** f /

NO BROKER, DEALER, SALESMAN, AGENT OR ANY OTHER PERSON HAS
BEEN AUTHORIZED TO GIVE ANY INFORMATION OR TO MAKE ANY
REPRESENTATIONS OTHER THAN THOSE CONTAINED IN THIS PROSPECTUS.
PRACTICES TO THE CONTRARY ARE A CRIMINAL OFFENSE. IF GIVEN OR
MADE, SUCH INFORMATION OR REPRESENTATION MUST NOT BE RELIED UPON
AS HAVING" BEEN AUTHORIZED BY THE COMPANY. UTAH BROKERS WHO MAKE
A MARKET IN THE COMPANY'S STOCK DURING THE ONE-YEAR REGISTRATION
PERIOD MUST COMPLETE FORM 10.2-IB AND FILE IT WITH THE UTAH
SECURITIES DIVISION.
ANY AND ALL AMENDMENTS TO THIS PROSPECTUS WILL BE PROMPTLY
FILED WITH THE UTAH SECURITIES DIVISION, DISTRIBUTED TO
SHAREHOLDERS, AND MADE A PART OF ANY PROSPECTUS USED THEREAFTER.
THE COMPANY WILL PROMPTLY NOTIFY THE UTAH SECURITIES DIVISION,
MARKET MAKERS AND SECURITY HOLDERS IN WRITING OF ANY CHANGE IN THE
MANAGEMENT, PURPOSE AND CONTROL OF THE ISSUER, OR ANY MATERIAL OR
ADVERSE CONDITION AFFECTING THE COMPANY.
THE ONGOING INVESTIGATION BY THE UTAH DIVISION OF THE
COMPANY'S SECURITIES MAY RESULT IN THE ISSUANCE OF AN ORDER BY THE
DIVISION, AT SOME FUTURE DATE, STOPPING FURTHER TRADING IN THE
SECURITIES OF THE COMPANY.
REGISTRATION OF THIS PROSPECTUS WITH THE UTAH SECURITIES
DIVISION IS NEITHER A RECOMMENDATION NOR AN ENDORSEMENT OF ANY
SECURITY, INDIVIDUAL, FIRM, OR CORPORATION.

Brokers effecting transactions in the Company's stock mustr
provide Form 10.2-1B within five days of the execution of the first
trade in the Company's stock.

(THIS SPACE INTENTIONALLY LEFT BLANK)

11

TABLE OF CONTENTS
SUMMARY OF PROSPECTUS
Purpose of Prospectus
Risk Factors
The Company
The Offering Through Secondary Trading
Capitalization
Use of Proceeds
Financial Summary

1
1
1
1
2
2
2
2

RISK FACTORS

2

DILUTION

8

MARKET PRICE IN RELATION TO NET TANGIBLE BOOK VALUE

. .

9

USE OF PROCEEDS

10

DESCRIPTION OF BUSINESS
CORPORATE HISTORY
INTEGRITY AND EXISTENCE OF CORPORATE DOCUMENTS
PRODUCT DEVELOPMENT
Government Regulation
High Powered Surgical Aspirator and Surgical Cannula
Market
Rationale For High Powered Aspiration
NEW MEDICAL PRODUCTS
ACQUISITION OF OTHER PRODUCTS
LITIGATION AND ADMINISTRATIVE ACTIONS
PATENTS
COMPETITION
FINANCIAL STATUS
OFFICES
EMPLOYEES

10
10
10
11
12

14
18
18
18
18
18

CAPITALIZATION AND DESCRIPTION OF SECURITIES

19

12
13
13

MARKET PRICE OF SHARES
MANAGEMENT
OFFICERS AND DIRECTORS
COMPENSATION
INDEMNIFICATION OF OFFICERS AND DIRECTORS
FIDUCIARY RESPONSIBILITY

20
20
21
21
22

TRANSACTIONS WITH MANAGEMENT

23

PRINCIPAL SHAREHOLDERS

23

DIVIDENDS

27

iii

PLAN OF D I S T R I B U T I O N

27

LEGAL M A T T E R S

28

EXPERTS

28

OTHER M A T T E R S

29

EXHIBITS

30

FINANCIAL S T A T E M E N T S

31

iv

SUMMARY OP PROSPECTUS

The following is intended merely to summarize certain material
contained in this Prospectus and is qualified in its entirety by
the information and the financial statements appearing elsewhere
herein.
Purpose of Prospectus
On March 1, 1989, the Utah Securities Division issued Orders
which suspended secondary trading of the Company's common stock
within the state of Utah.
On September 1, 1989, the Division
publicly announced its decision to allow shares of the Company's
stock to resume trading as soon as the Division declares effective
the registration statement filed with the Division on behalf of the
Company.
The Division's decision to permit trading in U.S.A.
Medical stock to resume does not reflect any approval or
disapproval of these securities, nor does it reflect any opinion
about whether these securities have any value. At the date of this
prospectus, the Division's investigation into irregularities of
trading of the Company's stock is continuing. Such investigation
may result in the issuance of an order by the Division, at some
future date, stopping further trading in the securities of the
Company.
Risk Factors
The purchase of the Company's securities involves significant
risks to an investor, including the fact that the Company has
engaged in limited operations to date, stock certificates with
forged signatures or certificates issued following transfer or
cancellation of such certificates may exist, and other significant
factors which make investment herein a highly speculative venture.
(See "Risk Factors.'1)
The Company
Life Concepts, Inc., formerly U.S.A. Medical Corporation and
S.M.I., Inc.,
(the "Company"),
is a Wyoming
corporation
incorporated on January 12, 1979. The Company merged with a Utah
company, in December 1987, which was engaged in development and
manufacturing of medical products. Questions exist concerning the
legality of this merger. The Company has had limited operations
since its inception. (See "Description of Business.h)
The offices of the Company are presently located at 202 0 South
1900 West, Ogden, Utah 84401.
1

The Offering Through Secondary Trading
The Company's shares are not being offered by the Company and
the Company will receive no proceeds from the sale of shares
contemplated herein.
The shares are being registered with the
state of Utah and may be offered for sale by existing shareholders
through brokers and market makers.
Questions exist concerning
whether some presently existing shareholders acquired their shares
through a transfer of stock certificates with forged signatures.
Capitalization
Date of Capitalization
Shares of Common Stock: Insiders
Shares of Common Stock: Publicly-Held
Par Value Per Share
Book Value Per Share

December 31, 1990
16,000,000
10,352,500
$.001
($.00784)

Use of Proceeds
No proceeds will be received by the Company pursuant to this
registration and prospectus.
Financial Summary
The Company has had a limited operating history prior to this
prospectus and has had
only moderate revenue from operations
during such period since inception. There is no assurance that the
Company will ever have material revenues or that its operations
will ever be profitable.
(See the financial statements bound
herein.)
As of December 31, 1990:
Total Assets
Total Liabilities
Shareholders' Equity

$ 31,618
$238,293
($206,675)

RISK FACTORS

1* Absence of Significant Operations, Income and Profit.
Though the Company is not in the development stage, it is subject
to all the risks inherent in the operation of a business which has
limited capital resources, a limited history of operations and
income, and no profitability.
The Company's activities since
organization have been limited to product development, national
marketing and sales, organizational matters, and response to
2

litigation and administrative investigations. Unforseen expenses,
complications and delays are often associated with thinly
capitalized companies and with the introduction of products. There
is no assurance that products which are currently marketed, or may
eventually be developed and marketed, by the Company will continue
to be commercially accepted. (See "Description of Business.")
2. Absence of Patent Protection; Product Obsolescence.
Patents have been filed in the name of the Company's president,
Luke Glenn, who has assigned the patents to the Company.
Any
competitor of the Company using equipment and processes which are
generally available could manufacture and market similar products.
Moreover, new surgical products and devices are constantly being
developed and introduced to the marketplace, which may have the
effect of rendering obsolescent the products which the Company
proposes to develop and market. (See "Business—Patent.")
3. Limited Experience and Potential Change of Management.
The Company will be dependent upon the efforts and abilities of its
officers.
Luke Glenn
and Ted Hillstead have had varying
experience in the marketing of medical products which the Company
markets, but have had limited experience in managing a publiclyheld company. (See "Management.")
Mr. Glenn is the only person
who has been previously involved in executive management positions
of medical product companies or had experience in medical product
development, and manufacturing. (See "Remuneration of Officers and
Directors.") In the spring of 1990, Mr. Glenn .received an offer
for a position with another company* Though he did not accept the
position, failure of the Company to subsequently raise capital may
result in his having to accept a permanent full-time position with
another company.
Unless the business of the Company changes
through diversification of products or services, the loss or
unavailability of the services of Mr. Glenn could have a materially
adverse effect on the Company's business prospects and/or potential
earning capacity because of his experience in product development
and marketing and the services which he is expected to provide to
the Company in those areas. The Company does not, at present, have
any employment agreement with any of its officers, nor does the
Company presently insure any of its officers against anticipated
losses should their services be unavailable. Because of previous
health complications, the Company cannot purchase key-man insurance
on the life of Mr. Glenn.
If the Company acquires other products, assets or entities,
the transaction will most likely be consummated through an issuance
of additional stock. Such transaction may result in a change in
control and or management of the Company.
4. Competition.
The Company is engaged in a competitive
business and is attempting to compete with major U.S. and foreign
corporations who presently develop, manufacture and market medical
and surgical devices and products of all types, including products
3

directly competitive with those currently marketed and proposed to
be marketed by the Company. These firms are larger and have far
greater resources, assets, technical staffs, and experience than
those which are available to the Company. The Company is not at
present, and will not in the foreseeable future, be a significant
factor in the field in which it is engaged. Small firms such as
the Company with limited resources are at a very serious
disadvantage against established competitors.
(See "Business—
Competition.If)
5. Government Regulation. In the manufacture and sale of
its products, marketing and manufacturing by the Company will be
subject to regulation by the Food and Drug Administration ("FDA11),
'including registration of its manufacturing establishment (which
has been completed), listing of the products which it proposes to
market and sell (completed), and the necessity of submitting a
premarket notification with respect to each of its medical or
surgical products (completed).
The FDA could require that
premarket approvals be obtained with respect to some of the
Company's products, which would be costly, time consuming, and
adversely affect the Company's ability to operate profitably. In
1987, the FDA made an inspection of Company's previous facilities.
Certain information provided to prospectus shareholders may have
been materially incomplete as to FDA rules and regulations. (See
"Business—Government Regulation.")
6. No Feasibility Studies.
The Company has relied and
intends to continue to rely upon the judgment and conclusions of
its management based solely upon their experience, which is, in
essence, the limited experience of Luke Glenn, relative to the
needs of the Company. No formal feasibility studies or reports
have been obtained, nor are any such studies planned by the
Company.
7. Limited Staff, The Company currently has no formally
hired employees. Assuming the Company is successful in raising
additional capital, the Company intends to employ each of its
officers on a full-time basis with the exception of Mr. Hillstead
(See "Management" and "Remuneration of Officers and Directors11) ,
and to hire one full-time employee for secretarial and
administrative work. (See "Transactions With Management.")
8. Additional Financing.
Additional financing will be
required. There can be no assurance that such financing will be
available, or, if available, that it can be obtained on terms
satisfactory to the Company.
(See Paragraph 12 and "Business—
Financial Status.")
9.
Noncumulative Voting; Control by Management Stockholders.
The present management claims to own approximately 59 percent of
the issued and outstanding common stock of the Company. Disputes
may arise about ownership of this and all other stock in the
4

Company. Inasmuch as there are no cumulative voting rights under
the Company's Articles of Incorporation, the present management of
the Company will remain in control of the Company since they will
be able to elect all of the directors of the Company, and the
purchasers of the publicly-traded shares will not be able to elect
any of the directors of the Company.
(See "Capitalization and
Securities.M)
10. Transactions with Officers, Directors and Principal
Shareholders. Management and a shareholder have made loans to the
Company. The Company's operations are located in a building owned
by one of the directors. Management intends to temporarily employ
Judy Glenn, wife of the President, as secretary and office manager.
#
(See "Transactions With Management.")
11. No Dividends and None Anticipated. The Company has not
paid any dividends upon its common stock since its inception, and
by reason of its present financial condition and its contemplated
financial requirements, does not contemplate or anticipate paying
any dividends upon its common stock in the foreseeable future.
(See "Dividends.")
12. Uncertainty of Funds from Possible Private Offering. The
Company is considering a future private offering. The Company may
attempt to obtain the services of an underwriter (stockbroker) to
privately sell such shares on a "best efforts" basis, which means
that there will be no binding or "firm" obligation on the part of
the underwriter or any other person to buy any of the shares
proposed to be sold.
There is no assurance that such an
underwriter can be engaged. Alternatively, the Company may attempt
to sell such shares through the efforts of its officers and
directors. In addition, the sale of such shares may be formulated
so that none of the shares will be sold unless a specified minimum
portion thereof are, in fact, sold. The Company may also consider
merging with an existing private company.
There can be no
assurance that such private offering or merger will be completed
and if it is not, the Company will have suffered the loss of the
funds expended in pursuing such offering or merger.
(See
"Business—Financial Status.")
13. Possible Rule 144 Sale bv Affiliates. The common shares
presently owned by certain shareholders may be deemed to be
"control securities" as such term is used in relation to Rule 144
under the Securities Act of 1933, as amended. Rule 144 provides
that a person who is an affiliate of the Company may, within a
three-month period, sell in "brokers transactions" (as defined by
the Rule) , an amount equal to the greater of 1 percent of the
Issuer's outstanding securities of such class or the average weekly
reported volume of trading in such securities during the four
calendar weeks preceding the sale, if the conditions specified by
the Rule are satisfied. If such person is not an "affiliate" of
the issuer, as such term is defined by Rule 144, he may, after a
5

holding period of three years, in the case of restricted
securities, sell the shares without a volume limitation. Because
management currently owns 15 Million shares, future sales by such
affiliates may have a depressing affect on the market price of the
common shares, should a market for such shares exist,
14. "Qualified Opinion" From Independent Certified Public
Accountant. As shown in the financial statements attached hereto,
the current liabilities exceed current assets by $226,021, and its
total liabilities exceed total assets by $206,675. These factors
indicate that the Company may not be able to continue in existence
unless it is able to receive adequate funding. For this reason,
the independent certified public accountant for the Company has
issued a "qualified opinion" as to the financi?l condition of the
Company. (See "Financial Statements.")
15. Market Price of Shares Unreliable. The secondary trading
of the Company's shares outside of Utah has experienced significant
price fluctuations over the past two years. Since the order by the
Utah Securities Division suspending secondary trading, there has
been no public trading in the Companyfs stock in the state of Utah.
Management believes that current price quotes, if any, may bear
little or no relationship to the assets, earnings per share of the
stock, or any other criteria of value applicable to the Company.
Some shareholders have purchased stock based on speculation about
market "short positions." "Short selling" or "short positions"
occur when an investor sells shares of stock he does not own.
Following the sale, the investor must deliver shares to the
purchaser.
The short seller hopes to purchase share from the
market at a lower price than he sold it, thereby making a profit
on the difference in price. Such short positions in the market have
not been specifically identified and investment in these shares on
that basis would be extremely speculative. Continuing price
instability is probable. (See "Market Price of Shares")
16. Uncertainty of Litigation and Regulatory Action.
The
Company has been engaged in litigation which may result in large
expenses to defend or pursue legal rights. Additionally, state and
federal securities authorities have been investigating and continue
to investigate alleged market manipulation of the Company's stock
and the existence of stock certificates with forged signatures and
certificates issued following the transfer or cancellation of such
certificates.
Such regulatory review may adversely affect the
ability of the Company to raise needed capital, affect the stock
price, or drain the Company's capital resources to maintain legal
representation.
Additionally, the ongoing investigation by the
Utah Securities Division may result, at a future date, in the
issuance of an order suspending trading in the Company's
securities.
(See "Business—Litigation
and Administrative
Actions.")

6

17. No Manual Exemption. Subsequent
to the effectiveness of
the registration statement, any transaction in the Company's
securities by or through a Utah broker-dealer will not be exempt
through a "manual exemption" and, instead, may only be exempt if
there is compliance with the "secondary trading" exemption.

(THIS SPACE INTENTIONALLY LEFT BLANK)
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DILUTION
The following graphs illustrate the comparative stock
ownership of the Shares as of December 31, 1990. Acquisitions of
entities or product rights through the issuance of additional stock
would result in further ownership dilution to current shareholders.

Insiders
59%

Public
Shareholders
41%
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At December 31, 1990, the Company had an aggregate of
26,352,500 shares of common stock outstanding with a net tangible
book value as reflected on the Company's balance sheet of
($206,675) or approximately ($.0078) per share. Net tangible book
value per share represents the amount of the Company's tangible
assets less its liabilities, divided by the number of shares of
common stock outstanding. Upon purchase of shares, and assuming
no changes in the net tangible book value of the Company after
December 31, 1990, the purchaser will own shares with negative book
value. Public investors will most likely experience an immediate
dilution in the net tangible book value per share of the common
stock from the price per Share being offered on the secondary
market.
Uncertainty related to the existence of the stock
certificates with forged signatures or certificates issued
following the transfer or cancellation of such stock certificates
may affect the value of stock.
Dilution in this case represents the difference between the
public market trading price per share and the net tangible book
value per share.
The following graphs illustrate the per share dilution based
on a price as of December, 1989.
(See "Capitalization and
Description of Securities.11)
MARKET PRICE IN RELATION TO NET TANGIBLE BOOK VALUE
Cents
Per Share
10

Dilution to
Public Investors
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Net Tangible Book
($.0078)

9

Most
Recent Stock Price
$.10
(December 1989)

USE OF PROCEEDS
This registration of shares will not result in any proceeds
received by the Company,

DESCRIPTION OF BUSINESS

CORPORATE HISTORY
In approximately July of 1986, Luke Glenn and Ted Hillstead
formed a partnership called "U.S.A. Medical". The partnership was
formed to develop a machine called the "Maxim Aspirator", which is
a high powered deep vacuum suction aspirator. Additionally, the
partnership developed the suction cannula that is used in the
aspirator system and marketed tubing and surgical clothing.
Between July of 1986 and June of 1987, the partnership attended
various trade and medical shows and were successful in
manufacturing and selling the Aspirator and related products. In
June of 1987, the partnership formed U.S.A. Medical Corporation,
a privately-held Utah corporation.
On December 7, 1987, the
privately held
corporation
entered
into an Agreement of
Reorganization with SMI, Inc., a purportedly publicly held
corporation.
SMI, the surviving entity, was incorporated in
Wyoming on January 12, 1979•
Subsequent to the reorganization,
SMI changed its name to U.S.A. Medical Corporation (the "Company").
Though management of SMI represent* 1 that the Company was publiclyheld, current management believes chat the Company's shares may
have originally been held by a few undisclosed "control" persons
and nominees, and that some or all of the signatures on the stock
certificates of SMI at the time of the merger were forged.
Uncertainty exists about the validity of the shares the Company
issued following the merger. In March of 1991 the shareholders
authorized a name change to Life Concepts, Inc.
INTEGRITY AND EXISTENCE OF CORPORATE DOCUMENTS
The Reorganization Agreement with SMI included SMI financials
purporting assets worth $162,092 which primarily consisted of stock
in another corporation. Those shares have never been found and
management believes that the existence of this asset was
misrepresented.
Additionally, following the reorganization,
management never received bylaws, organizational minutes, board of
director minutes, shareholder minutes, or bank records.
The
10

Company has subsequently adopted
Articles of Incorporation.

new

Bylaws

and

amended

its

PRODUCT DEVELOPMENT
The Company was formed to design, manufacture and market highpowered surgical aspirators, precision surgical suction cannula,
and other medical products such as tubing, masks, and garments.
Though the aspirator may be used for a wide variety of fluid
vacuation, it has primarily been purchased by doctors engaged in
lipoplasty procedures.
Initially, the firm's marketing efforts
were directed primarily at plastic and reconstructive surgeons
through professional symposiums and live-surgery demonstrations
conducted around the country. Advertisements have also been placed
in major scientific journals. The following table consists of
sales estimates since formation of the original partnership:
Period

Aspirator

Cannula

July 1986 December 31, 19 86

1

50

Year 1987

50

1,500

Year 1988

30

400

1st Quarter 1989

6

50

2nd Quarter 1989

2

25

3rd Quarter 1989

2

10

4th Quarter 1989
1
5
The Company expected to sell 1,000 aspirators over a twelve
(12) month period between 1988 and 1989, which, at a retail price
of $2,295, would have produced gross revenues of $2.3 million
before sales discounts.
Sales of surgical suction hand-held
cannula were expected to reach 3,500 units over the period
resulting in additional revenue of $625,000 before sales discounts.
The combined revenue from these expected sales would be
approximately $2.9 million• After sales discounts, manufacturing
cost, and corporate expenses the Company hoped to achieve a net
profit of about $500,000. Due to non-performance and possible
stock manipulation by a "stock relations" firm which represented
it would raise $300,000 for the Company, and recent litigation,
there has been a delay in the planned private placement. This
private placement was to have provided capital necessary for the
Company to expand its manufacturing and marketing plans and
accomplish the above.
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Because of the nature of the products and the interest in
surgical procedures requiring aspirators, management believes that
with the proper capital the above revenue projections could be
obtained and increase each year, not including the addition of any
new products that are hoped to be added to the Company's marketing
mix: i.e., surgical compression garments, marking pens, cannula
brushes and cleaners, re-injection systems, disposable canisters,
electro-surgical knives, operating room safety equipment, etc.
Revenue expectations have been based solely on the experience of
management in the aspirator market and has not been supported by
independent market research.
Government Regulation
To the best of the Company fs knowledge, the FDA has refused
to approve marketing of any surgical aspirators manufactured by any
manufacturer for lipoplasty procedures. Nonetheless, the medical
profession uses high powered aspirators for liposuction.
The
aspirator manufactured by the Company is approved by the FDA as a
general high powered aspirator (Class I) .
Class I approval
requires the Company to satisfy the "general control11 provisions
of the Federal Food, Drug and Cosmetic Act. Management is not
aware of any product that has received classification beyond Class
I. The aspirator manufactured by the Company is not approved by
the FDA to be marketed as a liposuction device. A copy of the FDA
conditional approval letter (hereinafter "FDA letter") is attached
as an exhibit to this prospectus.
The Company provided oral and written information to brokers
and prospective shareholders in 1988 and 1989 which may have
violated the prohibition in the FDA letter against direct or
indirect promotion of the aspirator as a liposuction device. If
the Company has violated the prohibition, the FDA may sanction the
Company and this may affect the marketability of the aspirator and
the value of Company stock.
The Company has not received any
notice, letter, or other communication from the FDA threatening to
take any action against the Company, nor has the FDA made any
findings that the Company has violated the conditions contained in
the FDA letter.
The FDA is currently investigating possible
violations.
High Powered Surgical Aspirator and Surgical Cannula Market
The market for high-powered aspirators and related products
is primarily limited by the number of physicians who are and will
become skilled in using the equipment.
The growing number of
medical specialists becoming involved with procedures using highpowered aspirators includes plastic surgeons, obstetricians/
gynecologists, dermatologists, otolaryngologists, and general
surgeons. Concurrently, an increasing number of other physicians
with adequate training, facilities and necessary equipment are
expected to begin to use high vacuum machines in the future. There
12

are close to 500,000 physicians in the United States alone, 200,000
of whom may eventually use high power vacuum machines. Management
believes that the market outside the United States is even larger.
The Company is currently conducting preliminary discussion with
companies in foreign countries for establishing distributor/dealer
outlets for its equipment.
Rationale For High Powered Aspiration
Before high-powered aspirators and suction cannula came onto
the market, subcutaneous tissue and fluids was removed primarily
by major surgery requiring extensive tissue cutting and long
recuperation time. Today, with new technology and new cannula
^development, removal of tissue can be performed easily and safely
with only a minor incision.
1.

Advantages of the Maxim Aspirator:
a.
b.
c.
d.
e.
f.
g.

2.

One of the lowest cost high-powered aspirator on
the market.
Modern design - aesthetically pleasing.
Portable - carry or pull.
Self-contained tissue and fluid collection system
to eliminate accidental exposure to HIV virus.
Quiet operation.
Remote foot-switch.
Maintenance free - Oiless operation.

Advantages of Coolite Suction Cannula:
a.
b.
c.

More comfortable handle - reduces wrist fatigue.
Lightweight - easy to handle and 50% lighter than
most of the competition.
Quick-disconnect fitting - Easier and faster to
change cannula, less risk of fluid and tissue
emission.
NEW MEDICAL PRODUCTS

As aspirators become more widely used within the medical
profession, new techniques and equipment applications are sure to
result. Current experimentation in the transplantation of fatty
tissue from one anatomical site to another
(e.g. breast
enlargement, facial reconstruction, buttock enhancement, etc.) are
controversial and the subject of professional debate. As with many
. other surgical procedures in the past, however, it is possible that
acceptable applications of such procedures will eventually be
developed.
The Company is currently investigating the new
instrumentation and equipment design which will be required by
these new reconstruction techniques.
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Moreover, aspiration procedures have also been proven
effective in the removal of non-malignant lipomata from the neck,
arm, leg and abdominal sites with minimal trauma and post-operative
scarring.
In early 1988, the Company began to offer a revolutionary new
safety system for the collection and disposal of human blood and
tissue for all of the aspiration machines it has and will
manufacture.
Because the HIV (AIDS) virus is known to be
transferrable through human blood, sera and tissue, proposed and
pending federal and state legislation will soon mandate that full
protection from accidental exposure to these substances be assured
for all health workers and for the public.
ACQUISITION OF OTHER PRODUCTS
The Company is currently negotiating for the acquisition of
a business engage in marketing products which are unrelated to
surgical procedures or medical services.
While the Company
believes that there is a fair probability of consummating the
acquisition, the negotiations and due diligence by both parties are
continuing. Any definitive agreements will be publicly announced
and presented to the shareholders for ratification.
LITIGATION AND ADMINISTRATIVE ACTIONS
Shortly after the reorganization in December 1987, the Company
changed its transfer agent from Efficient Transfer, Inc. to
Standard Transfer and Registrar. On March 29, 1988, the Securities
and Exchange Commission filed a complaint for permanent injunction
in the United States District Court, District of Utah, Central
Division, against Efficient Transfer, Inc. and Roger Coleman, d/b/a
Efficient Transfer. Among other things, the Commission alleged
that Efficient had falsified the shareholder list of the Company.
On May 24, 1988, United Stated District Court Judge David K. Winder
ruled that Roger Coleman had failed to make and keep current logs,
tallies, journals, schedules, and other records relating to the
stocks that his business was handling.
During this period the
Company, through its counsel, consulted other co-counsel to aid in
worKing with 1 \e Securities and Exchange Commission to determine
how the Compan would be affected by Roger Coleman and Efficient
Transfer acting as transfer agent prior to December of 1987. The
Company continued discussions with the Securities and Exchange
Commission and there was no definitive action taken by the
Commission with regards to the Company.
The Company's counsel
determined that the prior relationship with Roger Coleman and
Efficient Transfer was not material upon the operations and
business of the Company, His opinion has not been approved or
adopted by either the Securities & Exchange Commission or the Utah
Securities Division.
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From December of 1987 through January of 1989, the Company's
shares experienced erratic fluctuations in price, possibly as a
result of stock manipulation and "short selling" by some brokerage
firms.
On February 16, 1989 Johnson-Bowles Company, Inc.
("Johnson"), a Utah brokerage firm allegedly holding a major short
position in the market, filed suit in the United States District
Court (Utah) against the Company and a large number of Utah
brokerage firms.
Pursuant to the complaint, Johnson sought
injunctive relief and monetary damages.
Johnson sought 1) a minimum of $3 00,000 in monetary damages,
2) a court order declaring that the Company is without registration
exemptions for its stock trading interstate and that all trading
contracts with plaintiff are void, 3) a Temporary Restraining
Order, 4) an Injunction against any shareholder meetings, 5) an
Order mandating that the Company file a registration statement with
the Securities and Exchange Commission, and 6) that the Company1s
stock be suspended from trading.
On February 21, 1989 Judge J. Thomas Greene granted Johnson
a Temporary Restraining Order restraining Midwest Clearing
Corporation from adjusting Johnson's accounts as it related to the
Company's stock. A hearing for a permanent injunction was set for
February 27.
After hearing Johnson's case in late February, the District
Court denied any injunctive relief for Johnson. In denying the
relief sought, the court stated the following as conclusions of
fact and law:
1.
With respect to Midwest Clearing, the Court
does find and rules that the temporary restraining order
which dissolved by its terms and any further injunctive
relief against Midwest clearing is denied. The Court
finds that it likely would cause interference with the
prompt and accurate clearance and settlement of
securities transactions and would negatively affect the
goals of Section 17(a) of the Act to continue injunctive
relief and restrain from the clearing functions of
Midwest Clearing.
2.
The Court finds that the stock of U.S.A.
Medical was unlawfully issued, has never been registered
with any proper regulatory authority, is not exempt from
such requisite registration and has been and is
continuing•to be traded illegally.
3.
The stock of U.S.A. Medical has been and
continues to be traded as part of fraudulent scheme and
device to manipulate and artificially inflate the price
of that stock in violation of the securities laws.
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4.
The Court finds, however, that the
Johnson-Bowles, knew or should have known
alleged irregularities as to non-registration,
status and illegal trading of U.S.A. Medical
that in fact Johnson-Bowles participated in
the stock after it became a market maker, and
with knowledge of these irregularities.

plaintiff,
about the
non-exempt
stock, and
trading in
is charged

5.
The Court finds that relative burden between
Johnson-Bowles and other parties as well as damage to the
public interest has not been shown by a preponderance of
the evidence and that there is a failure of burden of
proof to establish those elements.
On April 10, 1989 the Company filed an Answer to Johnson's
complaint and counter-claimed against the brokerage firmThe
counter claim sought minimum damages of $100,000 and was based on
the District Court's findings that Johnson knew about the nonregistered status of the Company's stock and actually participated
in the trading of the Company's stock in a manner which may have
been illegal. On March 27, 1990, the suit was dismissed without
prejudice. The Company is currently conducting research prior to
proceeding with any claims against Johnson-Bowles, or parties
believed to have participated in an illegal distribution of stock.
On January 29, 1991, Otra Securities Group Inc., a Deleware
Corporation, and Otra Clearing, Inc., a Colorado corporation, filed
a third-party complaint against Nathan Drage (current counsel to
the Company), Richard Leedy (counsel to Standard Registrar),
Michael Strand (a shareholder of the Company), Standard Registrar
and Transfer (former transfers agent for the Company), U.S.A.
Medical Corporation, and John Does 1-10, in the case of Burns v.
Richfield Securities, et al. The Complaint alleges the parties
conspired to artificially manipulate the price of the Company's
shares in violation of state, federal and common laws. The above
defendants have stated that they believe there is no merit to
Otra's third-party complaint. Though the Company believes there
is no merit to the suit, the Company will incur an unknown amount
of legal fees to defend the suit and assert any counter claims.
On March 6, 1989 the Securities and Exchange Commission
suspended trading of the Company's stock. The suspension was based
upon questions regarding market activity by brokerage firms and
individuals, control of the Company's shares, and the Company's
financial information. The suspension expired on March 15, 1989.
On March 1, 1989 the Securities Division of the Department of
Business Regulation of the State of Utah issued a Summary Order
Denying the Availability of Exemptions From Registration.
The
denial of exemptions was based upon the following conclusions: 1)
the failure to register securities, 2) failure to qualify for
exemptions from registration, and 3) a scheme to defraud by persons
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unknown and unnamed.
The Company is informed that the third
conclusion was based in part upon additional research and
investigation by the Division,
The Company worked with the
Securities Division between March and August of 1989 to determine
if their summary conclusions of fact were correct. P.G. McManus,
the original incorporator of SMI is believed to have a history of
securities violations.
In July of 1990 James Averett pleaded
guilty to a one count complaint accusing him of manipulating and
artificially raising the price of the Company's stock. At the date
of this prospectus, the Securities Division is continuing its
investigation.
By public release on September 1, 1989, the Division announced
a settlement Agreement with the Company which would allow the
Company secondary trading if it registered its shares. Until the
time of this registration, the Company's stock was denied
transactional exemptions within the state of Utah. The business
of the Company is affected by Utah's administrative actions mainly
to the extent that the Company has been limited in raising
operational capital through the sale of securities within the state
of Utah.
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By letters dated March 9 and June 22, 1989, the Company placed
stop transfer orders on stock certificates totaling 1,383,350 and
850,000 shares respectively.
These are certificates which the
Company believes may be held by undisclosed control persons or
persons who are not bona fide purchasers. With regard to such stop
transfers, the Company is in a very difficult situation. The only
way management can protect the Company from stock manipulation by
undisclosed control persons is to place stop transfer orders on
certificates management believes to be held by such persons. Stop
transfers, however, expose the Company to possible lawsuit by
shareholders whose shares have received transfer restrictions.
Additionally, the Company may be prevented from placing any stop
transfer orders should the transfer agent require the posting of
bonds. Consequently, if stock manipulation has occurred in the
past, or does occur in the future, the Company is significantly
limited in avoiding such manipulation.
In June 1990, the staff of the Securities & Exchange
Commission notified the Company and its management that it is
recommending that the SEC take enforcement action against the
Company, Mr. Glenn, and Mr. Hillstead.
No action has yet been
taken and it is unclear whether any action will be taken, or what
form the possible action may take, or what settlement may be
reached.
The Company currently intends to register its common stock,
or the Company, with the Securities and Exchange Commission when
it has sufficient capital to do so.
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PATENTS
The Company's president filed for patent protection on the
aspirator and related features on January 19, 1988. A U.S. patent
(No. 4,857,063) was issued on August 15, 1989. In November 1987,
the president assigned the patents to the Company, which assignment
appears on the patent,
COMPETITION
The high power aspirator market consists mainly of five
manufacturers.
These manufacturers may be better financed and
better known in the market.
FINANCIAL STATUS
The Company experienced losses of $78,470, $46,617, and
$34,692 during fiscal years 1988, 1989, and 1990 respectively.
Additionally, the Company has no current assets available to meet
its obligations.
Consequently, the Company will have to seek
additional capital through additional loans, a private placement,
public offering, or merger.
OFFICES
The Company has an informal agreement with one of its
directors to provide approximately
2,4 00 square feet of
office/manufacturing space. Management intends to conduct assembly
activities at such location and believes that such facilities will
be adequate for the Company for the foreseeable future.
The
director has designated a particular portion of the building for
the Company, and will provide such space and equipment as may be
reasonably required by the Company. The Company currently pays no
rent for use of its office space but hopes to pay reasonable rent
when the Company's financial condition allows it.
EMPLOYEES
The Company has no full-time employees. The president devotes
approximately ten percent of his time to the Company's operations
and, when finances permit, will return to full-time employment by
the Company and will be paid compensation which is deemed
reasonable and is expected to be $3,000 per month.
(See
"Compensation" and "Transactions With Management.")
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CAPITALIZATION AND DESCRIPTION OF SECURITIES

The capitalization of the Company as of December 31, 1990 is
as follows:
Title of
Class

Amount
Authorized

Amount
Outstanding
as of 12/31/90

Common Stock
$•001 par value

50,000,000
Shares

26,352,500
Shares

With some possible exceptions, all shares are believed to be
fully paid and non-assessable. All common shares are equal to each
other with respect to voting, liquidation and dividend rights.
Special meetings of the Shareholders may be called by the officers,
directors, or upon the request of holders of at least ten percent
of the outstanding voting shares. Holders of common shares are
entitled to one vote at any meeting of the Shareholders for each
common share they own as of the record date fixed by the Board of
Directors.
At any meeting of Shareholders, a majority of the
outstanding shares of the Company entitled to vote, represented in
person or by proxy, constitutes a quorum. A vote of the majority
of the shares represented at a meeting will govern even if this is
substantially less than a majority of the common shares
outstanding.
Holders of shares
are entitled to receive such
dividends as may be declared by the Board of Directors out of funds
legally available therefor, and upon liquidation are entitled to
participate pro rata in a distribution of assets available for such
a distribution to Shareholders.
There are no conversion,
preemptive or other subscription rights or privileges with respect
to any share. Reference is made to the Articles of Incorporation
and By-laws of the Company as well as to the applicable statutes
of the state of Wyoming for a more complete description of the
rights and liabilities of holders of shares. It should be noted
that the By-laws may be amended by the Board of Directors without
notice to the Shareholders. The shares of the Company do not have
cumulative voting rights, which means that the holders of more than
fifty percent of the shares voting for election of directors may
elect all the directors if they choose to do so. In such event,
the holders of the remaining shares aggregating less than fifty
percent will not be able to elect directors.
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MARKET PRICE OP SHARES
In the four month period prior to suspension of trading on
March 1, 1989 by the Utah Securities Division, the shares of the
Company fluctuated in price between $.01 and $1.00 (as adjusted for
the 10 for 1 forward split in the first quarter of 1989) . Possible
explanations of the increase in price include legitimate
speculation in the growth and earning capabilities of the Company,
deceptive manipulation by undisclosed shareholders holding large
positions in the stock, and/or legitimate speculation about "short
positions" held by brokers which would be bullish for investors
holding "long positions,"
A "long position" exists when an
individual or firm holds stock in that individual's or firm's
account. Estimates of the current market short ranges from 500,000
shares to 3,000,000 shares. The Company does not currently have
reliable information to either confirm or deny such estimates.

MANAGEMENT

OFFICERS AND DIRECTORS
The term of office of each director is one year or until his
successor is elected at the annual meeting of the Company, which
will be held in February 1991. The term of office for each officer
of the Company is at the pleasure of the Board of Directors. The
Board of Directors has no nominating, auditing or compensation
committee.
The following table states the name, address and positions
held for each of the executive officers and directors of the
Company.
Name and Residential Address

Title or
Position

Luke H. Glenn
4016 Porter
Ogden, UT 84403

President and Director

Ted W. Hillstead
601 Ogden Canyon Road
Ogden, UT 844 01

Secretary/Treasurer and Director
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LUKE H. GLENN, President and Director, Ogden, Utah has been
involved with the medical industry since 197 0 after graduating from
Weber State College, Ogden, Utah with a degree in Business
Management and Economics.
He took a position with Cutter
Laboratories (a major manufacturer of medical devices and products
used by hospitals worldwide) in 1970 as the Plant Quality Control
Manager and was responsible for all quality activities including:
quality engineering, statistical sampling, vendor approval, FDA
compliance, sterile product control and good manufacturing
practices (GMP) as outlined in the Food, Drug, and Cosmetic Act.
From 1977 to 1984 he co-founded the G & H Company to develop,
manufacture, and market vacuum/pressure systems.
From 1984 to
present he has been involved with the development, design, and
marketing of high-powered surgical aspirators and precision suction
cannula. In 1986 he co-founded U.S.A. Medical. He has traveled
extensively around the United States marketing aspirators and
cannula to plastic and reconstructive surgeons, clinics, and
hospitals. Age 48.
TED W. HILLSTEAD, Secretary/Treasurer and Director, Ogden,
Utah began his career in 1956 after graduating from the University
of Wyoming with a degree in Mechanical Engineering. From 1956 to
1964 he was with the Marquardt Corporation, Ogden, Utah,
developing, designing, and analyzing new jet engine systems. From
1964 to 1974 he was instrumental in the development of automated
material handling systems for Kenway Engineering and in 1974 he
founded Tareco Corporation, Ogden, Utah specializing in the design,
fabrication, and installation of automated material handling
equipment for such firms as Goodyear Tire and Rubber, Kennecott
Copper Corporation, Steelcase Corporation, and Caterpillar Tractor
Company. In July 1986 he co-founded U.S.A. Medical, Ogden, Utah.
Age 53.
At a meeting of the Board of Directors held November 28, 1990,
directors and shareholders representing over 60% of the shares
outstanding, voted to terminate, with cause, David Ballard as an
officer and director of the Company. The shareholders ratified
this action at the Annual Shareholders meeting to be held in
February of 1991.

COMPENSATION
When finances permit, Luke Glenn will devote his full-time
efforts to the operations of the Company, for wnich Mr. Glenn will
receive a monthly salary of approximately $3,000.
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The following persons have received compensation since January
1, 1989:
Name

Position

Amount

Luke Glenn

President, Director

Ted Hillstead

Secretary/Treasurer, Director

Judy Glenn

Former Director

David Ballard*

Former V.P, Director

$10,914.98
none
$

500.00
stock

*The Company and major shareholders are in the process of
filing suit to cancel the certificates representing 1,000,000
shares.
The Company has no written employment agreement with any of
its officers or directors and has no retirement, profit sharing,
pension or insurance plans covering them. (See "Transactions With
Management.")
INDEMNIFICATION OF OFFICERS AND DIRECTORS
Wyoming law expressly authorizes a Wyoming corporation to
indemnify its officers and directors against claims or liabilities
arising out of such persons' conduct as officers or directors if
they acted in good faith and in a manner they reasonably believed
to be in or not opposed to the best interests of the Company. The
Company intends to indemnify its officers and directors to the full
extent permitted by Wyoming law. INSOFAR AS SUCH INDEMNIFICATION
MAY BE DEEMED TO INCLUDE ANY CLAIM OR LOSS ARISING OUT OF ANY
VIOLATION OF FEDERAL SECURITIES LAWS OR REGULATIONS, THE COMPANY
HAS BEEN INFORMED, THAT, IN THE OPINION OF THE SECURITIES AND
EXCHANGE COMMISSION, SUCH INDEMNIFICATION IS AGAINST PUBLIC POLICY
AS EXPRESSED IN THE SECURITIES ACT OF 1933, AND IS, THEREFORE,
UNENFORCEABLE.
FIDUCIARY RESPONSIBILITY
The officers and directors are required to exercise good faith
and integrity in handling the Company's affairs. Management of
the Company has agreed to abide by this fiduciary duty.
Each
Shareholder of the Company or his duly authorized representative
may inspect the books and records of the Company at any time during
normal business hours. A Shareholder may be able to institute
legal action on behalf of himself and all other similarly situated
Shareholders to recover damages where the Company has failed or
refused to observe the law.
Shareholders may, subject to
applicable rules of civil procedure, be able to bring a class
action or derivative suit to enforce their rights, including rights
under certain federal and state securities laws and regulations.
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Shareholders who have suffered losses in connection with the
purchase or sale of their interest in the Company due to a breach
of fiduciary duty by an officer or director of the Company in
connection with such sale or purchase, including the misapplication
by any such officer or director of the proceeds from the sale of
these securities, may be able to recover such losses from the
Company- It should be noted that this is a rapidly developing and
changing area of the law. Investors are urged to consult their own
legal counsel.

TRANSACTIONS WITH MANAGEMENT

In November 1987, the president assigned the product patents
to the Company,
The Company's secretary/treasurer currently leases office and
warehouse space to the Company rent free.
Ted Hillstead, secretary/treasurer and a director of the
Company, has made loans to the Company, or retired bank loans made
to the Company, exceeding $ 100,000.
When finances permit, the Company intends to hire Luke Glenn.
Also, the Company intends to hire Judy Glenn, wife of the
Company's president, as a secretary and office manager.

PRINCIPAL SHAREHOLDERS
As of the date of this prospectus, the following persons were
shareholders who owned of record, or who was known by the Company
to own beneficially, ten percent or more of the Company's common
stock.
As of the date of this prospectus, these shareholders
express no intent on selling their shares; though they may choose
to do so at a later time. Questions concerning the existence of
stock certificates with forged signatures or certificates issued
following the transfer or cancellation of such certificates create
uncertainty about the accuracy of the information known to the
Company. The following table presents such information in tabular
form as of the date of this prospectus:
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Amount and Nature
of Beneficial
Ownership

Name of
Title of Class Beneficial Owner
Common Stock
($.001 Par
Value)

Percent
of Class

Luke Glenn

7,500,000c1)

29.62%

Ted Hillstead

7,500,000c1)

29.62%

(1) These shares were acquired on December 7, 1987 in
exchange for shares in U.S.A. Medical corporation, a privately-held
Utah company. James Averett, former counsel to the Company, has
olaimed an ownership interest in 1,666,666 of the 15,000,000 shares
held by Mr, Glenn and Mr. Hillstead. Due to the actions of Mr.
Averett and their affect on the Company and management, Glenn and
Hillstead intend to contest any ownership claims by Averett.
The following table sets forth the security ownership of
management of the Company as of the date of this prospectus.
Amount and Nature
of Beneficial
Ownership

Name of
Title of Class Beneficial Owner
Common Stock
($.001
Par Value)

Percent
of Class

Luke Glenn
(Beneficially and
of record)

7,500,000

29.62%

Ted Hillstead(1)

7,500,000

29.62%

Directors and
15f 000,000
Officers as a Group

59.24%

In addition to the above persons, management believes that
ownership by the next two largest shareholders should be disclosed:
Brian D. Burns(2)
1,859,500
7.00%
c}

Mr. Hillstead is the beneficial owner of these shares that
are held in the name of Tareco.
<2>

Shares held in the name of Brian D. Burns and Brian D.
Burns DC PC Retirement are treated here as being owned by Dr.
Burns. Dr. Burns loaned the Company $25,000 in December of 1989.
The loan was due in the first quarter of 1990. Mr. Glenn and Mr.
Hillstead have agreed to each transfer 250,000 shares of their
stock to Dr.. Burns in exchange for Dr. Burns suspending any legal
action to collect on the note until May 1991. Those additional
shares would bring total ownership to 2,359,500 or 8.95%.
An
additional 1.5 million shares have been pledged to Dr. Burns (see
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Mike Strand'

1,496,200

5.67%

footnote 3) , which brings the total number of shares under
beneficial ownership or control to approximately 3.8 million or
approximately 14.64%. Because of the large number of shares owned
or controlled by Dr. Burns, the Company has requested, and Dr.
Burns has given, consent to having his shares stamped with a legend
which restricts the public sale of his shares to the volume
guidelines of rule 144. This action by the Company should not be
construed as any indication that the Company considers Dr. Burns
to be a "control person."
Shares held in the name of Michael Strand Family
Partnership and John Dawson, are understood to be owned or
controlled by Michael Strand. Of these shares, 986,200 shares are
pledged to Brian D. Burns pursuant to an escrow agreement. An
additional 500,000 shares have also been pledged to Dr. Burns. Mr.
Strand is not an officer or director of the Company, but because
of allegations of his previous involvement with the Company
contained in a lawsuit filed in the United States District Court
(which was subsequently dismissed), information regarding Mr.
Strand is included herewith. Mr. Strand has been convicted of tax
and securities fraud. The tax liability which served as the basis
for the original charge has now been compromised civilly by the
Internal Revenue Service to a sum less than $2,000. By letter, Mr.
Strand's attorney has provided the following statement for
disclosure purposes:
Mr. Strand has been involved in the purchase and sale of
over-the-counter stocks in the Salt Lake area for many years
and has been associated with a variety, of over-the-counter
stock companies based in Salt Lake City.
In 1979, Mr. Strand was convicted in the United States
District Court for the District of Utah for tax violations
which involved failure to report certain income derived from
a finders fee on his tax returns and fraud in the sale of
securities. This conviction was appealed to higher Courts
over a number of years, but the appeals were unsuccessful.
Mr. Strand completed a satisfactory period of probation and
has no further legal obligation in connection with that
charge.
In May of 1987, Mr. Strand was convicted in the United
States District Court for the District of Wyoming on Three
Counts. One (1) of Conspiracy, one (1) of Mail Fraud, and one
(1) of Aiding and Abetting, in connection with a project known
as the Overland Dome Oil Field. This conviction has been
appealed to the United States Court of Appeals for the Tenth
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Management has not entered into any arrangements the operation
of which may at a subsequent date result in a change in control of
the Company. Management is currently exploring acquiring other
products or entities.
Such acquisitions would be accompanied
through the issuance of additional stock which may result in a
change of control. Except as set forth below, none of the Shares
held by management is subject to transferability restriction,
contractual or otherwise.
All shares held by present management are "restricted
securities" within the meaning of Rule 144. Rule 144 allows the
public resale without registration of restricted securities if
certain conditions are satisfied.
These conditions include the
public availability of current information with respect to the
Company, limitations on the volume of sales, and sales transacted
through brokers.
Information concerning the Company shall be
deemed to be available only if the issuer is current in filing its
reports with the Securities and Exchange Commission pursuant to
the Securities Exchange Act of 1934, or, if the issuer is not
subject to such reporting requirement, it has made publicly
available the information concerning the issuer specified in
clauses (1) to (14) , inclusive, and clause (16) of Paragraph (a)
(4) of Rule 15c2-ll under that Act.
As of, the date of this
prospectus, the Company is not subject to the reporting
requirements of the 1934 Act. Information is publicly available
by contacting broker/dealers making a market in the Company's stock
or by contacting the Company. Sales of securities of an affiliate,
or a non-affiliate who has owned the stock for less than three
years, are limited to one percent (1%) of the total outstanding
shares of the issuer during the three months preceding the sale.
Further, the securities must be sold in broker's transactions
within the meaning of Rule 144. Pursuant to Paragraph (k) of Rule
Circuit, who have remanded the case to the Trial Court for
rulings on Mr. Strand's Motion for a directed verdict of
acquittal. The Trial court has not yet ruled on these Motions
and so the matter is still pending in both Courts. There has
been no final adjudication in the case.
Because of the degree of communication between the Company
and Mr. Strand since October 1990, the Company has requested, and
Mr. Strand has consented to, having his shares stamped with a "soft
144" legend, thereby limiting his public sales of the Company's
shares to 1% of the total shares outstanding during any given 90
day period. This action by the Company should not be construed as
any indication that the Company considers Mr. Strand to be a
"control person."
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144, non-affiliates who have beneficially owned their shares for
more than three years are not subject to the limitations described
above regarding public availability of information, quantity of
sales, and broker transactions. As of the date of this prospectus,
Luke Glenn and Ted Hillstead is believed to have satisfied the twoyear holding requirement of Rule 144 and are being registered
pursuant to this document. The sale of such Shares may have a
depressing effect upon the market price, if any.

DIVIDENDS

The Company is currently an undercapitalized business and no
assurance can be given that it will generate earnings from which
cash dividends can be paid. If earnings are generated, management
may follow a policy of retaining all such earnings to finance the
expansion of its business. Such a policy could be maintained so
long as necessary to provide funds for the operations of the
Company. Any dividends that may be paid in the future will be
dependent upon the earnings and financial requirements of the
Company and all other relevant factors.

PLAN OF DISTRIBUTION
This prospectus registers shares with the Utah Securities
Division. The shares are not offered for sale by the Company, but
by individuals, entities, brokers, etc. through secondary trading
in the over-the-counter market of "Pink Sheet" companies.
The Division has ordered that Utah brokers who make
transactions in the Company's stock must provide this prospectus
to the purchasers and obtain from the purchaser a "Purchaser
Representation" form. This disclosure and purchaser representation
procedure must continue for one year after the date of this
prospectus. Any broker-dealer making a market in, or effecting a
trade in, the Company's stock must list such quote or transaction
on the OTC Stock Bulletin Board.
Any broker-dealers effecting a trade in the Company's stock
are prohibited from relying on the manual exemption provided at
Sec. 61-1-14(2)(b) of the Utah Uniform Securities Act. Instead,
the broker-dealer must rely on the transactional exemption from
registration as provided in Sec. 61-1-14(2)(m) of the Act.
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LEGAL MATTERS

To the best knowledge of the Company, its officers and
directors, other than disclosed herein, there are no material legal
actions pending or judgments entered against the Company or its
present officers and directors and no material legal actions are
contemplated or threatened against such persons.
Legal action
against former officers, directors, transfer agents, promoters,
agents, employees, or shareholders of the Company which may affect
the value or transfer of shares of common stock are possible.
This prospectus has been prepared pursuant to a Settlement
Agreement with the Utah Securities Division.
The Division has
required this registration of securities prior to allowing the
Company's shares secondary trading. Negotiations with the Division
and preparation of the prospectus was performed by Nathan W. Drage,
P.C., 2445 West North Temple, Salt Lake City, Utah 84116. Mr.
Drage was retained by the Company after the decision by the federal
district court was rendered and after trading was suspended by the
Utah Securities Division. In the opinion of Mr. Drage, shares that
are owned by bona fide purchasers are deemed legally issued, fullypaid and non-assessable.

EXPERTS

The financial statements of the Company for the period ended
December 31, 1990 appearing in this prospectus have been examined
by Tanner & Company, Certified Public Accountants, as indicated in
the report contained herein.
Such financial statements are
included herein in reliance upon the said report, given upon
authority of such person as an expert in accounting and auditing.
Tanner & Company was retained as the Company's auditors in the
spring of 1989.
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OTHER MATTERS

The Company's transfer agent and registrar of its shares is
Atlas Stock Transfer Corporation, 5899 South State, Murray, Utah.
The Company has filed a Registration Statement with the Utah
Securities Division, Salt Lake City, Utah,
The complete
Registration Statement may be inspected at such office and copies
may be obtained by the public at the Securities Division, 160 East
3 00 South, upon payment of the usual fees for reproduction.
The Company's fiscal year end is December 31.

EXHIBITS

The following exhibits are attached hereto and incorporated
into this Prospectus:
Audited financial statements of the Company dated
December 31, 1990, December 31, 1989 and December 31,
1988.
Financial statements of the Company dated December 31,
1987 have been excluded because management now believes
that the information necessary to create such statements
is either unavailable or unreliable.
Purchaser Representation Form
FDA Letter
Shareholder Letter - March 11, 1991

29

FINANCIAL STATEMENTS
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U.S.A. MEDICAL CORPORATION
Financial Statements December 31, 1990 and 1989
(With Auditors' Report Thereon)

*

INDEPENDENT AUDITORS' REPORT
TANNER-Co.

675 East 500 South, Suite 640
Salt Lake City, Utah 84102
Telephone i801) 532-7444
Fax (801) 532-491 1
v - r ->OFES£ ^ N A i

C7R30'*AT'ON

To the Board of Directors and Stockholders
of U.S.A. Medical Corporation

We have audited the accompanying balance sheet of U.S.A. Medical Corporation as of
December 31, 1990 and 1989, and the related statements of operations, stockholders' (deficit), and
cash flows for the years then ended. These financial statements are the responsibility of the
Company's management. Our responsibility is to express an opinion on these financial statements
based on our audits.
We conducted our audits in accordance with generally accepted auditing standards. Those
standards require that we plan and perform the audit to obtain reasonable assurance about whether
the financial statements are free of material misstatement. An audit includes examining, on a test
basis, evidence supporting the amounts and disclosures in the financial statements. An audit also
includes assessing the accounting principles used and significant estimates made by management,
as well as evaluating the overall financial statement presentation. We believe that our audits
provide a reasonable basis for our opinion.
In our opinion, the financial statements referred to above present fairly, in all material
respects, the financial position of U.S.A. Medical Corporation as of December 31, 1990 and 1989,
and the results of its operations and its cash flows for the years then ended in conformity with
generally accepted accounting principles.
As described in note 4 to the financial statements, the Company is party to various legal
and regulatory actions. Those actions have resulted in a suspension of trading of the Company's
stock and allege that the Company is in violation of the securities laws. The ultimate outcome of
these uncertainties cannot presently be determined. Accordingly, the accompanying financial
statements do not include any adjustments, if any, that might result from the outcome of these
uncertainties.

The accompanying financial statements have been prepared assuming that the Company
will continue as a going concern. Because of significant operating losses and the excess of current
liabilities over current assets, the Company's ability to continue as a going concern is dependent
on attaining future profitable operations, restructuring its financing arrangements, and obtaining
additional outside financing and/or capital. It is not possible to predict the outcome of future
operations or whether the necessary alternative financing or additional capital may be arranged.
The financial statements do not include any adjustments that might result from the outcome of this
uncertainty.

Salt Lake City, Utah
January 23, 1991

U.S.A. MEDICAL CORPORATION
Balance Sheet
December 31, 1990 and 1989

Assets

1990

1989

$

12,272
12,272

7,370
4,334
590
17,914
5.151
35.359

Less accumulated depreciation
Property and equipment, net

13,266
10.225
23,491
9.600
13.891

13,266
10.225
23,491
6.854
16.637

Patent costs, net of accumulated amortization
of $347 and $101, respectively

5,455

5,802

Current assets:
Cash
Accounts receivable
Marketable securities
Inventories
Prepaid expenses
Total current assets
Property and equipment, at cost:
Machinery and equipment
Furniture and fixtures

Liabilities and Stockholders' (Deficit)

Current liabilities:
Notes payable
Accounts payable
Accrued liabilities
Advances from shareholders
Total current liabilities

Stockholders' (deficit):
Common stock, $.001 par value. 50,000,000
shares authorized; 26,352,500 shares and
25,352,500 shares issued and outstanding
at December 31, 1990 and 1989, respectively
Additional paid-in capital
Accumulated (deficit)
Total stockholders' (deficit)

1990

1989

35,583
55,467
51,438
95,805
238,293

44,873
46,444
39,659
98,805
229,781

26,353
138,108
(371.136)
(206.675)

25,353
138,108
(335.444)
(171.983)

$ 31.618

See accompanying notes to financial statements.
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U.S.A. MEDICAL CORPORATION
Statement of Operations
Years Ended December 31, 1990 and 1989

1990

Revenue

1989

$ 18,266

11,491

7,973

21,346

Cost of goods sold
Gross margin

10.293

Selling, general and administrative expenses

Net operating (loss)

(9.855)

57,685

36,762

(47.392)

(46.617)

Other income (expense)
Loss on marketable securities

(590)

Gain on forgiveness of debt

12.290

_

11.700

Net (loss)

$ (35,692)

(Loss) per share

$

Weighted average number of shares outstanding

(.001)

26,102.500

See accompanying notes to financial statements.

-2-

(46,617)

(.002)
25,313.596

U.S.A. MEDICAL CORPORATION
Statement of Stockholders' (Deficit)
Years Ended December 31, 1990 and 1989

Common Stock
Shares
Amount

Balance, January 1, 1989

Stock issued for cash on
December 21, 1989 at $.25
per share

Additional
Accumulated
Paid-in Capital
(Deficit)

25,312,500

$25,313

128,148

40,000

40

9,960

(46,617)

Net (loss)

Balance, December 31, 1989

Stock issued for services
at $.001 per share

25,352,500

25,353

1,000,000

1,000

138,108

(335,444)

(35,692)

Net (loss)

Balance, December 31, 1990,

(288,827)

26,352,500

See accompanying notes to financial statements.
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$26,353

138,108

(371,136)

U.S.A. MEDICAL CORPORATION
Statement of Cash Flows
Years Ended December 3 1 , 1990 and 1989

1990
Cash flows from operating activities:
Net (loss)
Adjustments to reconcile net (loss) to
net cash (used in) operating activities:
(Increase) decrease in:
Depreciation and amortization
Gain on forgiveness debt
Loss on marketable securities
Accounts receivable
Inventories
Prepaid expenses
Deposits
Increase (decrease) in:
Accounts payable
Accrued liabilities
Common stock issued for services
Net cash (used in) operating activities

$(35,692)

(46,617)

3,093
(12,290)
590
4,334
5,642
5,151

2,847

4,897
(1,303)
775

9,023
11,779
1,000
(7.370)

Cash flows from investing activities:
Purchase of property and equipment
Increase in patent costs
Net cash provided by (used in) investing
activities

-

7,497
3,041
(28.863)

(4,791)
(1.000)
(5,791)

Cash flows from financing activities:
Issuance of common stock
Net borrowings - short-term notes payable
Net cash provided by financing activities

-

Net increase (decrease) in cash
Cash, beginning of period
Cash, end of period

1989

£

-

10,000
31.809
41.809

(7,370)

7,155

7.370

215

-

7,370

Noncash investing and financing activities:
Marketable securities issued for debt

$

9,290

Interest paid

$

3,410

See accompanying notes to financial statements.

U.S.A. M E D I C A L C O R P O R A T I O N
Notes to Financial Statements
December 3 1 , 1990 and 1989

(1) Summary of Significant Accounting Policies
Organization
The Company was incorporated January 12, 1979 in the State of Wyoming under the
name SMI, Inc. On December 7, 1987, the Company acquired all of the outstanding stock of
U.S.A. Medical Corporation in a tax free exchange and changed its name to U.S.A. Medical
Corporation. The Company is engaged in the manufacture, research and development of and
sale of medical equipment.
Inventories
Inventories are comprised of completed products held for sale, parts and supplies and
are valued at the lower of cost, determined using the first-in, first-out (FIFO) basis, or market.
Depreciation
Depreciation is calculated using the straight-line method based on estimated useful lives
of 7 to 15 years.
Patent Costs
The Company incurred costs of $5,903 in applying for patent rights.
amortizes these costs over the life of the patent.

The Company

Income Taxes
There have been no earnings through December 31, 1990 and, accordingly, no provision
for income taxes is reflected in the accompanying financial statements. The Company at
December 31, 1990 has a net operating loss carryforward of approximately $370,000.
(Loss) Per Common Share
(Loss) per share of common stock is calculated based upon the weighted average number
of common shares outstanding.
Cash Flow Statement
For purposes of reporting cash flows, cash and cash equivalents include cash on hand,
amounts due from banks, and federal funds sold. Generally, federal funds are purchased and
sold for one-day periods.
Reclassifications
Certain of the 1989 amount have been reclassified to conform with the 1990 presentation.
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U.S.A. MEDICAL CORPORATION
Notes to Financial Statements - Continued

12) Inventories
Inventories at December 31, 1990 and 1989 consist of the following:
1990
Finished goods
Parts
Supplies

$

12,272

$12.272
(3)

1989
8,585
8,529
800
17,914

Notes Payable
Notes payable at December 31, 1990 and 1989 consists of the following:
1990
Note payable to an individual with interest
12.5% due in January 1990, unsecured. The
Company is in default on the note.
Note payable to two shareholders due March 1,
1989 with interest at prime + 3%, unsecured.
The Company is in default on these notes.
Note payable to individuals payable upon
demand without interest

(4)

1989

$25,000

25,000

10,583

10,583

1_
$35,583

9,290
44,873

Contingencies
Going Concern
As shown in the accompanying financial statements, the Company incurred a net loss
of $35,692 during the year ended December 31, 1990 and as of that date, the Company's
current liabilities exceeded its current assets by $226,021 and its total liabilities exceeded its
total assets by $206,675. These factors create an uncertainty about the Company's ability to
continue as a going concern.
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U.S.A. MEDICAL CORPORATION
Notes to Financial Statements - Continued

(4)

Contingencies
Litigation
The Company is a party in legal actions regarding the trading of Company stock.
Currently, trading of the stock in the state of Utah has been suspended. The outcome of these
actions is uncertain. Management is unable to determine an adjustment, if any, that the
Company may incur relating to these uncertainties. Therefore, no adjustment to the financial
statement has been made based on their possible outcome.
Insurance Coverage
The Company at December 31, 1990 does not have any insurance coverage.

(5) Related Party Transactions
The accounts receivable at December 31, 1989, include amounts due from the Company's
president and his wife in the amount of $2,417 for personal use of company credit cards.
The company purchases medical equipment from a company owned by an employee of the
company. The Company has purchases and accounts payable to the related company at December
31, 1990 and 1989 of approximately $2,700 and $2,900, respectively.
The Company has also received unsecured non-interest bearing advances from shareholders
totaling $95,805 and $98,805 at December 31, 1990 and 1989, respectively.

(6)

Concentration of Credit
The Company primarily has sales in the medical equipment industry to individuals and business
in the United States.
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U.S.A. MEDICAL CORPORATION
Financial Statements - December 31, 1988
(With Auditors' Report Thereon)
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INDEPENDENT AUDITORS' REPORT
TANNER-Co.

376 East 400 South Suite 2CC
Salt Lake Cty Utah 84 111-2990

To the Board of Directors and Stockholders
of U.S.A. Medical Corporation

Telephone son 532 7444
*»«,,.
< .-fw»Aiiyi

We have audited the accompanying balance sheet of U.S.A. Medical Corporation as of
December 31, 1988, and the related statements of operations, stockholders' equity (deficit), and
cash flows for the year then ended. These financial statements are the responsibility of the
Company's management. Our responsibility is to express an opinion on these financial statements
based on our audit.
We conducted our audit in accordance with generally accepted auditing standards. Those
standards require that we plan and perform the audit to obtain reasonable assurance about whether
the financial statements are free of material misstatement. An audit includes examining, on a test
basis, evidence supporting the amounts and disclosures in the financial statements. An audit also
includes assessing the accounting principles used and significant estimates made by management,
as well as evaluating the overall financial statement presentation. We believe that our audit
provides a reasonable basis for our opinion.
In our opinion, the financial statements referred to above present fairly, in all material
respects, the financial position of U.S.A. Medical Corporation as of December 31, 1988, and the
results of its operations and its cash flows for the year then ended in conformity with generally
accepted accounting principles.
As described in note 4 to the financial statements, the Company is party to various legal
and regulatory actions. Those actions have resulted in a temporary suspension of trading of the
Company's stock and allege that the Company is in violation of the securities laws. The ultimate
outcome of these uncertainties cannot presently be determined. Accordingly, the accompanying
financial statements do not include any adjustments, if any, that might result from the outcome of
these uncertainties.
The accompanying financial statements have been prepared assuming that the Company
will continue as a going concern. Because of significant operating losses and the excess of current
liabilities over current assets, the Company's ability to continue as a going concern is dependent
on attaining future profitable operations, to restructure its financing arrangements, and obtaining
additional outside financing and/or capital. It is not possible to predict the outcome of future

operations or whether the necessary alternative financing or additional capital may be arranged.
The financial statements do not include any adjustments that might result from the outcome of this
uncertainty.

v

Salt Lake City, Utah
April 4, 1989, except for note 2 which is
dated May 5, 1989

*2- TANNER-Co.
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U.S.A. MEDICAL C O R P O R A T I O N
Balance Sheet
December 3 1 , 1988

Assets
Current assets:
Cash
Accounts receivable (note 5)
Inventory (notes 1 and 2)
Prepaid expenses
Total current assets

$

215
9231
16,611
__5J51
31,208

Property and equipment, at cost (note 1):
Machinery and equipment
Furniture and fixtures

13,266
5,601
18,867
4,275
14,592

Less accumulated depreciation
Property and equipment, net
Deposits
Patent costs (note 1)

775
4,903

£ 51,478
Liabilities and Stockholders' Equity (Deficit)
Current liabilities:
Accounts payable (note 5)
Accrued liabilities
Notes payable to related parties (note 3)
Total current liabilities

$ 38,947
36,618
111,279
186,844

Contingencies (note 4)
Stockholders' equity (deficit) (notes 4, 6 and 7):
Common stock, $.001 par value. 50,000,000
shares authorized; 2,531,250 shares
issued and outstanding
Additional paid-in capital
Accumulated (deficit)
Total stockholders' equity (deficit)

2,531
150,930
(288,827)
(135,366)
$ 51,478

See accompanying notes to financial statements.
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U.S.A. MEDICAL CORPORATION
Statement of Operations
Year Ended December 31, 1988

Revenue - sales
Cost of goods sold
Gross margin

Other expenses:
General and administrative
Selling and distribution
Interest
Depreciation

Net (loss)

(Loss) per share

Weighted average number of shares outstanding

See accompanying notes to financial statements.
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U.S.A. MEDICAL CORPORATION
Statement of Stockholders' Equity (Deficit)
Year Ended December 3 1 , 1988

Common Stock
Shares
Amount
Balance, December 31, 1987 as
previously reported

2,531,250

$2,531

Additional Accumulated
Paid-in Capital
(Deficit)

150,930

(11,633)

Prior period adjustment (note 6)
(198,724)
Restated balance, December 31, 1987

2,531,250

2,531

150,930

(210,357)

Net (loss)
(78,470)
Balance, December 31, 1988

2,531,250

See accompanying notes to financial statements.
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150.930

(288,827)

U.S.A. MEDICAL CORPORATION
Statement of Cash Flows
Year Ended December 31, 1988

Cash flows from operating activities:
Net (loss)
Adjustments to reconcile net (loss) to net
cash (used in) operating activities:
Depreciation
Decrease in accounts receivable
Decrease m inventory
Decrease in prepaid expenses
Increase in deposits
Increase in accounts payable
Increase in accrued liabilities
Net cash (used in) operating activities

$(78,470)

11,162
4,235
15,394
344
(775)
4,909
25,752
(17,449)

Cash flows from investing activities

Cash flows from financing activities:
15,427
Net borrowings - short term notes payable
(2,022)
Net decrease in cash
2.237
Cash, beginning of year
$
Cash, end of year

See accompanying notes to financial statements.
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U.S.A. MEDICAL C O R P O R A T I O N
Notes to Financial Statements
December 3 1 , 1988

(1) Summary of Significant Accounting Policies
A.

Organization
The Company was incorporated January 12, 1979 in the State of Wyoming under
the name SMI, Inc. On December 7, 1987, the Company acquired all of the outstanding
stock of U.S.A. Medical Corporation in a tax free exchange and changed its name to
U.S.A. Medical Corporation. The Company is engaged in the manufacture, research
and development of and sale of medical equipment.

B.

Inventories
Inventories are comprised of completed products held for sale, parts and supplies
and are valued at the lower of cost or market on a first-in, first-out (FIFO) basis.

C.

Depreciation
Depreciation is calculated using the straight-line method based on estimated
useful lives of 7 to 15 years.

D.

Patent Costs
The Company has incurred $4,903 in applying for patent rights. The Company
will amortize these costs over the life of the patent once approval has been granted.

E.

Income Taxes
There have been no earnings through December 31, 1988 and, accordingly, no
provision for income taxes is reflected in the accompanying financial statements. The
Company at December 31,1988 has a net operating loss carryforward of approximately
$280,000.

F.

Income (Loss) Per Common Share
Income (loss) per share of common stock is calculated based upon the weighted
average number of common shares outstanding during the year ended December 31,
1988.

(2) Inventories
Inventories at December 31, 1988 consist of the following:
Finished goods
Parts

$10,509
5,722

Supplies

380
$16,611
-5-
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U.S.A. MEDICAL CORPORATION
Notes to Financial Statements - Continued

(3) Notes Payable
Notes payable at December 31, 1988 consist of the following:
Note payable to a stockholder payable on
demand without interest, unsecured
Note payable to two shareholders due March 1,
1989 with interest at prime + 3%, unsecured

$ 95,805

15,474
$111,279

(4)

Contingencies
A.

Going Concern
As shown in the accompanying financial statements, the Company incurred a net
loss of $78,470 during the year ended December 31, 1988, and as of that date, the
Company's current liabilities exceeded its current assets by $155,636 and its total
liabilities exceeded its total assets by $127,779. In addition, the Company has a short
term note payable to two stockholders in the amount of $15,474 which is past due.
Those factors create an uncertainty about the Company's ability to continue as a going
concern.

B.

Litigation
The Company is a party in legal actions regarding the trading of Company stock.
Currently, trading of the stock in the state of Utah has been suspended. The outcome
of these actions is uncertain. Management is unable to determine an adjustment, rf any,
that the Company may incur relating to these uncertainties. Therefore, no adjustment
to the financial statement has been made based on their possible outcome.

C.

Insurance Coverage
The Company at April 4, 1989 does not have any insurance coverage.

(5) Related Party Transactions
The accounts receivable include amounts due from the Company's president and his
wife in the amount of $2,417 for personal use of company credit cards.
The company purchases medical equipment from a company owned by a director of
the company. The Company has accounts payable to the related company at December 31,
1988 Of $2,448.
The Company has two notes payable to stockholders totaling $111,279 (see note 3).

"> TANNER-Co.

U.S.A. MEDICAL C O R P O R A T I O N
Notes to Financial Statements - Continued

(6) Prior Period Adjustment
During the year ended December 31, 1988, it was determined that costs which had in
prior years been capitalized as development costs were in fact normal operation expenses
and research and development expenses. These previously capitalized costs total $198,724.
The Company has charged the prior year's accumulated (deficit) for the $198,724 and
removed the capitalized development costs. This charge will increase the loss in the prior
year by $198,724 and increase the amount of loss per share by approximately $.078 per
share.
(7) Subsequent Events
On December 31, 1988, the Board of Directors authorized a 10 for 1 forward stock split.
This action is pending the authorization by three-fourths of the outstanding shares of company
stock.
Effective February 6, 1988, the Company acquired all of the outstanding stock of
Impulse Corporation in exchange for 5,000,000 shares of Company stock in a tax free
exchange. The following is summarized operating data for Impulse Corporation for the year
ended December 31, 1988.
Sales
Cost of sales
Gross margin
Other income
Total income
Operating expenses

$47,731
3,349
44,382
653
45,035
45.961

Net (loss)

$ (926)

The following pro forma schedule shows the effect had the transaction taken place
January 1, 1988:
USA
Impulse
Pro Forma
Medical
Corporation
Combined
Sales
Net (loss)
(Loss) per share

$ 26,555
$(70,883)
(.028)

47,731
(926)
(.00)

74,286
(71,809)
(.op

On May 5, 1989, the Company entered into a loan agreement to meet its immediate
operational needs whereby the Company will borrow $41,000 between May 5, 1989 and July
15, 1989 to be repaid with interest at 12% per annum on December 1, 1989. The agreement
also provides that the company pay a royalty of $200 for each Maxim Aspirator sold between
May 5, 1989 and December 1, 1989 to the lender of the funds.
-7-
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LIFE CONCEPTS, INC.
Secondary Trading Purchaser Representation
The Utah Securities Division requires ail brokers transacting
the sale of Life Concepts, Inc. (the Company), formerly U.S.A.
Medical Corporation, common stock within the state of Utah to have
this form completed by the purchaser. The original shall be kept
on file at the office of the broker/dealer.
The undersigned purchaser of the Company's common stock hereby
represents and affirms the following:
1.
I have purchased the securities with my own funds and not
as a nominee for someone else, unless otherwise disclosed herein.
2.
A prospectus dated March 9, 1991 has been delivered to
me prior to my purchase and I understand the risks associated with
purchasing these securities.
3.

Name
Address

Phone Number
Purchase Date

Broker Firm

Social Security Number
4.

Date

5.

signature

6.

The undersigned broker has reviewed the "Summary of
Prospectus" section (pages 1 and 2) of the Prospectus
with the Purchaser.
Broker

DEPARTMENT OF HEALTH & HUMAN SERVICES

AUG

Mr. Ted Hillstead
Official Correspondent
USA Medical Corporation
1569 W. 2650 S. Suite 7
Ogden, Utah 84401

- 4
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Re:

Public Health Service

Food and Drug Administration
8757 Georgia Avenue
Silver Spring MO 2 0 9 1 0

K862751
USA Aspirator
Dated: July 9, 1986
Received: July 22, 1986

Dear Mr, Hillstead:
We have reviewed your Section 510(k) notification of intenc to market the
above device and we have determined Che device to be substantially equivalent
to devices marketed In interstate commerce prior to May 28, 1976, the
anactment date of the Medical Device Amendments. You may, therefore, market
7*our device subject to the general controls provisions of the Federal Food,
Drug, and Cosmetic Act (Act) until such time as your device has been
(Classified under Section 513. At that time, if your device is classified into
either "class* II (Performance Standards) or class III (Premarket Approval), it
irould be subject to additional controls.
Dur substantially equivalent decision is based on the device not being
Intended for use in. suction lipectomy. Devices Intended for this use are
rurrently considered to be classified by statute in class III under the
provisions of Section 513(f) of the Act. Any direct or indirect promotion of
this device for suction lipectomy would first require that a premarket
ipproval application (PMA) be approved or the device reclassified.
General controls presently include regulations on annual registration, listing
if devices, good manufacturing practice> labeling, and the misbranding and
idulteration provisions of the Act. In the future, the scope of general
lontrols may be broadened to include additional regulations.
U.1 regulations and information on meetings of the device advisory committees,
their recommendations, and the final decisions of the Food and Drug
Administration (FDA) will be published in the FEDERAL REGISTER. We suggest
rou subscribe to this publication so that you can convey your views to FDA if
fou desire and be notified of any additional requirements imposed on your
ievice. Subscriptions may be obtained from the Superintendent of Documents,
J.S. Government Printing Office, Washington, D.C. 20402. Such information
ilso may be reviewed in the Dockets Management Branch (HFA-305), Food and Drug
Administration, Room 4-62, 5600 Fishers Lane, Rockville, Maryland 20857.

Page 2 - Mr. Ted Hilistead
This letter does not in any way denote official FDA approval of your device or
its labeling. Any representation that creates an impression of official
approval of this device because of compliance with the premarket notification
regulations is misleading and constitutes misbranding. If you desire advice
on the labeling for your device or other information on your responsibilities
under the Act, please contact the Office of Compliance, Division of Compliance
Operations (HJZ-320), 8757 Georgia Avenue, Silver Spring, Maryland 20910.

Sincerely yours,

Carl A. Larson, Ph.D.
Director
Division of Surgical
and Rehabilitation Devices
Office of Device Evaluation
Center for Devices
and Radiological Health

LIFE CONCEPTS, INC.
(Formerly U.S.A. Medical Corporation)
2020 South 1900 West
Ogden, Utah 84401

Annual Shareholder Meeting Report
March 11, 1991
bear Shareholder:
An annual meeting of the shareholders of Life Concepts, Inc.
(formerly U.S.A. Medical Corporation and S.M.I., Inc.) was held at
9:30 a.m. on March 9, 1991.
At the
following:

meeting

the

shareholders

voted

in

favor

of

the

1) Election of Luke Glenn and Ted Hillstead to the Board of
Directors;
2)
Changing the Company's
Corporation to Life Concepts, Inc.;

name

from

U.S.A.

Medical

3)
Creation of a wholly-own Utah subsidiary and merger of
that subsidiary for purposes of changing domicile; waiving the
thirty day waiting period;
4)
Ratified actions of the Board since the last annual
meeting, including amendments to the Bylaws and termination of a
director, and change of transfer agent to Atlas Stock and Transfer.
The Company also announced the signing of a preliminary
agreement to merge or acquire Heiner Bottling Company in exchange
for approximately 51% of the shares of the Company. Heiner bottles
and markets mineral water from Northern Utah springs. Prior to
consummation of that reorganization, Heiner is required to obtain
audited financial information and the Company is to have another
shareholder meeting to increase the number of shares authorized in
order to complete the reorganization.

Ted Hillstead
Secretary

HEINER BOTTLING COMPANY
805 E. Como Springs Road
P.O. Box 386
Morgan, Utah 84050
(801) 829-6779
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INTRODUCTION AND BRIEF HISTORY
HEINER BOTTLING COMPANY was formed to engage in the business
of bottling mineral water for distribution throughout the western
United States,
The springs that produce ANNIE HEINER PURE ROCKY MOUNTAIN
MINERAL SPRING WATER are of volcanic origin. In the early 1870's
Dr. Kohler of the Rush Medical College of Indiana came to the
Morgan Valley.
His attention was drawn to the Springs and he
analyzed the water and found it to contain wonderful properties.
As time passed, a Dr. T. S. Wadsworth and a Dr. C. F. Osgood made
their homes in Morgan, and when they heard about the springs
flowing freely under the rocks at COMO SPRINGS, they too analyzed
the water and reached the same conclusion that Dr. Kohler had.
The analysis done by Ford Chemical Laboratories confirmed that the
water is a top quality MINERAL SPRING WATER.
The natural mineral spring water flows from twenty-one springs
located at Como Springs in Morgan, Utah. To confirm the fact that
this is of the highest quality, we have included a comparison of
our water and Perrier which is the largest selling bottled mineral
water in the world. These tests clearly show our water to be one
of the best in the world.
Huish Chemical Company of Salt Lake has been distributing
laundry and dish wash detergent throughout the western United
States for over eight years. They have a network of over 160
brokers, and a fleet of trucks for distribution. Dan Huish has
been working with us on the bottling company, and his company will
assist us with the distribution and sales to the major grocery
chains. The relationships already established between Huish and
these chains will allow our distributors immediate access to the
marketplace. also, with Huish1s trucking network, we will be in
places like California at less cost than the California bottlers.
Initially, the company will produce two sizes and three
flavors of ALL NATURAL MINERAL SPRING WATER. We will have a ten
ounce and a one liter size, in glass containers. The all natural
flavors will be 1) Natural - no flavors added, 2) lemon-lime, 3)
Cherry. Our Market research indicates the mix of the two sizes to
approximately 60-40.

HEINER BOTTLING OCMPANY
OOMD SPRINGS, UTAH

KAY L. BOWEN & ASSOCIATES
CERTIFIED PUBLIC ACCOUNTANT

HEINER BOTTLING COMPANY
805 E. Como Springs Road
P.O. Box 386
Morgan, Utah 84050

(801) 829-6779
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TO THE BOARD OF DIRECTORS
AND STOCKHOLDERS
HEINER BOTTLING COMPANY
COMO SPRINGS, UTAH
THE ACCOMPANYING BALANCE SHEET OF HEINER BOTTLING COMPANY ( A
UTAH CORPORATION) AS OF DECEMBER 31, 1990, AND THE RELATED
STATEMENTS OF INCOME, RETAINED EARNINGS, AND CASH FLOWS FOR THE
THREE MONTHS THEN ENDED HAS BEEN PREPARED FROM THE BOOKS AND
RECORDS OF THE COMPANY.
TO THE BEST OF MY KNOWLEDGE, THE INFORMATION PRESENTED IN THESE
FINANCIAL STATEMENTS IS COMPLETE AND ACCURATE.
SINCERELY.
<G>
R. HEINER, PRESIDENT
RUARY 26, 1990

HEINER BOTTLING COMPANY
COMO SPRINGS , UTAH
UNAUDITED BALANCE SHEET
DECEMBER 31, 1990
ASSETS
Current Assets:
Cash
Accounts receivable
Subscriptions receivable
Inventory - raw materials
Inventory - finished goods

2,175
3,559
3,163
15,974
19,395

Total Current Assets

Property, Plant & Equipment:
Water rights - 500 acre feet
Leasehold improvements
Machinery and equipment
Furniture and fixtures
Total
Less accumulated depreciation

$44,266

1,250,000
179,398
374,556
13,924
1,817,878
10 , 825

Total Property, Plant & Equipment

Other Assets:
Pre-production costs
Less accumulated amortization
Total Other Assets
TOTAL ASSETS

$1,807,050

61,553
3,268
58,285
$1,909,601

HEINER BOTTLING COMPANY
COMO SPRINGS, UTAH
UNAUDITED BALANCE SHEET
DECEMBER 31, 1990
LIABILITIES AND STOCKHOLDERS EQUITY
Current Liabilities:
Accounts payable
Notes payable - current portion
Accrued taxes and
withholding payable
Advertising reserve
Accrued interest payable

2 ,057
24 , 5 8 3
465
964
300

Total Liabilities
Long-Term Liabilities:
Notes and mortgages payable
Notes payable - stockholders

28,369

133,591
188,186

Total Long-Term Liabilities
Stockholders Equity:
Common stock $1.00 par value,
5,000,000 shares authorized,
1,030,000 shares issued and
outstanding
Paid in capital
Retained earnings (deficit)

321,777

1,030,000
555,200
<25,745>

Total Stockholders Equity
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY

1,559,455
$1,909,601

HEINER BOTTLING COMPANY
COMO SPRINGSf UTAH
UNAUDITED STATEMENT OF INCOME AND RETAINED EARNINGS
FOR THE THREE MONTH PERIOD ENDED DECEMBER 31, 1990
Sales

$
Less cost of goods sold
Gross Income

817

Less Operating Expenses:
Interest expense
Rent expense
Depreciation expense
Amortization expense
Telephone and utilities
Office expense
Janitorial and cleaning expense
Vehicle expense
Supplies expense
Repairs and maintenance
Taxes and licenses

4,772
5,250
8,121
2,451
738
358
22
194
281
72
110

Total Operating Expenses

22,369

Net Income (Loss)
Add Interest Income
Net Income (Loss)

<21,552>
389
<21,163>

Retained Earnings - October 1, 1990

<4,582>

Retained Earnings - December 31, 1990
Earnings (Loss) Per Share

1,888
1,071

<25,745>
$<.02>

HEINER BOTTLING COMPANY
COMO SPRINGS, UTAH
UNAUDITED STATEMENT OF CASH FLOWS
FOR THE THREE MONTH PERIOD ENDED DECEMBER 31 f 1990
Cash Flows From Operating Activities:
Operations:
Net Income (Loss)
Add (Deduct) Items Not Affecting Cash:
Depreciation and amortization expense
(Increase) in accounts receivable
(Decrease) in inventories
(Increase) in accounts payable
(Decrease in accrued taxes and
withholding payable
Increase in advertising reserve
Increase in accrued interest payable

<21,163>

$

10,572
5,321
<6/097>
1,074
<21>
176
4_7

Total

11,072

Net Cash Provided (Used) From Operations
Cash Flows From Investing Activities:
Purchase of fixed assets and
preproduction costs
Cash Flows from Financing Activities:
Increase in notes and mortgages payable
Increase in notes payable - stockholders

<10,091>

<26,620>
12,654
14,750

Cash Provided From Financing Activities

27,404

Net Increase in Cash

<9,307>

Cash Balance - October 1, 1990

11,482

Cash Balance - December 31, 1990

2,175

HEINER BOTTLING COMPANY
COMO SPRINGS, UTAH
UNAUDITED NOTES TO THE FINANCIAL STATEMENT
DECEMBER 31, 1990
Note 1 - Summary of Significant Accounting Policies:
Heiner Bottling Company was incorporated under the laws of the
State of Utah on June 12, 1986. It was organized to engage in the
business of bottling mineral water, from the mineral water sprints
£t Como Springs in Morgan, Utah,
Revenue Recognition:
Sales are recorded when an order for the product has been
received, and the product has been shipped from the plant, by
common carrier or in the buyer's own trucks. Shipments made on the
Company's own trucks are not recorded as sales, until the product
is received by the purchasing Company.
Inventories:
Raw material inventories are recorded at cost, using the
First-in, First-out Method of inventory valuation. Finished goods
inventories are recorded using the Full Absorption Costing Method
for manufacturing costs.
Repair parts and supplies are expensed in the period they are
purchased.
Property, Plant & Equipment:
Property, plant and equipment are recorded at cost. The water
rights were transferred to the Company, at incorporation, for
capital stock.
They were valued at $2,500 per acre foot, as
appraised by the Lester S. Froerer, on August 9, 1989.
Depreciation is provided using the following estimated periods
of useful life, using a straight line method of depreciation.
Machinery and Equipment
Leasehold Improvements
Furniture and Fixtures

5 - 1 5 years
25 years
5 - 1 0 years

Expenditures, which materially extend the useful life of an
asset, are capitalized as incurred. Normal maintenance and minor
repairs are expensed.

Pre-production Costs:
Pre-production costs are the costs that were incurred in 19871990, before actual production began, that could not be assigned to
a specific function, equipment installation or leasehold equipment
expenditure.
These costs can reasonably be expected to be
recovered over the next five years, and thus, are being amortized
over sixty months.
Note 2 - Notes and Mortgages Payable:
The Company obtained long-term financing from First Security
Blink, with an SBA loan on April 25, 1990, The loan is at prime
plus 2% and matures on April 25, 1997. The loan calls for monthly
payments of principle and interest in the amount of $2,702.00 per
month. Collateral for the loan is the equipment and the inventory
of the Company.
The Company also has a note payable on a van in the amount of
$9,250 dated December 31, 1990. The note is payable in monthly
installments of $255.71 with interest at 12.9%.
Also on December 31, 1990, the Company borrowed $7,000.00 on
its line of credit at Valley Bank and Trust Co.
Note 3 - Lease on Plant:
The Company leases its facility, a 14,000 square foot
facility, and surrounding grounds for $1,750.00 per month. The
lease began on October 1, 1988 and extends for a period of five
years, with three (3) five-year extensions on the lease available
in the lease agreement.
Note 4 - Notes Payable - Stockholdings:
The amounts due Stockholders are advances, to the Company by
the Stockholders, which draw no interest and are payable to the
Stockholders from future earnings of the Company.
Also past due lease payments have been recorded as notes
payable to Como Springs Corporation.
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Exempted Securities— § 3(b)

H 2367]

Statement Required in all Offering Circulars

2635-3

Reg. § 230.259. There shall be set forth on the cover page of every offering
:ircular the following statement in capital letters printed in boldface roman type at
east as large as ten-point modern type and at least two points leaded,
T H E UNITED STATES SECURITIES AND EXCHANGE COMMISSION DOES
W T PASS UPON THE MERITS OF OR GIVE ITS APPROVAL TO ANY
SECURITIES OFFERED OR THE TERMS OF THE OFFERING, NOR DOES IT
?>ASS UPON THE ACCURACY OR COMPLETENESS OF ANY OFFERING
ZIRCULAR OR OTHER SELLING LITERATURE THESE SECURITIES ARE
3FFERED PURSUANT TO AN EXEMPTION FROM REGISTRATION WITH
rHE COMMISSION; HOWEVER, THE COMMISSION HAS NOT MADE AN
INDEPENDENT ^DETERMINATION THAT THE SECURITIES OFFERED
HEREUNDER ARE EXEMPT FROM REGISTRATION."
[Adopted in Release No. 33-3663, July 23, 1956, 21 F. R. 5739, amended in
Release No. 33-6340fl[83,015), effective September 17, 1981, 46 F R. 41766.]
H 2368]

Reports of Sales Hereunder

Reg. § 230.260. Within 30 days after the end of each six-month period following
he date of the original offering circular (offering statement—Part II) required by
} 230.256, or of the statement required by §230 257, the issuer or other person for
vhose account the securities are offered shall file with the Regional Office of the
Commission with which the offering statement was filed four copies of a report on Form
!-A containing the information called for by that form. A final report shall be made
lpon completion or termination of the offering and may be made prior to the end of the
ix-month period in which the last sale is made.
[Adopted in Release No. 33-3663, July 23, 1956, 21 F. R. 5739, amended in
Release No. 33-6340 (If 83,015), effective September 17, 1981,46 F. R 41766.]
11 2369]

Suspension of Exemption

Reg. §230.261. (a) The Commission may, at any time after the filing of an
iffering statement, enter an order temporarily suspending the exemption, if it has
eason to believe that— [Amended in Release No. 33-6340 (If 83,015), effective Sepember 17,1981,46 F. R. 41766.]
(1) no exemption is available under §§230.251 to 230.262 for the securities
mrported to be offered hereunder or any of the terms or conditions of § §230 251 to
130.262 have not been complied with, including failure to file any report as required by
(230.260;
(2) the offering statement or any other sales literature contains any untrue
tatement of ajnaterial fact or omits to state a material fact necessary in order to
nake the statements made, in the light of the circumstances under which they are
nade, not misleading; [Amended in Release No. 33-6340 (jf 83,015), effective September 17, 1981, 46 F. R. 41766.]
(3) the offering is being made or would be made in violation of Section 17 of the
kct;
(4) any event has occurred after the filing of the offering statement which would
lave rendered the exemption hereunder unavailable if it had occurred prior to such
iling; [Amended in Release No. 33-6340 (jf 83,015), effective September 17, 1981, 46
\ R. 41766.]
(5) any person specified in paragraph (c) of § 230.252 has been indicted for any
rime or offense of the character specified in subparagraph (3) thereof, or any
iroceeding has been initiated for the purpose of enjoining any such person from
'ederal Securities Law Reports

Reg. §230.261 112369

2635-4

Securities Act—Exemptions
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engaging in or continuing any conduct or practice of the character specified in
subparagraph (4) of such paragraph;
(6) any person specified in paragraph (d) of § 230 252 has been indicted for any
crime or offense of the character specified in subparagraph (1) thereof, or any
proceeding has been initiated for the purpose of enjoining any such person from
engaging in or continuing any conduct or practice of the character specified in
subparagraph (2) of such paragraph; or
(7) the issuer or any promoter, officer, director or underwriter has failed to
cooperate, or has obstructed or refused to permit the making of an investigation by the
Commission in connection with any offering made or proposed to be made hereunder.
(b) Upon the entry of an order under paragraph (a) of this section the Commission
will promptly give notice to the persons on whose behalf the offering statement was
filed (1) that such order has been entered, together with a brief statement of the
reasons for the entry of the order, and (2) that the Commission, upon receipt of a
written request within 30 days after the entry of such order, will, within 20 days after
the receipt of such request, set the matter down for hearing at a place to be designated
by the Commission. If no hearing is requested and none is ordered by the Commission,
the order shall become permanent on the thirtieth day after its entry and shall remain
in effect unless or until it is modified or vacated by the Commission. Where a hearing is
requested or is ordered by the Commission, the Commission will, after notice of an
opportunity for such hearing, either vacate the order or enter an order permanently
suspending the exemption. [Amended in Release No. 33-6340 (jf 83,015), effective
September 17, 1981, 46 F. R. 41766.]
(c) The Commission may, at any time after notice of and opportunity for hearing,
enter an order permanently suspending the exemption for any reason upon which it
could have entered a temporary suspension order under paragraph (a) of this rule. Any
such order shall remain in effect until vacated by the Commission.
(d) All notices required by this rule shall be given to the person or persons on
whose behalf the offering statement was filed by personal service, registered or certified
mail or confirmed telegraphic notice at the addresses of such persons given in the
offering statement. [Amended in Release No. 33-6340 (f 83,015), effective September
17,1981, 46 F.R. 41766.]
[Adopted in Release No. 33-3663, July 23, 1956, 21 F. R. 5739; amended by
Release No. 33-3935, July 11, 1958, 23 F. R. 4455; and Release No. 33-4744, effective
December 11, 1964, 29 F. R. 16982; amended in Release No. 33-6340 fll 83,015),
effective September 17, 1981, 46 F. R. 41766.]
[H 2370]
Consent to Service of Process
Reg. § 230.262. (a) If the issuer, any of its directors or officers, any person for
whose account any of the securities are to be offered, or any underwriter of the
securities to be offered, is not a resident of the United States, each such non-resident
person shall, at the time of filing the offering statement required by §230 255, furnish
to the Commission in a form prescribed by or acceptable to it, a written irrevocable
consent and power of attorney which—[Amended in Release No. 33-6340 (fl 83,015),
effective September 17, 1981,46 F. R. 41766.]
(1) designates the Securities and Exchange Commission as an agent upon whom
may be served any process, pleadings, or other papers in any civil suit or action
brought against the person executing the consent and power of attorney or to which he
has been joined as defendant or respondent, in any appropriate court in any place
subject to the jurisdiction of the United States, where the cause of action (i) accrues on
or after the effective date of this rule, and (ii) arises out of any offering made or
purported to be made under §§230.251 to 230.262 or any purchase or sale of any
security in connection therewith; and

H2370 Reg. §230.262
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